data_2lrp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 114.324 0.489 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.443 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.691 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.265 0 CA-C-O 121.163 0.313 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.533 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.45 HD13 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.57 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.455 HD12 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.674 -0.514 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.325 1.0 OUTLIER -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.715 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.237 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.507 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.433 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.405 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 CA-C-O 121.152 0.306 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.498 ' CZ3' ' CG ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.457 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE1' ' CB ' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.443 ' CB ' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CG ' ' HE1' ' A' ' 113' ' ' TRP . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 143' ' ' ASP . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 141' ' ' ASP . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.438 ' CD1' ' CD1' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 CA-C-O 121.504 0.502 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 111' ' ' SER . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.704 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.467 HD13 ' CD2' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 119.989 -0.339 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.522 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.522 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.713 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 N-CA-C 114.307 0.483 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.49 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 111' ' ' SER . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.407 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.49 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.418 HD13 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.975 -0.05 . . . . 0.0 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.478 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.61 ' H ' ' CA ' ' A' ' 114' ' ' LYS . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.442 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.61 ' CA ' ' H ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.428 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.443 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.465 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.739 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 121' ' ' SER . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 119' ' ' PRO . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.45 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.417 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 115.479 0.952 . . . . 0.0 115.479 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.516 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.522 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.522 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.449 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.61 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.61 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.433 ' HH ' ' CG2' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.452 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' CG2' ' HH ' ' A' ' 22' ' ' TYR . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 111' ' ' SER . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.41 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 143' ' ' ASP . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 141' ' ' ASP . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.513 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 N-CA-C 116.059 1.183 . . . . 0.0 116.059 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.493 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.458 ' H ' ' CB ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 19' ' ' TRP . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . 0.402 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.429 ' HH ' ' HB ' ' A' ' 118' ' ' ILE . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' HB ' ' HH ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.447 ' NE2' ' H ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.479 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' ' H ' ' A' ' 87' ' ' PHE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 122' ' ' SER . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.402 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.45 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.11 29.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m 51.28 32.73 8.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.65 -18.49 3.11 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.22 1.408 . . . . 0.0 114.12 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.54 160.32 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.243 1.417 . . . . 0.0 112.111 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.28 2.44 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.757 1.646 . . . . 0.0 114.324 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.443 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.49 34.88 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.66 164.63 16.48 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -115.1 90.18 3.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.403 1.881 . . . . 0.0 108.443 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 127.188 2.195 . . . . 0.0 112.6 -172.753 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.91 13.63 0.19 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 138.03 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.888 2.475 . . . . 0.0 112.768 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.99 119.01 32.78 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.317 1.047 . . . . 0.0 112.252 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.44 156.42 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.047 1.339 . . . . 0.0 112.414 -172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.59 36.61 1.39 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.411 1.482 . . . . 0.0 114.588 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.691 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.61 -167.24 8.41 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.57 169.46 18.22 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.238 -1.154 . . . . 0.0 113.889 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.5 tp -145.72 39.9 1.16 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.354 1.862 . . . . 0.0 110.04 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.399 2.68 . . . . 0.0 114.807 175.792 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.813 0.34 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.02 138.56 38.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.379 1.072 . . . . 0.0 113.167 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -113.19 154.64 26.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.823 1.249 . . . . 0.0 111.856 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.5 61.62 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.76 144.02 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.847 1.259 . . . . 0.0 111.255 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.67 95.59 0.09 OUTLIER Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.502 2.001 . . . . 0.0 113.74 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.436 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.533 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.45 HD13 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.55 -13.13 63.67 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.57 177.13 4.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 111.709 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.2 tp -139.01 37.01 2.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.235 . . . . 0.0 110.94 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.849 1.66 . . . . 0.0 112.021 -160.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 tmm? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.28 135.84 52.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.617 1.167 . . . . 0.0 113.649 -172.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -94.78 174.4 7.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.204 1.802 . . . . 0.0 114.645 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.22 172.49 8.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.458 1.503 . . . . 0.0 112.975 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.53 132.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.57 1.148 . . . . 0.0 111.458 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.26 9.45 36.13 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.423 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.57 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.455 HD12 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.41 -176.74 51.22 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.61 147.61 52.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 111.597 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp -125.27 123.23 39.05 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.07 0.948 . . . . 0.0 109.293 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.594 1.957 . . . . 0.0 111.192 -153.591 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 119.477 -0.296 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 156.6 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.204 1.001 . . . . 0.0 111.658 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.0 m -81.07 45.88 0.87 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.796 0.838 . . . . 0.0 112.567 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.16 162.56 22.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.979 2.512 . . . . 0.0 109.133 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t 67.82 -42.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 127.928 2.491 . . . . 0.0 115.865 169.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.06 57.19 8.9 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.765 1.65 . . . . 0.0 114.236 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.325 1.0 OUTLIER -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.715 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.715 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.36 -74.55 0.59 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -82.74 154.37 24.82 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 113.565 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.52 124.51 20.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.033 2.133 . . . . 0.0 108.876 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.569 1.548 . . . . 0.0 112.311 -176.613 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.16 129.07 12.53 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.725 0.81 . . . . 0.0 111.62 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 p -158.09 150.31 22.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.99 1.716 . . . . 0.0 111.173 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.13 -28.92 12.42 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.121 1.368 . . . . 0.0 112.563 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.32 129.49 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.407 1.483 . . . . 0.0 109.99 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.76 -55.38 0.73 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.539 1.543 . . . . 0.0 115.89 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.507 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.507 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.91 -20.4 11.52 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -103.38 163.67 12.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.566 1.546 . . . . 0.0 112.321 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.5 tp -140.11 69.23 1.35 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.831 1.252 . . . . 0.0 110.632 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 C--O 1.253 1.237 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -177.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 140.41 51.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.698 0.799 . . . . 0.0 111.948 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.1 m -75.27 -17.0 60.4 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.646 0.778 . . . . 0.0 112.212 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 146.2 31.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.003 1.321 . . . . 0.0 113.517 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 m -139.4 164.45 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 128.215 2.606 . . . . 0.0 110.194 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.5 82.56 0.88 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.314 0.959 . . . . 0.0 112.432 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.433 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.405 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.07 -7.57 37.89 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.19 144.34 40.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.36 1.08 . . . . 0.0 110.955 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.6 20.53 14.9 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.278 1.513 . . . . 0.0 113.544 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.044 2.538 . . . . 0.0 110.79 -161.794 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tmm? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.83 153.3 35.98 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 112.843 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -79.04 156.61 28.3 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.013 0.925 . . . . 0.0 112.667 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 125.15 17.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 0.0 110.261 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 53.14 20.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.885 1.674 . . . . 0.0 114.438 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -59.33 2.68 Favored Glycine 0 N--CA 1.472 1.092 0 O-C-N 120.421 -1.425 . . . . 0.0 112.676 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.498 ' CZ3' ' CG ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.29 -128.51 3.37 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.24 156.14 39.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.02 1.328 . . . . 0.0 112.877 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp -124.57 130.97 53.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.247 1.419 . . . . 0.0 110.729 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.423 2.289 . . . . 0.0 112.701 -173.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.64 -10.1 0.62 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.605 1.562 . . . . 0.0 114.944 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 t -90.78 139.62 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.149 1.34 . . . . 0.0 112.809 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.47 -7.25 21.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.85 1.26 . . . . 0.0 113.702 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.08 -47.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 127.211 2.204 . . . . 0.0 113.758 -161.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.65 133.87 3.07 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.809 2.623 . . . . 0.0 110.977 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.457 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CE1' ' CB ' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.443 ' CB ' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CG ' ' HE1' ' A' ' 113' ' ' TRP . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 143' ' ' ASP . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 141' ' ' ASP . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.438 ' CD1' ' CD1' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.4 -129.15 0.18 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.06 160.85 28.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.62 1.168 . . . . 0.0 112.632 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -147.07 33.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.501 1.12 . . . . 0.0 111.676 -169.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.197 2.599 . . . . 0.0 114.744 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.503 0.192 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.07 165.42 11.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.726 1.611 . . . . 0.0 113.129 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -83.44 -174.24 5.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.452 1.901 . . . . 0.0 112.54 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.03 13.88 3.72 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.864 1.666 . . . . 0.0 115.185 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.96 163.12 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.923 1.289 . . . . 0.0 112.373 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.35 98.74 0.4 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 126.198 1.856 . . . . 0.0 112.138 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.704 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 111' ' ' SER . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.704 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.467 HD13 ' CD2' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.33 -15.14 20.33 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 153.88 28.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.63 1.172 . . . . 0.0 112.959 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 tp -151.88 42.48 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.171 0.986 . . . . 0.0 112.397 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.586 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' H2 ' ' C ' ' A' ' 172' ' ' GLU . 4.4 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.52 154.06 29.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 112.218 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 m -157.43 1.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.383 1.473 . . . . 0.0 114.256 170.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.61 -35.55 0.26 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.54 150.88 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.184 1.794 . . . . 0.0 110.6 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.21 15.1 67.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.847 0.737 . . . . 0.0 113.804 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.522 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.522 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.713 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.24 -6.97 0.72 Allowed Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.71 160.46 17.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.237 1.519 . . . . 0.0 114.089 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -86.83 40.75 0.92 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.36 1.864 . . . . 0.0 112.346 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.416 ' C ' ' H2 ' ' A' ' 1' ' ' MET . 42.8 mm-40 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.713 1.605 . . . . 0.0 111.718 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.02 124.86 16.05 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -93.03 161.33 14.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.837 2.055 . . . . 0.0 110.995 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.3 172.16 16.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.2 -36.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.779 1.631 . . . . 0.0 111.108 162.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.28 43.77 0.36 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.377 1.465 . . . . 0.0 114.307 -174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 111' ' ' SER . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.407 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.49 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.418 HD13 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.8 -12.01 64.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -98.11 151.21 20.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.021 1.328 . . . . 0.0 113.67 -174.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.65 32.78 2.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.697 1.599 . . . . 0.0 113.076 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.908 1.683 . . . . 0.0 113.247 -175.833 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 150.38 39.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 59.18 -3.12 0.09 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.062 2.145 . . . . 0.0 116.335 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.79 160.25 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.315 1.446 . . . . 0.0 112.091 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.32 156.65 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.223 1.409 . . . . 0.0 112.198 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.25 91.48 0.54 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.079 1.323 . . . . 0.0 112.975 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.478 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.92 -160.95 29.76 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.53 163.1 11.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.382 1.073 . . . . 0.0 112.996 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.3 tp -140.55 85.3 1.99 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.676 1.19 . . . . 0.0 108.95 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.676 1.59 . . . . 0.0 115.177 -152.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 134.09 55.39 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.027 -1.046 . . . . 0.0 113.778 -175.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -153.71 121.24 5.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.584 1.954 . . . . 0.0 110.387 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.64 -170.82 3.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 112.116 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -75.23 138.08 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.42 -0.8 . . . . 0.0 110.326 161.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.01 3.51 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.513 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.61 ' H ' ' CA ' ' A' ' 114' ' ' LYS . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.442 ' CD ' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.466 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.61 ' CA ' ' H ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.428 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.451 HD12 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.95 -144.77 5.17 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.47 152.43 51.79 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.222 1.409 . . . . 0.0 112.49 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 27.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -169.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.091 1.756 . . . . 0.0 112.544 174.799 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tmm? . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.59 38.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.394 1.078 . . . . 0.0 113.833 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -93.12 -26.12 17.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.081 1.352 . . . . 0.0 114.104 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.21 -173.29 2.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.203 1.801 . . . . 0.0 110.109 162.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 60.93 8.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.94 36.5 1.68 Allowed Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.906 1.717 . . . . 0.0 113.99 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.443 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.465 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.739 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.739 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 121' ' ' SER . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 119' ' ' PRO . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.04 165.01 23.73 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 157.68 27.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 114.716 -170.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.26 93.49 2.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.112 1.365 . . . . 0.0 109.933 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.76 1.624 . . . . 0.0 111.505 -165.047 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.44 167.33 20.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.465 0.706 . . . . 0.0 111.843 170.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -114.32 124.94 53.24 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.232 -0.918 . . . . 0.0 109.15 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.49 158.15 44.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.139 0.975 . . . . 0.0 112.898 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.33 157.34 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.812 1.645 . . . . 0.0 111.229 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.89 78.72 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 80' ' ' GLY . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 79' ' ' ASP . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.45 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.45 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.417 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.86 172.97 52.19 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.38 171.85 2.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.806 1.642 . . . . 0.0 114.055 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.512 ' CD1' ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -79.43 36.15 0.3 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.708 2.403 . . . . 0.0 113.534 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.793 2.037 . . . . 0.0 112.507 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 159.79 33.62 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.834 0.854 . . . . 0.0 112.258 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t -61.04 135.12 57.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 112.877 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.92 58.33 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.83 153.92 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.31 1.444 . . . . 0.0 111.901 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.8 -21.42 3.2 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.848 1.213 . . . . 0.0 115.479 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.516 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.522 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.522 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.449 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -99.99 -0.9 56.1 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.12 167.92 9.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 113.5 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.3 pp -140.06 30.46 2.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.309 1.844 . . . . 0.0 113.613 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.877 2.471 . . . . 0.0 112.433 -174.087 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.58 34.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.667 1.587 . . . . 0.0 110.849 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -131.09 9.6 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.598 1.159 . . . . 0.0 113.98 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.09 -178.62 5.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.539 1.936 . . . . 0.0 112.088 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t 63.86 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 127.326 2.25 . . . . 0.0 115.034 168.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.29 -51.74 30.86 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.316 0.96 . . . . 0.0 111.59 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.61 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.61 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.433 ' HH ' ' CG2' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.452 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' CG2' ' HH ' ' A' ' 22' ' ' TYR . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 111' ' ' SER . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 110' ' ' ASP . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.41 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 143' ' ' ASP . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 141' ' ' ASP . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.513 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.15 -7.17 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.45 24.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.098 1.449 . . . . 0.0 112.482 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 38.0 tp -103.19 55.21 0.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.182 1.793 . . . . 0.0 109.607 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 C--O 1.251 1.137 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -150.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.43 170.04 15.11 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -170.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 m -72.69 164.43 26.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.233 1.413 . . . . 0.0 113.047 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.46 -32.43 10.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 113.296 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.4 123.68 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.274 1.03 . . . . 0.0 111.994 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.72 -5.71 61.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.736 1.636 . . . . 0.0 116.059 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.493 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' H ' ' CB ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 11' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 19' ' ' TRP . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . 0.402 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.429 ' HH ' ' HB ' ' A' ' 118' ' ' ILE . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' HB ' ' HH ' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.447 ' NE2' ' H ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.75 -43.7 14.12 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.83 32.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.226 2.21 . . . . 0.0 110.546 172.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.25 68.04 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.868 2.067 . . . . 0.0 109.269 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.366 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -147.19 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.621 0.248 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 155.45 18.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.257 1.023 . . . . 0.0 113.742 -167.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -65.93 124.26 22.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.312 1.045 . . . . 0.0 110.937 171.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.41 38.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.926 0.33 . . . . 0.0 111.331 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.32 169.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.435 1.494 . . . . 0.0 112.072 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.98 75.94 1.07 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.683 0.658 . . . . 0.0 111.968 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.479 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.479 ' HB2' ' H ' ' A' ' 87' ' ' PHE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 122' ' ' SER . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.402 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.45 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.22 -174.77 37.55 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.0 160.34 38.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.152 0.981 . . . . 0.0 112.035 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -142.06 83.15 1.83 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.984 1.713 . . . . 0.0 114.013 -172.219 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 114.324 0.489 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 107' ' ' ILE . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.639 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.539 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.265 0 CA-C-O 121.163 0.313 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 149' ' ' HIS . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 101' ' ' GLU . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 91' ' ' GLU . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.583 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.583 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' TRP . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.674 -0.514 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.465 ' OD1' ' CZ2' ' A' ' 19' ' ' TRP 0.325 11.4 p30 -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.6 ' CE2' HD13 ' A' ' 118' ' ' ILE . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.603 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.6 HD13 ' CE2' ' A' ' 105' ' ' TYR . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.476 HG23 ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.237 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 57' ' ' VAL . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG23 ' CE1' ' A' ' 22' ' ' TYR . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.592 ' H ' ' HB3' ' A' ' 135' ' ' ASP . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.529 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.592 ' HB3' ' H ' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' HE1' HG22 ' A' ' 57' ' ' VAL . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.49 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 149' ' ' HIS . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB3' HG22 ' A' ' 107' ' ' ILE . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 105' ' ' TYR . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.533 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 CA-C-O 121.152 0.306 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' H ' ' HE3' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.589 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.469 HG22 HD13 ' A' ' 118' ' ' ILE . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 116' ' ' ILE . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 49' ' ' THR . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 118' ' ' ILE . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.635 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 105' ' ' TYR . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.516 HD11 ' CG ' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 CA-C-O 121.504 0.502 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 149' ' ' HIS . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 107' ' ' ILE . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 87' ' ' PHE . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.585 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 57' ' ' VAL . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 119.989 -0.339 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.543 HG23 ' H ' ' A' ' 52' ' ' GLY . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 49' ' ' THR . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.547 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.614 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.547 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB2' ' H ' ' A' ' 65' ' ' TRP . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 N-CA-C 114.307 0.483 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 149' ' ' HIS . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.569 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.498 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.571 ' CE1' HG13 ' A' ' 57' ' ' VAL . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.975 -0.05 . . . . 0.0 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 49' ' ' THR . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 114' ' ' LYS . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' HG23 ' A' ' 57' ' ' VAL . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 52' ' ' GLY . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 49' ' ' THR . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 149' ' ' HIS . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 114' ' ' LYS 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' H ' ' N ' ' A' ' 115' ' ' THR . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.489 ' CE1' HG13 ' A' ' 57' ' ' VAL . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 149' ' ' HIS . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 135' ' ' ASP . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 123' ' ' PHE 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 122' ' ' SER . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' SER . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 140' ' ' LEU . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' CE1' HG13 ' A' ' 57' ' ' VAL . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 49' ' ' THR . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 118' ' ' ILE . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.454 ' CE ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 98' ' ' GLY . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' HG22 ' A' ' 97' ' ' VAL . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.849 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.849 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.4 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 71' ' ' ILE . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.454 HG13 ' CE ' ' A' ' 76' ' ' LYS . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 115.479 0.952 . . . . 0.0 115.479 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.461 HG13 ' CE1' ' A' ' 149' ' ' HIS . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 118' ' ' ILE . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 118' ' ' ILE . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 118' ' ' ILE . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CE1' HG13 ' A' ' 57' ' ' VAL . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.657 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 19' ' ' TRP . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.451 ' H ' HD23 ' A' ' 17' ' ' LEU . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 53' ' ' TYR . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 24' ' ' GLY . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.406 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.55 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 N-CA-C 116.059 1.183 . . . . 0.0 116.059 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.601 ' H ' ' HB3' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.601 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 52' ' ' GLY . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 49' ' ' THR . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.446 HD12 ' CZ3' ' A' ' 65' ' ' TRP . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.475 ' CE1' HG13 ' A' ' 57' ' ' VAL . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.686 ' HA ' ' H ' ' A' ' 120' ' ' PHE . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.857 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.802 ' CD2' HD12 ' A' ' 107' ' ' ILE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.802 HD12 ' CD2' ' A' ' 105' ' ' TYR . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.857 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.602 HG22 ' HD2' ' A' ' 119' ' ' PRO . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 118' ' ' ILE . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.686 ' H ' ' HA ' ' A' ' 70' ' ' LYS . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.481 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 57' ' ' VAL . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.51 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.11 29.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m 51.28 32.73 8.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.65 -18.49 3.11 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.22 1.408 . . . . 0.0 114.12 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.54 160.32 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.243 1.417 . . . . 0.0 112.111 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.28 2.44 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.757 1.646 . . . . 0.0 114.324 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.49 34.88 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.66 164.63 16.48 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -115.1 90.18 3.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.403 1.881 . . . . 0.0 108.443 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 127.188 2.195 . . . . 0.0 112.6 -172.753 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.91 13.63 0.19 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 138.03 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.888 2.475 . . . . 0.0 112.768 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.99 119.01 32.78 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.317 1.047 . . . . 0.0 112.252 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.44 156.42 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.047 1.339 . . . . 0.0 112.414 -172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.59 36.61 1.39 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.411 1.482 . . . . 0.0 114.588 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 107' ' ' ILE . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.639 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.539 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.61 -167.24 8.41 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.57 169.46 18.22 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.238 -1.154 . . . . 0.0 113.889 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.5 tp -145.72 39.9 1.16 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.354 1.862 . . . . 0.0 110.04 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.399 2.68 . . . . 0.0 114.807 175.792 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.813 0.34 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.02 138.56 38.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.379 1.072 . . . . 0.0 113.167 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -113.19 154.64 26.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.823 1.249 . . . . 0.0 111.856 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.5 61.62 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.76 144.02 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.847 1.259 . . . . 0.0 111.255 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.67 95.59 0.09 OUTLIER Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.502 2.001 . . . . 0.0 113.74 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 149' ' ' HIS . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 101' ' ' GLU . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 91' ' ' GLU . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.55 -13.13 63.67 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.57 177.13 4.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 111.709 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.2 tp -139.01 37.01 2.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.235 . . . . 0.0 110.94 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.849 1.66 . . . . 0.0 112.021 -160.253 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 tmm? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.28 135.84 52.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.617 1.167 . . . . 0.0 113.649 -172.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -94.78 174.4 7.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.204 1.802 . . . . 0.0 114.645 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.22 172.49 8.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.458 1.503 . . . . 0.0 112.975 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.53 132.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.57 1.148 . . . . 0.0 111.458 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.26 9.45 36.13 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.583 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.583 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' TRP . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.41 -176.74 51.22 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.61 147.61 52.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 111.597 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp -125.27 123.23 39.05 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.07 0.948 . . . . 0.0 109.293 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.594 1.957 . . . . 0.0 111.192 -153.591 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 119.477 -0.296 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 156.6 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.204 1.001 . . . . 0.0 111.658 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.0 m -81.07 45.88 0.87 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.796 0.838 . . . . 0.0 112.567 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.16 162.56 22.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.979 2.512 . . . . 0.0 109.133 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t 67.82 -42.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 127.928 2.491 . . . . 0.0 115.865 169.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.06 57.19 8.9 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.765 1.65 . . . . 0.0 114.236 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' OD1' ' CZ2' ' A' ' 19' ' ' TRP 0.325 11.4 p30 -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.6 ' CE2' HD13 ' A' ' 118' ' ' ILE . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.603 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.6 HD13 ' CE2' ' A' ' 105' ' ' TYR . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.476 HG23 ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.36 -74.55 0.59 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -82.74 154.37 24.82 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 113.565 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.52 124.51 20.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.033 2.133 . . . . 0.0 108.876 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.569 1.548 . . . . 0.0 112.311 -176.613 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.16 129.07 12.53 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.725 0.81 . . . . 0.0 111.62 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 p -158.09 150.31 22.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.99 1.716 . . . . 0.0 111.173 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.13 -28.92 12.42 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.121 1.368 . . . . 0.0 112.563 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.32 129.49 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.407 1.483 . . . . 0.0 109.99 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.76 -55.38 0.73 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.539 1.543 . . . . 0.0 115.89 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 57' ' ' VAL . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG23 ' CE1' ' A' ' 22' ' ' TYR . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.592 ' H ' ' HB3' ' A' ' 135' ' ' ASP . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.529 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.592 ' HB3' ' H ' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' HE1' HG22 ' A' ' 57' ' ' VAL . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.91 -20.4 11.52 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -103.38 163.67 12.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.566 1.546 . . . . 0.0 112.321 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.5 tp -140.11 69.23 1.35 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.831 1.252 . . . . 0.0 110.632 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 C--O 1.253 1.237 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -177.303 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 140.41 51.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.698 0.799 . . . . 0.0 111.948 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.1 m -75.27 -17.0 60.4 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.646 0.778 . . . . 0.0 112.212 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 146.2 31.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.003 1.321 . . . . 0.0 113.517 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 m -139.4 164.45 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 128.215 2.606 . . . . 0.0 110.194 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.5 82.56 0.88 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.314 0.959 . . . . 0.0 112.432 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.49 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 149' ' ' HIS . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB3' HG22 ' A' ' 107' ' ' ILE . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 105' ' ' TYR . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.533 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.07 -7.57 37.89 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.19 144.34 40.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.36 1.08 . . . . 0.0 110.955 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.6 20.53 14.9 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.278 1.513 . . . . 0.0 113.544 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.044 2.538 . . . . 0.0 110.79 -161.794 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tmm? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.83 153.3 35.98 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 112.843 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -79.04 156.61 28.3 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.013 0.925 . . . . 0.0 112.667 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 125.15 17.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 0.0 110.261 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 53.14 20.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.885 1.674 . . . . 0.0 114.438 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -59.33 2.68 Favored Glycine 0 N--CA 1.472 1.092 0 O-C-N 120.421 -1.425 . . . . 0.0 112.676 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' H ' ' HE3' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.589 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.469 HG22 HD13 ' A' ' 118' ' ' ILE . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 116' ' ' ILE . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.29 -128.51 3.37 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.24 156.14 39.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.02 1.328 . . . . 0.0 112.877 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp -124.57 130.97 53.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.247 1.419 . . . . 0.0 110.729 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.423 2.289 . . . . 0.0 112.701 -173.848 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.64 -10.1 0.62 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.605 1.562 . . . . 0.0 114.944 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 t -90.78 139.62 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.149 1.34 . . . . 0.0 112.809 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.47 -7.25 21.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.85 1.26 . . . . 0.0 113.702 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.08 -47.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 127.211 2.204 . . . . 0.0 113.758 -161.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.65 133.87 3.07 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.809 2.623 . . . . 0.0 110.977 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 49' ' ' THR . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 118' ' ' ILE . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.635 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 105' ' ' TYR . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.516 HD11 ' CG ' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.4 -129.15 0.18 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.06 160.85 28.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.62 1.168 . . . . 0.0 112.632 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -147.07 33.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.501 1.12 . . . . 0.0 111.676 -169.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.197 2.599 . . . . 0.0 114.744 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.503 0.192 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.07 165.42 11.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.726 1.611 . . . . 0.0 113.129 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -83.44 -174.24 5.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.452 1.901 . . . . 0.0 112.54 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.03 13.88 3.72 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.864 1.666 . . . . 0.0 115.185 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.96 163.12 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.923 1.289 . . . . 0.0 112.373 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.35 98.74 0.4 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 126.198 1.856 . . . . 0.0 112.138 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 149' ' ' HIS . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 107' ' ' ILE . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 87' ' ' PHE . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.585 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 57' ' ' VAL . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.33 -15.14 20.33 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 153.88 28.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.63 1.172 . . . . 0.0 112.959 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 tp -151.88 42.48 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.171 0.986 . . . . 0.0 112.397 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.586 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.52 154.06 29.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 112.218 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 m -157.43 1.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.383 1.473 . . . . 0.0 114.256 170.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.61 -35.55 0.26 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.54 150.88 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.184 1.794 . . . . 0.0 110.6 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.21 15.1 67.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.847 0.737 . . . . 0.0 113.804 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.543 HG23 ' H ' ' A' ' 52' ' ' GLY . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 49' ' ' THR . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.547 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.614 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.547 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB2' ' H ' ' A' ' 65' ' ' TRP . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.24 -6.97 0.72 Allowed Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.71 160.46 17.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.237 1.519 . . . . 0.0 114.089 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -86.83 40.75 0.92 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.36 1.864 . . . . 0.0 112.346 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.713 1.605 . . . . 0.0 111.718 177.082 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.02 124.86 16.05 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -93.03 161.33 14.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.837 2.055 . . . . 0.0 110.995 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.3 172.16 16.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.2 -36.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.779 1.631 . . . . 0.0 111.108 162.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.28 43.77 0.36 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.377 1.465 . . . . 0.0 114.307 -174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 149' ' ' HIS . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.569 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.498 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.571 ' CE1' HG13 ' A' ' 57' ' ' VAL . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.8 -12.01 64.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -98.11 151.21 20.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.021 1.328 . . . . 0.0 113.67 -174.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.65 32.78 2.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.697 1.599 . . . . 0.0 113.076 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.908 1.683 . . . . 0.0 113.247 -175.833 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 150.38 39.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 59.18 -3.12 0.09 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.062 2.145 . . . . 0.0 116.335 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.79 160.25 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.315 1.446 . . . . 0.0 112.091 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.32 156.65 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.223 1.409 . . . . 0.0 112.198 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.25 91.48 0.54 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.079 1.323 . . . . 0.0 112.975 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 49' ' ' THR . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 114' ' ' LYS . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.92 -160.95 29.76 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.53 163.1 11.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.382 1.073 . . . . 0.0 112.996 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.3 tp -140.55 85.3 1.99 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.676 1.19 . . . . 0.0 108.95 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.676 1.59 . . . . 0.0 115.177 -152.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 134.09 55.39 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.027 -1.046 . . . . 0.0 113.778 -175.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -153.71 121.24 5.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.584 1.954 . . . . 0.0 110.387 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.64 -170.82 3.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 112.116 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -75.23 138.08 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.42 -0.8 . . . . 0.0 110.326 161.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.01 3.51 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' HG23 ' A' ' 57' ' ' VAL . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 52' ' ' GLY . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 49' ' ' THR . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 149' ' ' HIS . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 114' ' ' LYS 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' H ' ' N ' ' A' ' 115' ' ' THR . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.489 ' CE1' HG13 ' A' ' 57' ' ' VAL . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.95 -144.77 5.17 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.47 152.43 51.79 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.222 1.409 . . . . 0.0 112.49 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 27.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -169.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.091 1.756 . . . . 0.0 112.544 174.799 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tmm? . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.59 38.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.394 1.078 . . . . 0.0 113.833 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -93.12 -26.12 17.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.081 1.352 . . . . 0.0 114.104 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.21 -173.29 2.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.203 1.801 . . . . 0.0 110.109 162.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 60.93 8.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.94 36.5 1.68 Allowed Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.906 1.717 . . . . 0.0 113.99 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 149' ' ' HIS . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 135' ' ' ASP . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 123' ' ' PHE 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 122' ' ' SER . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' SER . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 140' ' ' LEU . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' CE1' HG13 ' A' ' 57' ' ' VAL . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.04 165.01 23.73 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 157.68 27.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 114.716 -170.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.26 93.49 2.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.112 1.365 . . . . 0.0 109.933 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.76 1.624 . . . . 0.0 111.505 -165.047 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.44 167.33 20.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.465 0.706 . . . . 0.0 111.843 170.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -114.32 124.94 53.24 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.232 -0.918 . . . . 0.0 109.15 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.49 158.15 44.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.139 0.975 . . . . 0.0 112.898 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.33 157.34 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.812 1.645 . . . . 0.0 111.229 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.89 78.72 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 49' ' ' THR . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 118' ' ' ILE . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.454 ' CE ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 98' ' ' GLY . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' HG22 ' A' ' 97' ' ' VAL . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.849 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.849 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.4 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 71' ' ' ILE . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.454 HG13 ' CE ' ' A' ' 76' ' ' LYS . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.86 172.97 52.19 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.38 171.85 2.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.806 1.642 . . . . 0.0 114.055 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.815 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -79.43 36.15 0.3 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.708 2.403 . . . . 0.0 113.534 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.793 2.037 . . . . 0.0 112.507 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 159.79 33.62 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.834 0.854 . . . . 0.0 112.258 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t -61.04 135.12 57.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 112.877 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.92 58.33 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.83 153.92 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.31 1.444 . . . . 0.0 111.901 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.8 -21.42 3.2 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.848 1.213 . . . . 0.0 115.479 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.461 HG13 ' CE1' ' A' ' 149' ' ' HIS . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 118' ' ' ILE . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 118' ' ' ILE . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 118' ' ' ILE . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CE1' HG13 ' A' ' 57' ' ' VAL . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -99.99 -0.9 56.1 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.12 167.92 9.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 113.5 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.3 pp -140.06 30.46 2.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.309 1.844 . . . . 0.0 113.613 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.877 2.471 . . . . 0.0 112.433 -174.087 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.58 34.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.667 1.587 . . . . 0.0 110.849 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -131.09 9.6 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.598 1.159 . . . . 0.0 113.98 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.09 -178.62 5.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.539 1.936 . . . . 0.0 112.088 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t 63.86 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 127.326 2.25 . . . . 0.0 115.034 168.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.29 -51.74 30.86 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.316 0.96 . . . . 0.0 111.59 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.657 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 19' ' ' TRP . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.451 ' H ' HD23 ' A' ' 17' ' ' LEU . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 53' ' ' TYR . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 24' ' ' GLY . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.406 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.55 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.15 -7.17 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.45 24.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.098 1.449 . . . . 0.0 112.482 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 38.0 tp -103.19 55.21 0.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.182 1.793 . . . . 0.0 109.607 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 C--O 1.251 1.137 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -150.774 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.43 170.04 15.11 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -170.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 m -72.69 164.43 26.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.233 1.413 . . . . 0.0 113.047 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.46 -32.43 10.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 113.296 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.4 123.68 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.274 1.03 . . . . 0.0 111.994 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.72 -5.71 61.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.736 1.636 . . . . 0.0 116.059 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.601 ' H ' ' HB3' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.601 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 52' ' ' GLY . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 49' ' ' THR . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.446 HD12 ' CZ3' ' A' ' 65' ' ' TRP . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.475 ' CE1' HG13 ' A' ' 57' ' ' VAL . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.75 -43.7 14.12 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.83 32.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.226 2.21 . . . . 0.0 110.546 172.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.25 68.04 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.868 2.067 . . . . 0.0 109.269 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.366 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -147.19 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.621 0.248 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 155.45 18.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.257 1.023 . . . . 0.0 113.742 -167.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -65.93 124.26 22.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.312 1.045 . . . . 0.0 110.937 171.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.41 38.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.926 0.33 . . . . 0.0 111.331 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.32 169.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.435 1.494 . . . . 0.0 112.072 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.98 75.94 1.07 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.683 0.658 . . . . 0.0 111.968 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.686 ' HA ' ' H ' ' A' ' 120' ' ' PHE . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.857 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.802 ' CD2' HD12 ' A' ' 107' ' ' ILE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.802 HD12 ' CD2' ' A' ' 105' ' ' TYR . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.857 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.602 HG22 ' HD2' ' A' ' 119' ' ' PRO . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 118' ' ' ILE . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.686 ' H ' ' HA ' ' A' ' 70' ' ' LYS . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.481 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 57' ' ' VAL . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.51 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.22 -174.77 37.55 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.0 160.34 38.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.152 0.981 . . . . 0.0 112.035 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -142.06 83.15 1.83 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.984 1.713 . . . . 0.0 114.013 -172.219 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 114.324 0.489 . . . . 0.0 114.324 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.363 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 149' ' ' HIS . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 107' ' ' ILE . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.639 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.539 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.561 ' CE1' HG13 ' A' ' 57' ' ' VAL . 43.6 m-70 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.265 0 CA-C-O 121.163 0.313 . . . . 0.0 113.74 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 149' ' ' HIS . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 101' ' ' GLU . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 91' ' ' GLU . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 149' ' ' HIS . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.583 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.583 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' TRP . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.51 ' CE1' HG13 ' A' ' 57' ' ' VAL . 74.7 m-70 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.674 -0.514 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.325 1.0 OUTLIER -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.6 ' CE2' HD13 ' A' ' 118' ' ' ILE . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.603 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.6 HD13 ' CE2' ' A' ' 105' ' ' TYR . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.476 HG23 ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.237 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 57' ' ' VAL . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.683 HG23 ' CE1' ' A' ' 22' ' ' TYR . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.592 ' H ' ' HB3' ' A' ' 135' ' ' ASP . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.529 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.592 ' HB3' ' H ' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' HE1' HG22 ' A' ' 57' ' ' VAL . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.022 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.49 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 149' ' ' HIS . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB3' HG22 ' A' ' 107' ' ' ILE . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 105' ' ' TYR . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.533 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.092 0 CA-C-O 121.152 0.306 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.612 ' H ' ' HE3' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.589 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.469 HG22 HD13 ' A' ' 118' ' ' ILE . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 116' ' ' ILE . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 49' ' ' THR . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 149' ' ' HIS . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 118' ' ' ILE . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.635 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 105' ' ' TYR . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.516 HD11 ' CG ' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.469 ' CE1' HG13 ' A' ' 57' ' ' VAL . 89.7 m-70 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 CA-C-O 121.504 0.502 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 149' ' ' HIS . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 107' ' ' ILE . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 87' ' ' PHE . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.585 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 57' ' ' VAL . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.23 0 CA-C-O 119.989 -0.339 . . . . 0.0 113.804 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.543 HG23 ' H ' ' A' ' 52' ' ' GLY . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 49' ' ' THR . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.547 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.614 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.547 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB2' ' H ' ' A' ' 65' ' ' TRP . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 N-CA-C 114.307 0.483 . . . . 0.0 114.307 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 149' ' ' HIS . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.569 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.498 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.571 ' CE1' HG13 ' A' ' 57' ' ' VAL . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 N-CA-C 112.975 -0.05 . . . . 0.0 112.975 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 49' ' ' THR . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 114' ' ' LYS . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' HG23 ' A' ' 57' ' ' VAL . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 52' ' ' GLY . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 49' ' ' THR . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 149' ' ' HIS . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 114' ' ' LYS 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' H ' ' N ' ' A' ' 115' ' ' THR . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.489 ' CE1' HG13 ' A' ' 57' ' ' VAL . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 113.99 0.356 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 149' ' ' HIS . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 135' ' ' ASP . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 123' ' ' PHE 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 122' ' ' SER . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' SER . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 140' ' ' LEU . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' CE1' HG13 ' A' ' 57' ' ' VAL . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 49' ' ' THR . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 118' ' ' ILE . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.454 ' CE ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 98' ' ' GLY . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' HG22 ' A' ' 97' ' ' VAL . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.849 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.849 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.4 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 71' ' ' ILE . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.454 HG13 ' CE ' ' A' ' 76' ' ' LYS . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 115.479 0.952 . . . . 0.0 115.479 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.461 HG13 ' CE1' ' A' ' 149' ' ' HIS . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 118' ' ' ILE . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 118' ' ' ILE . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 118' ' ' ILE . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CE1' HG13 ' A' ' 57' ' ' VAL . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.657 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 19' ' ' TRP . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.451 ' H ' HD23 ' A' ' 17' ' ' LEU . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 53' ' ' TYR . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 24' ' ' GLY . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.406 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.55 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.268 0 N-CA-C 116.059 1.183 . . . . 0.0 116.059 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.601 ' H ' ' HB3' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.601 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 52' ' ' GLY . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 49' ' ' THR . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.446 HD12 ' CZ3' ' A' ' 65' ' ' TRP . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.475 ' CE1' HG13 ' A' ' 57' ' ' VAL . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.686 ' HA ' ' H ' ' A' ' 120' ' ' PHE . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.857 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.802 ' CD2' HD12 ' A' ' 107' ' ' ILE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.802 HD12 ' CD2' ' A' ' 105' ' ' TYR . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.857 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.602 HG22 ' HD2' ' A' ' 119' ' ' PRO . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 118' ' ' ILE . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.686 ' H ' ' HA ' ' A' ' 70' ' ' LYS . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.481 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 57' ' ' VAL . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.51 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.12 148.11 29.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m 51.28 32.73 8.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.65 -18.49 3.11 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.22 1.408 . . . . 0.0 114.12 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 m -134.54 160.32 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.243 1.417 . . . . 0.0 112.111 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.43 70.28 2.44 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.757 1.646 . . . . 0.0 114.324 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -138.07 152.9 49.25 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.445 1.498 . . . . 0.0 111.892 168.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -142.28 137.24 30.51 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.223 1.409 . . . . 0.0 111.392 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.3 ttm -80.17 131.54 35.74 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -170.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -91.22 -60.01 2.01 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.765 1.226 . . . . 0.0 110.985 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -155.26 128.14 8.09 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.642 0.777 . . . . 0.0 111.964 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -121.81 14.54 10.85 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.132 1.373 . . . . 0.0 111.415 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.256 84.8 m-85 68.76 7.35 6.08 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.684 2.393 . . . . 0.0 117.369 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -74.7 13.24 0.66 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -124.1 -142.08 5.91 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.721 2.105 . . . . 0.0 113.402 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.4 t -94.95 138.22 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.889 1.676 . . . . 0.0 111.017 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.41 104.47 3.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.837 1.655 . . . . 0.0 111.612 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -90.77 -2.24 57.81 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -74.66 147.07 41.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 113.03 -169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.56 161.05 42.25 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 125.066 1.317 . . . . 0.0 113.85 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.4 m -143.92 149.28 36.61 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.965 1.306 . . . . 0.0 110.954 161.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -166.5 162.81 17.02 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.23 172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.2 p -158.95 173.0 17.18 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.06 172.15 39.0 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.794 1.188 . . . . 0.0 112.143 160.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 54.78 47.43 22.41 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.289 1.436 . . . . 0.0 114.083 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.17 -10.77 73.06 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.299 1.428 . . . . 0.0 115.905 170.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -82.56 162.13 22.06 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.979 1.389 . . . . 0.0 111.01 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.05 157.83 43.73 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.551 1.54 . . . . 0.0 110.824 -175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.73 143.02 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.758 1.623 . . . . 0.0 111.015 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.8 m -142.97 107.31 4.76 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.213 1.405 . . . . 0.0 111.458 168.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.8 p -91.51 129.42 37.49 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.966 1.306 . . . . 0.0 112.216 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.71 148.72 32.29 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -72.29 142.55 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.683 1.193 . . . . 0.0 110.798 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.09 -171.27 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 127.557 2.343 . . . . 0.0 109.847 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.7 m -84.68 142.2 30.05 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 119.749 -1.845 . . . . 0.0 111.834 168.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.42 -171.09 14.77 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 121.256 -0.902 . . . . 0.0 115.211 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -58.67 -21.17 53.57 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.367 1.867 . . . . 0.0 115.031 -162.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.0 t -148.02 130.99 16.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.05 0.94 . . . . 0.0 109.166 159.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 -121.4 25.24 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 121.326 0.403 . . . . 0.0 112.185 -173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.46 160.27 14.39 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.947 0.88 . . . . 0.0 112.85 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.72 -170.83 14.89 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.234 2.349 . . . . 0.0 110.991 175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.9 ttp -134.99 133.19 39.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.23 0.612 . . . . 0.0 110.863 166.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -105.67 145.24 31.32 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.735 2.014 . . . . 0.0 109.196 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.03 122.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.289 0.566 . . . . 0.0 111.266 172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -101.65 149.52 24.04 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.358 1.463 . . . . 0.0 111.139 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.471 ' CD2' ' HD1' ' A' ' 54' ' ' TRP . 24.2 m-85 -141.43 153.32 44.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.303 1.041 . . . . 0.0 113.527 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.5 m -99.15 142.55 30.5 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 143.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 151.9 16.88 Favored Glycine 0 N--CA 1.477 1.422 0 CA-C-N 120.325 1.42 . . . . 0.0 112.787 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.1 p -129.07 -167.28 1.76 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.989 1.394 . . . . 0.0 110.932 171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.1 p -106.02 -49.04 3.47 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.358 1.435 . . . . 0.0 112.657 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.33 -1.67 55.71 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.396 1.078 . . . . 0.0 113.141 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.88 -152.68 24.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.022 1.296 . . . . 0.0 114.852 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -159.68 138.98 11.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.24 1.416 . . . . 0.0 110.243 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.471 ' HD1' ' CD2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -149.98 129.87 13.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.63 1.172 . . . . 0.0 108.41 -175.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.92 153.38 24.7 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -158.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -146.37 141.62 27.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.849 1.659 . . . . 0.0 110.657 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -135.81 151.73 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -139.74 137.52 35.17 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.073 0.949 . . . . 0.0 112.118 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.8 t -110.96 132.01 54.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.763 1.225 . . . . 0.0 109.7 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.99 150.26 38.99 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -163.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.07 -16.98 12.16 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 124.39 3.393 . . . . 0.0 113.727 170.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -137.95 141.59 40.54 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.93 1.292 . . . . 0.0 111.886 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 24.95 2.92 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.26 1.41 . . . . 0.0 113.04 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -129.39 41.15 3.5 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.445 1.898 . . . . 0.0 110.463 -165.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.275 0.0 OUTLIER -100.47 32.79 2.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.844 1.658 . . . . 0.0 114.676 -164.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 m -39.71 -40.16 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.354 1.862 . . . . 0.0 115.759 172.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -78.43 -13.75 59.7 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -90.42 155.68 18.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.785 1.634 . . . . 0.0 110.77 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.39 -36.66 5.21 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -135.2 154.22 51.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.062 0.945 . . . . 0.0 112.865 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.8 tt -84.75 161.7 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 154.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.2 t -143.45 138.66 29.45 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.667 1.187 . . . . 0.0 110.115 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.4 160.67 39.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.92 0.888 . . . . 0.0 110.951 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -108.59 108.94 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.4 tt -139.29 146.33 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.446 1.098 . . . . 0.0 112.148 -157.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -140.02 157.08 46.22 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 167.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -80.41 114.37 19.25 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.741 2.016 . . . . 0.0 108.161 165.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.345 1.6 p -120.57 33.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 124.671 2.177 . . . . 0.0 110.115 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -85.81 -18.49 32.78 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.375 2.27 . . . . 0.0 114.067 172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.66 -2.46 30.6 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.334 1.445 . . . . 0.0 114.238 -170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.9 m -138.61 -156.52 0.69 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.849 2.06 . . . . 0.0 110.379 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.83 95.57 4.0 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.25 1.42 . . . . 0.0 110.226 166.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -106.85 142.13 36.97 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -170.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -90.16 165.18 14.12 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.066 1.746 . . . . 0.0 115.446 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 pt -138.2 152.36 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.177 1.791 . . . . 0.0 113.425 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -117.61 41.96 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.648 1.979 . . . . 0.0 111.967 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . 0.259 0.6 OUTLIER -76.63 165.88 24.16 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -155.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 20.1 ttt -134.79 149.46 50.4 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.627 1.171 . . . . 0.0 112.894 -152.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.68 141.98 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.917 2.087 . . . . 0.0 109.219 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.72 136.98 46.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.662 1.185 . . . . 0.0 112.291 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -86.63 152.03 22.94 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.311 1.844 . . . . 0.0 110.607 167.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -71.27 144.7 49.92 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.055 1.742 . . . . 0.0 112.266 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 43.4 t -60.65 137.76 58.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.527 1.531 . . . . 0.0 113.4 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 pt -83.59 -6.61 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 CA-C-N 118.746 0.703 . . . . 0.0 112.744 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -104.24 -2.76 25.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.477 1.511 . . . . 0.0 113.61 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.91 18.14 78.84 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 119.403 1.001 . . . . 0.0 113.825 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -136.2 129.02 46.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 127.819 2.448 . . . . 0.0 108.562 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.86 -134.1 51.1 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.453 0.549 . . . . 0.0 112.612 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -116.74 172.77 7.02 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.511 1.924 . . . . 0.0 111.081 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -117.66 -38.79 0.81 Allowed Glycine 0 N--CA 1.476 1.331 0 N-CA-C 116.167 1.227 . . . . 0.0 116.167 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -158.62 156.47 30.11 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.176 1.488 . . . . 0.0 109.582 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -126.92 127.64 45.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.125 -0.985 . . . . 0.0 111.597 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -133.96 142.13 47.57 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.132 1.773 . . . . 0.0 111.791 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.37 154.47 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -90.57 164.88 14.05 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.558 3.143 . . . . 0.0 112.684 170.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.0 m -136.42 113.36 10.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.391 1.476 . . . . 0.0 108.249 148.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.7 pt -151.15 156.76 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.213 1.005 . . . . 0.0 112.37 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 t -132.62 140.91 39.27 Favored Pre-proline 0 N--CA 1.484 1.232 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 169.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -81.13 -158.16 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 1 C-N-CA 125.873 4.382 . . . . 0.0 111.721 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -131.86 -167.72 1.92 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.32 -1.488 . . . . 0.0 112.965 151.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 m -72.35 -3.34 23.35 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.682 1.593 . . . . 0.0 114.246 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.7 p -131.63 157.75 42.86 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.595 1.558 . . . . 0.0 114.246 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -72.06 84.87 1.0 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.293 1.437 . . . . 0.0 114.631 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -91.55 150.17 21.32 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.882 2.073 . . . . 0.0 109.372 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 m -80.93 128.41 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.75 90.87 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.734 0.814 . . . . 0.0 109.693 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -82.24 111.43 18.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.618 0.767 . . . . 0.0 110.935 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.13 128.17 26.18 Favored Pre-proline 0 N--CA 1.486 1.329 0 C-N-CA 124.226 1.011 . . . . 0.0 110.936 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -84.44 164.03 12.71 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.656 2.238 . . . . 0.0 113.845 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -59.7 -20.49 56.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 172.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 45.8 p -85.1 12.66 7.35 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.772 -1.205 . . . . 0.0 113.798 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 t -81.5 -24.04 36.95 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.178 1.391 . . . . 0.0 114.082 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -87.46 162.22 17.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -154.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.67 168.94 18.67 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.888 1.675 . . . . 0.0 110.839 160.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -68.91 158.37 34.74 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 120.643 1.565 . . . . 0.0 113.04 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -75.47 108.98 8.64 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 158.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.85 -10.32 24.91 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -155.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -83.02 -24.46 32.83 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 165.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -148.45 118.77 7.32 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.721 -0.612 . . . . 0.0 112.62 -152.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -147.05 161.05 38.29 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.43 1.092 . . . . 0.0 112.252 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -74.12 164.26 34.75 Favored 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.703 2.935 . . . . 0.0 116.139 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.87 -27.87 3.63 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.928 3.085 . . . . 0.0 114.185 174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.13 46.0 1.89 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.428 1.489 . . . . 0.0 113.052 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.33 150.54 31.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -158.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.98 143.78 37.28 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.09 154.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.1 mtp -132.63 40.68 3.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.14 1.776 . . . . 0.0 111.879 171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 91.4 p -69.74 -1.71 9.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.4 4.48 64.7 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.025 1.297 . . . . 0.0 114.149 -175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.2 t -158.7 165.06 35.26 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.771 1.228 . . . . 0.0 113.297 -173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -72.87 131.39 42.19 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.249 1.02 . . . . 0.0 111.568 167.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -107.98 100.13 9.51 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.669 1.588 . . . . 0.0 109.661 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -13.23 61.72 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.43 -0.794 . . . . 0.0 112.242 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -60.52 -19.18 56.2 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.663 1.985 . . . . 0.0 114.467 164.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -140.88 42.28 1.83 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.314 1.046 . . . . 0.0 111.987 -154.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.34 136.26 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.378 -1.451 . . . . 0.0 113.065 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -104.77 -54.15 2.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.431 1.892 . . . . 0.0 113.258 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 p -163.09 160.16 24.04 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.751 1.22 . . . . 0.0 112.227 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.43 150.48 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.427 1.091 . . . . 0.0 112.831 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -145.24 129.85 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.62 1.168 . . . . 0.0 112.06 -158.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.99 141.29 47.74 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.413 -0.804 . . . . 0.0 110.933 168.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 92.5 mtp -141.0 139.0 34.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.614 0.765 . . . . 0.0 112.012 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -67.01 137.03 56.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.15 2.58 . . . . 0.0 113.754 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.99 18.51 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.127 1.771 . . . . 0.0 112.061 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -154.98 164.65 38.59 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.251 2.62 . . . . 0.0 107.823 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -116.44 14.65 15.66 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -67.27 144.72 55.77 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.782 1.233 . . . . 0.0 114.321 -170.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.4 m -89.22 130.49 35.62 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.285 -0.87 . . . . 0.0 108.98 149.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.92 -154.22 25.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 119.546 -0.585 . . . . 0.0 113.01 -167.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -142.03 160.21 40.67 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -134.68 161.52 34.9 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.313 1.845 . . . . 0.0 110.529 165.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 12.6 p -157.52 144.99 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.738 -1.226 . . . . 0.0 113.736 -173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.93 155.38 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -134.93 -172.94 3.17 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.338 0.655 . . . . 0.0 110.122 142.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 m120 61.46 47.87 6.35 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 12.1 mt -82.47 122.98 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 119.994 -1.691 . . . . 0.0 110.416 176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -144.79 164.77 30.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.202 1.401 . . . . 0.0 113.508 -170.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.5 mt -98.28 145.89 26.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.411 1.884 . . . . 0.0 110.16 157.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mm -125.11 139.47 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.669 1.588 . . . . 0.0 110.093 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.49 34.88 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.496 1.046 . . . . 0.0 113.566 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.66 164.63 16.48 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -115.1 90.18 3.28 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.403 1.881 . . . . 0.0 108.443 171.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 . . . . . 0 C--O 1.25 1.089 0 C-N-CA 127.188 2.195 . . . . 0.0 112.6 -172.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.91 13.63 0.19 Allowed 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -44.66 138.03 3.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.888 2.475 . . . . 0.0 112.768 167.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.99 119.01 32.78 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.317 1.047 . . . . 0.0 112.252 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.44 156.42 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.047 1.339 . . . . 0.0 112.414 -172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.59 36.61 1.39 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.411 1.482 . . . . 0.0 114.588 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -156.05 141.8 17.93 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.318 1.847 . . . . 0.0 111.406 -178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -135.37 132.58 37.76 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.232 -0.917 . . . . 0.0 112.743 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 ttp -77.5 133.65 38.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.414 1.086 . . . . 0.0 113.158 -174.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.45 -53.98 4.2 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.883 0.873 . . . . 0.0 109.925 162.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -154.73 168.58 26.36 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.5 18.35 0.72 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.0 1.32 . . . . 0.0 112.122 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 60.38 13.31 3.96 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.559 2.744 . . . . 0.0 116.629 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -79.07 -13.04 60.0 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 120.11 -1.619 . . . . 0.0 113.908 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.22 -142.89 12.78 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.808 1.671 . . . . 0.0 112.807 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.54 133.6 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.345 1.458 . . . . 0.0 109.528 170.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 tt -76.16 107.48 8.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.624 0.647 . . . . 0.0 111.245 -174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.513 ' ND2' ' CH2' ' A' ' 19' ' ' TRP . 1.5 p-10 -105.13 32.2 4.37 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 116.86 2.171 . . . . 0.0 116.86 -155.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.711 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 71.3 m95 -121.74 143.49 49.34 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -163.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.88 151.29 45.68 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.809 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 m -146.18 153.52 40.72 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.724 1.262 . . . . 0.0 110.631 162.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.39 155.49 24.63 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.506 0.723 . . . . 0.0 112.315 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.5 p -147.96 164.09 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -158.77 152.04 23.09 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.498 1.047 . . . . 0.0 113.649 170.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.272 8.0 mm-40 58.69 37.01 25.24 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.305 2.242 . . . . 0.0 115.107 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.93 -23.14 11.0 Favored Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.717 1.627 . . . . 0.0 115.626 163.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.69 164.4 26.57 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.061 0.93 . . . . 0.0 110.318 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -152.58 157.46 41.07 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.009 1.324 . . . . 0.0 110.722 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -136.7 139.26 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.531 1.133 . . . . 0.0 111.824 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -143.67 128.27 18.1 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.246 1.018 . . . . 0.0 111.353 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.6 p -100.69 144.34 29.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 126.424 1.89 . . . . 0.0 111.916 170.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.34 161.49 40.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.843 1.657 . . . . 0.0 111.797 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.6 mt -98.91 132.27 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.455 1.502 . . . . 0.0 110.902 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.1 m -142.66 -171.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 126.219 1.807 . . . . 0.0 111.422 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 t -70.35 144.94 51.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 119.98 -1.7 . . . . 0.0 112.134 164.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.94 -175.77 13.98 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.931 1.253 . . . . 0.0 114.413 172.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -52.2 -36.12 51.09 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.571 1.948 . . . . 0.0 112.889 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.0 p -145.52 116.78 7.93 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.055 1.342 . . . . 0.0 109.171 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.42 -123.57 33.64 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -166.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.81 158.04 15.89 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.53 1.132 . . . . 0.0 112.29 -176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.0 178.61 18.81 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 127.675 2.559 . . . . 0.0 112.128 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 ttp -108.93 134.96 50.9 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.598 1.559 . . . . 0.0 109.961 163.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -100.41 143.09 31.0 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.884 1.274 . . . . 0.0 109.121 160.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.36 141.65 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.377 1.071 . . . . 0.0 111.075 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.7 t -138.51 134.16 33.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.01 1.324 . . . . 0.0 112.787 -167.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 54' ' ' TRP . 43.7 m-85 -132.45 146.59 52.05 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.102 1.361 . . . . 0.0 113.497 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 m -98.3 145.3 26.81 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 138.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.53 157.61 14.94 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.012 1.291 . . . . 0.0 113.111 175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 p -145.89 151.35 37.72 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.258 1.529 . . . . 0.0 113.815 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.3 p -68.78 -32.94 73.04 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -165.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -117.02 7.29 13.08 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.12 -149.24 10.97 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.915 1.245 . . . . 0.0 114.497 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.29 147.98 14.66 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.616 2.367 . . . . 0.0 108.62 168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 46' ' ' TYR . 0.7 OUTLIER -155.2 128.7 8.46 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -173.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.68 179.94 41.82 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 117.244 1.658 . . . . 0.0 117.244 -162.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 m -160.18 146.3 15.54 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.377 1.071 . . . . 0.0 112.128 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 149' ' ' HIS . 24.9 t -136.9 152.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -167.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 t80 -137.92 116.38 12.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.756 0.789 . . . . 0.0 112.792 -173.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.4 t -99.23 112.74 24.83 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.888 2.075 . . . . 0.0 108.182 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.24 153.78 90.35 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -167.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.99 -42.44 4.2 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.206 1.938 . . . . 0.0 111.1 164.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -147.59 142.99 27.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.243 1.417 . . . . 0.0 112.283 167.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.87 46.48 1.14 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 127.133 2.301 . . . . 0.0 111.376 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -131.48 78.23 1.82 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.372 1.869 . . . . 0.0 109.153 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.11 -5.69 15.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.6 p -52.1 -22.62 4.33 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 -171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -73.5 -25.42 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 126.106 1.762 . . . . 0.0 115.013 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -86.33 -168.23 2.16 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.727 2.011 . . . . 0.0 111.175 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.0 tp -126.42 -36.37 2.29 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -134.33 158.09 44.69 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -169.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.1 tt -96.76 162.49 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.169 0.988 . . . . 0.0 109.596 156.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.1 t -150.55 130.08 13.03 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.665 1.186 . . . . 0.0 111.504 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.87 156.87 46.03 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.6 1.56 . . . . 0.0 111.459 167.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.54 119.21 38.18 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.46 0.704 . . . . 0.0 111.066 173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 tt -149.23 129.11 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 O-C-N 120.018 -1.676 . . . . 0.0 113.765 -163.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -160.5 169.98 21.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.79 135.14 35.91 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.701 2.001 . . . . 0.0 109.942 168.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -97.22 -13.47 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.155 0.982 . . . . 0.0 111.803 172.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -103.34 -0.11 30.62 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.468 2.307 . . . . 0.0 115.547 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.49 14.55 78.12 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.744 1.458 . . . . 0.0 116.744 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.2 t -71.94 159.87 33.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 120.56 2.18 . . . . 0.0 113.331 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.28 29.38 1.81 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.492 1.917 . . . . 0.0 111.892 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -68.15 158.63 32.72 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.1 120.75 25.24 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.012 1.325 . . . . 0.0 112.461 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.0 pt -144.44 177.72 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 125.752 1.621 . . . . 0.0 111.356 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.15 145.35 51.32 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.954 -1.716 . . . . 0.0 110.534 166.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 107' ' ' ILE . 4.8 m-30 -83.86 138.03 33.39 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 156.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 19.3 ttt -131.42 145.32 51.75 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.39 1.076 . . . . 0.0 112.575 -170.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.4 mt -132.63 140.95 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.612 1.565 . . . . 0.0 109.41 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.62 131.19 54.64 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.864 1.265 . . . . 0.0 111.607 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.65 155.26 17.85 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.958 1.303 . . . . 0.0 111.48 175.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -70.58 145.2 50.91 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.9 t -66.2 141.58 58.01 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.489 1.916 . . . . 0.0 111.945 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.7 pt -67.33 -16.74 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 121.69 -0.631 . . . . 0.0 112.582 170.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -90.8 -15.11 30.65 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.28 1.832 . . . . 0.0 112.499 173.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.9 -2.33 69.64 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.843 1.687 . . . . 0.0 115.554 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.58 143.34 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.615 1.966 . . . . 0.0 109.476 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.98 -137.53 38.64 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.49 0.567 . . . . 0.0 112.781 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -113.81 159.42 19.82 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.039 1.336 . . . . 0.0 111.366 174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.47 -54.83 1.21 Allowed Glycine 0 N--CA 1.464 0.561 0 C-N-CA 124.532 1.063 . . . . 0.0 112.683 173.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.92 155.2 43.99 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -107.91 127.72 53.99 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.748 1.219 . . . . 0.0 110.594 165.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -126.76 138.69 53.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.71 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 10.6 m -135.79 156.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.952 1.301 . . . . 0.0 113.748 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CE2' ' CD1' ' A' ' 107' ' ' ILE . 54.5 t80 -141.23 109.86 6.02 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.02 2.528 . . . . 0.0 104.97 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.0 m -104.17 118.16 35.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.011 0.924 . . . . 0.0 111.934 -153.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.423 ' CD1' ' CE2' ' A' ' 105' ' ' TYR . 2.1 tp -150.48 -175.67 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -138.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.0 p -150.64 157.69 36.04 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 128.073 2.549 . . . . 0.0 109.898 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.05 145.29 19.37 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.965 2.444 . . . . 0.0 111.392 167.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -82.99 179.91 7.63 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.528 -0.733 . . . . 0.0 110.965 165.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 m -109.22 3.21 21.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.548 1.939 . . . . 0.0 112.711 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -135.86 144.79 45.81 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.531 1.532 . . . . 0.0 113.816 -174.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.639 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.312 1.9 t90 -74.51 108.3 7.19 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 127.79 2.436 . . . . 0.0 107.999 -177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 mmmm -159.12 132.38 7.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 129.785 3.234 . . . . 0.0 110.045 -167.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 m -92.02 113.73 26.07 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.867 0.842 . . . . 0.0 111.412 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.57 92.4 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.632 1.973 . . . . 0.0 109.834 -169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -74.23 119.92 19.1 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.287 1.035 . . . . 0.0 111.108 168.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -126.06 124.9 24.71 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 125.687 1.595 . . . . 0.0 109.63 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -82.48 160.44 17.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.761 2.307 . . . . 0.0 112.232 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -64.22 -14.69 57.14 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.246 -0.909 . . . . 0.0 113.075 168.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.7 m -63.24 -25.45 68.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.685 1.194 . . . . 0.0 112.979 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -101.52 -7.76 22.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -172.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -75.32 149.06 38.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.484 1.038 . . . . 0.0 111.238 172.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.09 158.46 37.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.254 1.022 . . . . 0.0 112.505 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -73.67 147.46 43.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.754 1.221 . . . . 0.0 111.61 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -63.26 144.56 56.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.281 1.033 . . . . 0.0 109.833 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 -37.14 2.78 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.42 -24.09 65.61 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.098 -1.002 . . . . 0.0 111.068 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -140.7 146.43 37.81 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.784 2.034 . . . . 0.0 111.163 -167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.32 135.32 7.8 Favored Pre-proline 0 CA--C 1.546 0.795 0 CA-C-O 118.385 -0.817 . . . . 0.0 112.102 163.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.13 150.79 63.23 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.625 2.216 . . . . 0.0 113.646 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -67.06 -19.04 51.84 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.065 2.51 . . . . 0.0 112.641 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.9 5.4 48.41 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.159 1.838 . . . . 0.0 115.954 173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.51 144.24 43.11 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.743 1.771 . . . . 0.0 114.156 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.04 139.86 35.48 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 122.201 1.001 . . . . 0.0 109.922 155.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -80.31 15.88 1.46 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.58 1.552 . . . . 0.0 113.661 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 61.2 p -68.15 -32.66 73.08 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.688 -1.257 . . . . 0.0 113.298 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.09 78.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.132 0.872 . . . . 0.0 112.61 -168.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 47.1 m -140.5 146.76 38.58 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.927 1.691 . . . . 0.0 110.732 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.88 147.52 38.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.04 0.924 . . . . 0.0 112.85 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.31 86.59 2.59 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.424 1.49 . . . . 0.0 110.71 -176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -66.79 -13.57 61.64 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.07 -22.65 67.02 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.068 1.747 . . . . 0.0 113.303 167.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.62 69.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.939 1.296 . . . . 0.0 113.677 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -83.5 143.58 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.848 0.859 . . . . 0.0 110.784 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.53 -56.98 2.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.591 1.156 . . . . 0.0 111.88 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 p -159.93 162.18 34.41 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -172.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.539 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -100.44 146.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.639 1.576 . . . . 0.0 109.966 171.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.561 ' CE1' HG13 ' A' ' 57' ' ' VAL . 43.6 m-70 -144.65 162.56 36.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.511 1.524 . . . . 0.0 112.528 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -102.47 165.31 11.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.524 0.729 . . . . 0.0 111.422 154.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 21.3 ptm -150.88 155.01 38.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 165.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -112.97 63.74 0.64 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.758 1.223 . . . . 0.0 113.403 -140.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -63.42 -1.4 1.14 Allowed 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -145.36 156.59 43.87 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.35 0.977 . . . . 0.0 111.577 163.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.74 39.03 3.87 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.594 1.558 . . . . 0.0 111.533 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -86.66 171.45 10.97 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.613 1.565 . . . . 0.0 112.407 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.1 m -97.17 143.91 27.51 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.01 0.924 . . . . 0.0 110.571 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.51 168.42 39.5 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 116.151 1.22 . . . . 0.0 116.151 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -133.52 129.68 37.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.96 1.704 . . . . 0.0 111.529 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -140.5 160.82 39.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.381 1.073 . . . . 0.0 112.17 -165.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -132.46 143.02 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.33 1.452 . . . . 0.0 114.289 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.35 138.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.342 1.457 . . . . 0.0 111.078 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -136.33 166.97 22.21 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.204 150.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.8 m120 67.05 129.56 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.43 1.492 . . . . 0.0 113.604 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.0 mt -147.14 100.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.967 1.307 . . . . 0.0 107.965 167.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -140.12 161.35 37.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.189 1.396 . . . . 0.0 113.662 -173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.49 154.19 17.54 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.218 1.407 . . . . 0.0 110.026 164.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 23.6 mt -135.47 140.36 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.663 1.585 . . . . 0.0 110.066 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -71.61 -167.24 8.41 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.897 1.236 . . . . 0.0 113.937 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.57 169.46 18.22 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.238 -1.154 . . . . 0.0 113.889 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.5 tp -145.72 39.9 1.16 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.354 1.862 . . . . 0.0 110.04 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.399 2.68 . . . . 0.0 114.807 175.792 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 mmt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.813 0.34 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.02 138.56 38.07 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.379 1.072 . . . . 0.0 113.167 -176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.9 t -113.19 154.64 26.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.823 1.249 . . . . 0.0 111.856 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.5 61.62 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 167.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.76 144.02 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.847 1.259 . . . . 0.0 111.255 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.67 95.59 0.09 OUTLIER Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.502 2.001 . . . . 0.0 113.74 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -115.85 156.46 26.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.912 1.685 . . . . 0.0 114.587 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -141.12 133.38 28.09 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.304 2.241 . . . . 0.0 110.256 178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -89.57 148.1 23.56 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.312 -0.867 . . . . 0.0 112.966 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.0 mt -113.33 -53.92 2.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.953 1.301 . . . . 0.0 112.347 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -148.07 117.85 7.12 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.997 0.919 . . . . 0.0 110.772 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -95.69 3.31 54.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.477 1.511 . . . . 0.0 112.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 60.15 2.59 0.44 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.239 2.615 . . . . 0.0 116.414 -168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.49 -19.69 61.5 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.504 1.121 . . . . 0.0 113.223 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.07 -147.23 7.91 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.936 1.255 . . . . 0.0 112.447 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.2 t -108.19 130.33 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 125.875 1.67 . . . . 0.0 110.713 175.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.71 128.45 37.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.19 2.196 . . . . 0.0 112.504 -174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.511 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -113.4 -1.33 14.23 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 118.624 2.824 . . . . 0.0 118.624 -171.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.696 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.4 m95 -95.2 138.93 32.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.801 0.84 . . . . 0.0 113.214 -157.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.53 168.49 42.64 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.368 0.985 . . . . 0.0 115.383 -170.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -144.96 151.7 39.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.261 1.025 . . . . 0.0 112.213 172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -156.99 149.65 23.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.337 1.855 . . . . 0.0 110.32 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 93.1 p -151.37 161.64 42.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -143.83 144.31 13.39 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.349 0.976 . . . . 0.0 114.406 171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 60.47 17.74 7.56 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.346 2.659 . . . . 0.0 117.134 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.89 9.73 58.2 Favored Glycine 0 CA--C 1.533 1.161 0 O-C-N 120.78 -1.2 . . . . 0.0 114.375 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.67 161.22 30.13 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.17 0.985 . . . . 0.0 110.023 151.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -153.43 153.36 32.36 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -168.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.81 135.27 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.559 2.344 . . . . 0.0 110.151 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.3 m -152.16 95.72 2.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.306 0.642 . . . . 0.0 112.18 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.0 p -84.39 146.2 27.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.828 1.251 . . . . 0.0 113.011 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.19 166.76 23.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.596 1.958 . . . . 0.0 111.043 169.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.6 mm -115.86 140.83 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.946 1.298 . . . . 0.0 111.684 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.2 m -147.2 -178.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 127.842 2.457 . . . . 0.0 110.831 -163.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -63.68 148.21 49.62 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.355 -1.466 . . . . 0.0 112.326 166.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -154.87 179.93 30.55 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 116.494 1.358 . . . . 0.0 116.494 160.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 113' ' ' TRP . 68.0 mttt -54.94 -28.64 52.67 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.048 1.739 . . . . 0.0 113.507 -167.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.2 p -117.88 119.65 35.51 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.046 2.139 . . . . 0.0 106.652 165.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 47.01 -106.15 0.14 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 121.138 1.79 . . . . 0.0 115.497 173.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -97.89 153.88 18.03 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.525 1.155 . . . . 0.0 113.418 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.36 -170.51 23.88 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 126.549 2.023 . . . . 0.0 111.12 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.7 ttp -128.09 142.95 51.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.531 1.533 . . . . 0.0 110.025 168.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -121.01 148.14 44.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.155 1.782 . . . . 0.0 109.976 173.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.34 141.33 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.55 -0.719 . . . . 0.0 110.689 162.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 t -98.6 111.05 23.54 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 153.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -97.31 137.18 36.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.612 0.765 . . . . 0.0 109.876 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.0 m -124.18 136.61 54.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.357 1.063 . . . . 0.0 110.828 -174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.9 165.71 15.47 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.843 1.687 . . . . 0.0 115.416 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.4 t -155.42 169.22 24.76 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.519 1.128 . . . . 0.0 112.731 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.9 p -56.23 -32.39 64.42 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.746 2.018 . . . . 0.0 115.597 -172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -120.17 -5.09 9.98 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.015 1.726 . . . . 0.0 113.254 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.81 -178.14 23.76 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.921 1.248 . . . . 0.0 114.946 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.433 ' HA ' ' CE1' ' A' ' 152' ' ' TYR . 54.7 p90 -159.46 159.6 33.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.262 1.425 . . . . 0.0 113.653 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 52.6 p-90 -125.32 162.41 24.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.321 1.449 . . . . 0.0 110.564 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.13 164.14 32.73 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 121.753 -0.592 . . . . 0.0 113.975 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -134.37 147.91 50.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.648 1.579 . . . . 0.0 111.476 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.538 HG13 ' CE1' ' A' ' 149' ' ' HIS . 95.4 t -116.23 145.48 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 119.434 1.015 . . . . 0.0 108.465 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.696 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -146.1 130.51 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 112.965 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -91.13 126.39 36.2 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.372 1.469 . . . . 0.0 112.263 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.2 mt -94.29 138.52 22.46 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.513 1.125 . . . . 0.0 110.946 172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.89 -16.2 5.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.49 2.793 . . . . 0.0 115.161 -167.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -127.01 133.35 50.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.952 2.101 . . . . 0.0 109.324 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.11 13.29 6.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.331 1.443 . . . . 0.0 115.244 -168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -124.22 123.33 40.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.724 2.01 . . . . 0.0 107.372 158.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -152.57 6.84 0.42 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.424 -134.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 m -63.08 -22.63 66.99 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -77.71 -30.22 51.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 120.573 1.533 . . . . 0.0 112.139 170.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -79.58 45.71 0.7 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.515 1.526 . . . . 0.0 112.433 176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -71.24 -9.11 57.57 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -157.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 148.69 52.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.437 . . . . 0.0 111.51 167.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 tt -92.83 167.11 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.101 0.96 . . . . 0.0 108.892 161.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -149.91 155.28 39.73 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.446 -1.409 . . . . 0.0 112.896 156.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -146.69 157.59 43.73 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.615 1.166 . . . . 0.0 110.6 161.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -95.19 110.19 22.19 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.992 0.517 . . . . 0.0 110.011 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.1 tt -136.44 135.65 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -165.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HE2' ' CE2' ' A' ' 113' ' ' TRP . 25.5 pttt -148.15 169.23 20.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.203 1.401 . . . . 0.0 113.134 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 t -80.59 147.66 30.65 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.957 2.103 . . . . 0.0 111.611 173.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.277 12.2 p -120.72 26.68 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 122.764 1.269 . . . . 0.0 111.038 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -153.35 25.37 0.53 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.667 2.387 . . . . 0.0 114.981 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.82 -53.9 4.3 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 127.168 2.318 . . . . 0.0 113.255 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.2 m -151.19 144.23 24.61 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.832 2.453 . . . . 0.0 106.984 158.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -68.25 0.41 Allowed 'General case' 0 CA--C 1.527 0.075 0 CA-C-N 118.56 0.618 . . . . 0.0 109.723 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.86 -167.4 0.07 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.154 2.982 . . . . 0.0 108.8 169.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -82.57 132.03 35.2 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.777 -0.577 . . . . 0.0 110.995 164.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 pt -131.89 -177.92 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.876 1.27 . . . . 0.0 112.107 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -129.6 138.04 51.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.119 1.367 . . . . 0.0 112.798 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -97.02 153.14 18.09 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.077 0.951 . . . . 0.0 109.997 159.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.1 ttt -141.48 143.68 33.97 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.456 1.502 . . . . 0.0 110.434 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.3 mt -126.91 142.46 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 127.365 2.266 . . . . 0.0 106.881 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.37 131.67 56.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.617 0.767 . . . . 0.0 111.065 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 101' ' ' GLU . 49.4 mt-10 -68.93 168.21 14.13 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.21 0.604 . . . . 0.0 110.526 160.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttt -82.49 152.2 26.17 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.593 -1.942 . . . . 0.0 113.698 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -66.86 151.28 47.83 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.023 2.129 . . . . 0.0 114.527 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.4 pt -70.35 -9.59 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -100.0 -9.89 22.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.185 1.794 . . . . 0.0 113.108 171.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.41 -18.25 52.87 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.349 1.452 . . . . 0.0 113.814 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.89 128.34 75.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.576 2.35 . . . . 0.0 109.533 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 137.2 -146.46 18.37 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.672 1.129 . . . . 0.0 113.779 -176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -138.38 4.91 2.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -167.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.3 -86.74 0.11 Allowed Glycine 0 N--CA 1.47 0.954 0 C-N-CA 125.541 1.544 . . . . 0.0 115.574 158.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.409 ' H ' ' HB2' ' A' ' 91' ' ' GLU . 42.0 tt0 -145.27 139.04 26.82 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.057 2.143 . . . . 0.0 106.744 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -102.6 121.49 42.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.994 0.518 . . . . 0.0 110.703 -159.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -125.99 118.29 25.06 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.052 0.941 . . . . 0.0 111.32 -168.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.48 159.51 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.993 1.317 . . . . 0.0 114.442 -164.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -148.99 152.62 36.63 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.071 0.948 . . . . 0.0 112.653 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.4 m -122.15 133.0 54.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.496 1.519 . . . . 0.0 112.528 -171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.18 155.27 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.845 1.258 . . . . 0.0 113.788 -170.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.2 p -124.38 132.73 24.34 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 127.31 2.244 . . . . 0.0 110.079 164.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.5 143.95 15.62 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.755 2.303 . . . . 0.0 113.258 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.4 175.69 10.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.648 1.179 . . . . 0.0 111.732 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.7 m -82.19 -9.23 59.58 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.175 1.79 . . . . 0.0 114.665 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 83.3 p -143.72 154.6 43.65 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.047 1.339 . . . . 0.0 112.817 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE2' ' HE2' ' A' ' 76' ' ' LYS . 12.0 m0 -75.3 100.72 4.46 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -84.06 146.55 27.87 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 159.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.2 m -76.04 107.24 8.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 163.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.1 mt -91.27 88.85 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-O 122.23 1.014 . . . . 0.0 109.138 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.94 87.41 7.41 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.618 1.167 . . . . 0.0 111.533 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.3 mm -82.11 125.81 76.24 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 121.568 -0.707 . . . . 0.0 110.303 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -86.99 162.38 8.82 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.439 2.759 . . . . 0.0 112.137 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -48.19 -30.12 4.36 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 165.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 54.4 p -79.0 -4.75 51.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.736 1.615 . . . . 0.0 114.529 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 50.6 m -96.6 -20.79 18.07 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.88 142.78 46.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.275 1.03 . . . . 0.0 112.752 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.93 161.83 19.13 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.073 2.149 . . . . 0.0 111.571 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -94.24 156.77 16.37 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.611 1.564 . . . . 0.0 114.472 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 125.14 40.97 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.515 1.126 . . . . 0.0 110.047 155.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.1 tp -150.19 -8.05 0.29 Allowed 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -170.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -92.31 -29.15 16.52 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.421 -1.424 . . . . 0.0 111.674 165.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -81.87 127.85 33.43 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 149.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -153.02 132.52 7.1 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 125.381 1.472 . . . . 0.0 110.619 165.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -77.55 -175.54 2.73 Favored 'Trans proline' 0 CA--C 1.559 1.745 0 C-N-CA 124.69 3.593 . . . . 0.0 111.039 155.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -89.54 -13.88 2.67 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.577 2.851 . . . . 0.0 115.546 -167.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.45 28.93 2.62 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 126.619 2.057 . . . . 0.0 115.277 -167.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.78 135.71 55.08 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -134.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -46.88 66.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.773 2.029 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . 0.25 25.8 ptt? 48.77 27.66 1.63 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.137 2.575 . . . . 0.0 116.6 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.2 p -76.25 -10.56 59.5 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.78 -5.46 61.55 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.847 1.213 . . . . 0.0 114.741 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.0 m -133.18 143.07 48.96 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.747 2.019 . . . . 0.0 110.601 -177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 17.2 tp -75.58 106.23 7.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.602 1.561 . . . . 0.0 110.232 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.64 96.8 10.06 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.134 1.374 . . . . 0.0 111.399 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.96 40.5 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.073 -1.017 . . . . 0.0 113.555 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -9.47 42.58 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.416 1.086 . . . . 0.0 112.791 171.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -155.04 67.95 0.68 Allowed 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -167.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 50.3 mm -104.57 132.19 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.329 1.452 . . . . 0.0 113.012 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -95.26 -55.94 2.89 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.803 1.641 . . . . 0.0 113.831 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 p -165.37 168.76 16.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.182 0.993 . . . . 0.0 112.8 -165.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -126.33 145.73 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.23 1.412 . . . . 0.0 109.036 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CE1' HG13 ' A' ' 57' ' ' VAL . 42.0 m-70 -141.71 148.32 38.86 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.973 1.309 . . . . 0.0 110.161 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -130.79 128.88 41.62 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.045 0.938 . . . . 0.0 109.539 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 77.1 mtm -153.14 179.86 8.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.268 1.427 . . . . 0.0 111.735 -167.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -118.32 168.36 10.69 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.012 0.925 . . . . 0.0 113.428 167.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -122.66 24.89 8.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.606 1.562 . . . . 0.0 111.741 170.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -129.56 -162.15 1.18 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.374 1.87 . . . . 0.0 111.682 -155.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -133.86 -9.82 2.71 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.972 1.709 . . . . 0.0 113.641 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -77.59 162.96 26.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 126.167 1.787 . . . . 0.0 114.311 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.6 m -102.96 166.17 10.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.809 1.644 . . . . 0.0 111.959 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.75 159.16 24.06 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 115.262 0.865 . . . . 0.0 115.262 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -118.73 134.66 54.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.336 1.455 . . . . 0.0 111.899 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.52 161.79 40.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.01 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.651 1.981 . . . . 0.0 112.875 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.7 t -140.31 142.95 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.239 1.416 . . . . 0.0 111.832 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -126.0 173.91 8.81 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 147.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 63.85 66.94 0.64 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 159.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 27.2 mt -80.11 125.6 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.612 -1.305 . . . . 0.0 110.557 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -146.48 164.26 33.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.52 1.928 . . . . 0.0 113.247 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 74.7 mt -112.61 151.22 30.36 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.993 2.117 . . . . 0.0 109.662 166.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mm -112.11 116.0 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 123.843 0.857 . . . . 0.0 109.413 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.55 -13.13 63.67 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.237 1.399 . . . . 0.0 114.796 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.57 177.13 4.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 111.709 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.2 tp -139.01 37.01 2.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.235 . . . . 0.0 110.94 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 125.849 1.66 . . . . 0.0 112.021 -160.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 tmm? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.28 135.84 52.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.617 1.167 . . . . 0.0 113.649 -172.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -94.78 174.4 7.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.204 1.802 . . . . 0.0 114.645 -171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.22 172.49 8.39 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.458 1.503 . . . . 0.0 112.975 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.53 132.52 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.57 1.148 . . . . 0.0 111.458 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.26 9.45 36.13 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.345 1.698 . . . . 0.0 117.345 169.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -64.96 143.75 57.74 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.732 1.766 . . . . 0.0 114.674 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.03 142.04 51.04 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.839 1.256 . . . . 0.0 112.896 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.1 tmm? -70.17 142.18 52.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.083 1.353 . . . . 0.0 112.67 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.37 -49.64 3.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.681 1.592 . . . . 0.0 110.345 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -155.95 133.23 10.78 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.195 1.798 . . . . 0.0 109.812 161.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -110.65 12.29 22.66 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.769 -1.207 . . . . 0.0 112.519 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 59.91 19.69 8.67 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.699 2.0 . . . . 0.0 115.659 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -77.05 17.38 0.45 Allowed 'General case' 0 CA--C 1.552 1.03 0 O-C-N 120.494 -1.379 . . . . 0.0 113.914 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.33 -172.94 16.13 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.87 2.652 . . . . 0.0 110.652 166.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 147.4 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 124.822 1.249 . . . . 0.0 112.102 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.77 126.82 28.64 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.038 -1.039 . . . . 0.0 112.92 -176.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 6.3 p-10 -113.35 31.27 6.59 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.718 2.007 . . . . 0.0 115.361 -170.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.76 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 68.1 m95 -132.94 152.57 51.9 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.677 1.591 . . . . 0.0 111.016 -162.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.02 156.25 47.82 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.139 -0.976 . . . . 0.0 112.497 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.25 138.09 18.01 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.41 1.605 . . . . 0.0 112.094 161.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.423 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 10.7 p90 -166.38 175.45 8.18 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.748 1.219 . . . . 0.0 112.886 -175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.0 p -159.63 173.72 15.66 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -161.92 164.23 35.2 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.692 2.091 . . . . 0.0 112.024 168.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 50.25 44.93 26.33 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 122.703 1.24 . . . . 0.0 113.429 -174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.75 -3.74 61.03 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 117.331 1.692 . . . . 0.0 117.331 160.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 172.67 10.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.677 1.738 . . . . 0.0 112.207 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -167.22 144.79 4.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.202 1.401 . . . . 0.0 110.463 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.24 141.4 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -151.89 119.32 6.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.156 1.382 . . . . 0.0 112.271 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -108.31 141.09 40.62 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.884 1.274 . . . . 0.0 113.823 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 153.51 43.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.395 1.078 . . . . 0.0 112.873 -177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.48 136.8 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.418 1.087 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 m -141.27 -176.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.971 2.108 . . . . 0.0 111.037 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.6 m -67.76 142.21 56.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 119.93 -1.731 . . . . 0.0 111.704 164.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.86 -160.78 13.09 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.26 1.41 . . . . 0.0 115.707 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -94.89 -25.82 16.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.549 1.54 . . . . 0.0 112.573 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -133.72 127.48 32.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.029 0.531 . . . . 0.0 109.642 153.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.26 -122.33 29.76 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 123.695 0.664 . . . . 0.0 112.983 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.58 161.68 16.05 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.544 0.688 . . . . 0.0 111.383 176.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.74 -177.59 17.93 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.704 2.097 . . . . 0.0 110.595 173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.6 tpp -128.23 119.89 26.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.294 1.038 . . . . 0.0 110.052 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -84.68 137.86 33.0 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.069 0.948 . . . . 0.0 109.864 169.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.88 121.45 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 109.945 156.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -93.53 139.51 30.66 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.158 0.983 . . . . 0.0 108.741 158.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 0.7 OUTLIER -147.21 154.97 41.68 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 171.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.2 m -98.52 124.81 43.48 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 157.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -114.41 164.12 12.11 Favored Glycine 0 N--CA 1.467 0.756 0 CA-C-N 119.784 1.174 . . . . 0.0 113.167 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -129.94 160.68 32.85 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -71.6 -34.16 69.62 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.854 -1.154 . . . . 0.0 111.097 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -118.77 3.29 11.64 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -164.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -111.25 -147.05 10.77 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 115.413 0.925 . . . . 0.0 115.413 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.2 149.07 26.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 122.998 1.38 . . . . 0.0 111.898 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.438 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR 0.257 0.0 OUTLIER -126.24 -178.05 4.19 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.45 1.5 . . . . 0.0 107.751 175.076 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -164.77 139.46 5.84 Favored Glycine 0 N--CA 1.467 0.735 0 O-C-N 120.001 -1.687 . . . . 0.0 115.8 -162.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.3 m -152.89 138.15 17.47 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.929 1.292 . . . . 0.0 108.481 159.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 149' ' ' HIS . 32.7 t -132.25 142.94 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -167.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.76 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -142.39 127.08 18.04 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.162 0.982 . . . . 0.0 111.383 -169.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 t -96.45 120.3 36.5 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.887 1.275 . . . . 0.0 109.94 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.7 mt -82.66 140.76 44.29 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.535 0.734 . . . . 0.0 111.15 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -56.46 -30.48 82.19 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.736 2.958 . . . . 0.0 115.599 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -160.42 -169.11 2.34 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 126.165 1.786 . . . . 0.0 113.161 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.583 ' HA2' ' CZ3' ' A' ' 65' ' ' TRP . . . -144.35 93.0 0.17 Allowed Glycine 0 N--CA 1.475 1.234 0 C-N-CA 128.482 2.944 . . . . 0.0 109.969 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -157.69 48.23 0.4 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.494 0.664 . . . . 0.0 111.366 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.583 ' CZ3' ' HA2' ' A' ' 63' ' ' GLY . 2.9 m95 -83.71 6.69 20.12 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.185 -1.572 . . . . 0.0 110.591 176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -72.65 -5.78 39.77 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.474 -1.391 . . . . 0.0 113.975 -164.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -109.66 8.36 24.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 128.311 2.644 . . . . 0.0 112.854 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -121.57 157.43 30.75 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.845 2.058 . . . . 0.0 109.975 -173.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.85 -40.69 3.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -161.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -141.65 156.12 45.67 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.108 0.963 . . . . 0.0 111.699 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.3 tt -91.63 163.95 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 156.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -145.48 153.53 41.24 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.604 -1.31 . . . . 0.0 112.095 157.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -140.01 169.09 18.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.514 1.526 . . . . 0.0 110.431 164.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -109.72 145.08 37.2 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.217 0.607 . . . . 0.0 111.071 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.0 tt -148.61 148.39 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.62 154.53 41.59 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 147.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 t -77.58 140.39 39.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.108 1.363 . . . . 0.0 111.462 171.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.251 8.7 p -116.3 12.65 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.497 1.119 . . . . 0.0 111.298 164.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -98.22 -23.19 15.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.306 1.842 . . . . 0.0 113.081 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.51 43.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.634 1.588 . . . . 0.0 116.457 174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.1 p -74.91 169.24 18.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.97 1.708 . . . . 0.0 114.399 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.98 85.76 4.84 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.688 1.195 . . . . 0.0 109.533 165.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -124.16 159.48 29.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.164 1.386 . . . . 0.0 113.161 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -131.83 148.52 52.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.215 1.006 . . . . 0.0 112.467 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 pt -135.41 163.49 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.429 1.491 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.32 152.23 50.77 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.297 1.039 . . . . 0.0 111.989 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -120.64 156.24 32.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.465 2.306 . . . . 0.0 110.31 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -155.86 144.45 20.25 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.567 0.747 . . . . 0.0 110.178 -173.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 tt -129.29 148.17 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.712 1.205 . . . . 0.0 110.36 167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.5 133.81 49.64 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.647 1.179 . . . . 0.0 111.876 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -81.75 163.61 22.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.386 1.074 . . . . 0.0 110.946 162.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.22 145.16 33.76 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.742 -1.224 . . . . 0.0 113.474 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.95 142.25 57.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.711 1.204 . . . . 0.0 111.059 167.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.2 pt -74.37 -15.16 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.9 -12.89 16.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.735 1.614 . . . . 0.0 113.032 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.53 15.82 75.06 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.213 1.387 . . . . 0.0 116.055 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.18 137.7 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 125.939 1.695 . . . . 0.0 108.479 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.13 -135.24 27.61 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 -168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -136.53 -179.4 5.66 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.645 1.178 . . . . 0.0 112.893 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.0 -135.82 5.57 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.064 1.792 . . . . 0.0 111.997 166.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.34 149.71 48.13 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.009 0.904 . . . . 0.0 110.472 167.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.447 ' CE1' ' CE1' ' A' ' 129' ' ' TYR . 40.5 m170 -100.28 135.19 42.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.636 0.774 . . . . 0.0 109.712 164.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -125.28 122.99 38.51 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.686 1.195 . . . . 0.0 110.842 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.0 153.17 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -159.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -152.33 163.59 39.15 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.964 1.706 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -125.0 139.93 53.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.87 1.668 . . . . 0.0 113.172 -173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.01 157.07 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.498 1.519 . . . . 0.0 113.423 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -130.89 135.29 27.11 Favored Pre-proline 0 N--CA 1.483 1.201 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -83.8 178.5 5.42 Favored 'Trans proline' 0 CA--C 1.542 0.916 1 C-N-CA 126.115 4.543 . . . . 0.0 113.994 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.69 175.15 6.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 110.941 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.3 p -74.45 11.09 1.07 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.828 2.051 . . . . 0.0 116.027 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.9 p -149.59 150.41 32.17 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.555 1.942 . . . . 0.0 111.924 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -46.01 128.32 9.1 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.305 1.442 . . . . 0.0 114.031 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -139.82 147.58 40.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.375 1.87 . . . . 0.0 111.128 170.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 m -85.04 121.85 28.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.126 0.97 . . . . 0.0 108.935 167.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.7 mm -100.12 95.36 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.963 1.305 . . . . 0.0 107.695 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -82.2 133.3 35.25 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 110.564 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.0 mt -130.86 119.29 17.98 Favored Pre-proline 0 N--CA 1.477 0.912 0 C-N-CA 123.425 0.69 . . . . 0.0 109.641 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -83.49 161.54 14.77 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.401 2.734 . . . . 0.0 111.777 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -65.73 -14.15 60.73 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.036 -1.04 . . . . 0.0 113.384 171.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.6 m -73.94 -6.87 49.91 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.6 m -104.11 -9.02 19.04 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -86.14 140.82 29.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.334 1.054 . . . . 0.0 113.597 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -121.89 175.05 6.5 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.174 1.79 . . . . 0.0 110.63 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -105.34 159.65 15.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -103.94 136.57 43.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.486 2.314 . . . . 0.0 109.229 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.4 tp -151.28 -8.2 0.24 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -76.43 -25.86 54.87 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.268 -1.52 . . . . 0.0 111.374 163.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.447 ' CE1' ' CE1' ' A' ' 102' ' ' HIS . 3.5 t80 -97.64 137.99 35.71 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.375 2.27 . . . . 0.0 110.009 157.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 141.54 6.96 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.137 0.975 . . . . 0.0 110.854 163.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -66.4 156.41 65.39 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.111 2.54 . . . . 0.0 112.981 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.04 -23.97 10.1 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 124.035 3.157 . . . . 0.0 114.304 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.27 36.76 3.7 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.635 1.588 . . . . 0.0 113.385 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.64 151.83 39.27 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -167.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -56.75 128.68 37.79 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.573 -1.194 . . . . 0.0 109.34 147.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 11.8 ttt -123.15 31.69 5.91 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.65 1.58 . . . . 0.0 111.55 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.7 p -75.77 -17.11 60.0 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.712 1.205 . . . . 0.0 114.043 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.94 -2.99 72.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.953 1.263 . . . . 0.0 116.247 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 50.9 m -144.79 156.05 43.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.248 1.419 . . . . 0.0 110.814 -174.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.63 124.73 25.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.297 1.039 . . . . 0.0 112.616 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -115.43 91.78 3.71 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.452 1.901 . . . . 0.0 110.028 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' TRP . 6.4 mt -73.66 -10.88 60.15 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.98 -1.075 . . . . 0.0 113.341 -174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -68.03 -8.51 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.339 1.856 . . . . 0.0 112.645 166.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -138.01 30.55 2.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.97 1.308 . . . . 0.0 112.977 -165.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.6 mm -77.85 144.03 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -115.86 -46.64 2.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.731 1.612 . . . . 0.0 114.646 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 p -166.39 166.48 16.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.103 0.961 . . . . 0.0 113.057 -166.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.0 pt -130.25 153.9 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 125.58 1.552 . . . . 0.0 111.444 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.51 ' CE1' HG13 ' A' ' 57' ' ' VAL . 74.7 m-70 -138.62 151.11 46.96 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.911 1.284 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -83.26 151.98 25.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.296 159.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 47.2 mtt -140.68 152.49 45.4 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.678 1.191 . . . . 0.0 111.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 29.8 m-85 -120.34 100.56 7.24 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -146.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.65 14.46 24.46 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.499 1.92 . . . . 0.0 113.262 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -133.37 148.67 51.84 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.03 0.932 . . . . 0.0 112.825 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -128.05 4.04 5.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.816 1.247 . . . . 0.0 114.176 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -71.05 170.4 12.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.391 1.076 . . . . 0.0 112.5 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.7 m -94.64 133.31 38.43 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 148.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 174.59 -172.24 45.25 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 115.505 0.962 . . . . 0.0 115.505 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -133.72 142.45 47.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.081 1.352 . . . . 0.0 112.746 -171.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -151.58 162.08 41.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.855 0.862 . . . . 0.0 112.648 167.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.6 138.2 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 125.062 1.345 . . . . 0.0 111.363 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 33.6 m -123.02 167.12 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.795 1.638 . . . . 0.0 112.101 170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -154.86 172.88 17.29 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.012 0.925 . . . . 0.0 111.773 168.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 62.68 47.81 4.59 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 148.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 2.4 mt -68.46 131.37 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.913 1.285 . . . . 0.0 109.773 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -155.6 161.06 40.9 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.976 1.71 . . . . 0.0 113.145 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -108.54 138.33 45.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.204 1.802 . . . . 0.0 110.085 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.04 134.63 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.184 1.794 . . . . 0.0 110.576 -171.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.41 -176.74 51.22 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 122.403 1.002 . . . . 0.0 114.879 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.61 147.61 52.58 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 111.597 169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 pp -125.27 123.23 39.05 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.07 0.948 . . . . 0.0 109.293 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 . . . . . 0 C--O 1.256 1.44 0 C-N-CA 126.594 1.957 . . . . 0.0 111.192 -153.591 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 119.477 -0.296 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.47 156.6 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.204 1.001 . . . . 0.0 111.658 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.0 m -81.07 45.88 0.87 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.796 0.838 . . . . 0.0 112.567 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.16 162.56 22.85 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.979 2.512 . . . . 0.0 109.133 172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t 67.82 -42.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 127.928 2.491 . . . . 0.0 115.865 169.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.06 57.19 8.9 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.765 1.65 . . . . 0.0 114.236 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.99 150.73 37.37 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.527 1.663 . . . . 0.0 113.159 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -148.14 136.44 21.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.129 1.771 . . . . 0.0 111.044 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -77.38 135.15 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.6 mt -112.6 -41.65 3.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.362 1.465 . . . . 0.0 113.835 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -161.92 164.06 28.75 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.728 2.011 . . . . 0.0 110.231 167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -146.35 17.34 1.34 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.055 -1.653 . . . . 0.0 113.996 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 54.27 36.49 25.28 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 169.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -83.37 34.13 0.47 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.603 1.561 . . . . 0.0 111.321 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.06 179.11 40.39 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 127.948 2.689 . . . . 0.0 110.853 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.9 t -56.03 145.43 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.229 1.412 . . . . 0.0 112.657 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 tt -58.11 124.42 19.31 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.863 1.665 . . . . 0.0 112.5 -174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.325 1.0 OUTLIER -108.17 37.28 2.52 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -168.818 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.68 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 74.9 m95 -135.58 147.75 48.82 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 127.719 2.408 . . . . 0.0 111.571 -166.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 123.4 7.21 Favored Glycine 0 C--N 1.34 0.793 0 N-CA-C 115.607 1.003 . . . . 0.0 115.607 -155.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -94.31 156.33 16.57 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.68 161.6 36.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.593 1.557 . . . . 0.0 110.972 165.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.6 p -155.24 144.12 20.72 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 155.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.27 172.96 33.37 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 121.846 -0.534 . . . . 0.0 111.806 156.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -53.7 -38.17 63.97 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.845 -1.386 . . . . 0.0 113.918 -170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.81 -5.27 88.16 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 116.992 1.557 . . . . 0.0 116.992 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.24 167.05 10.59 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.919 1.86 . . . . 0.0 113.559 -173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -155.12 156.02 35.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.761 2.024 . . . . 0.0 112.167 169.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.73 127.02 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 125.6 1.56 . . . . 0.0 109.706 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.4 t -153.15 124.11 7.41 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.906 -1.121 . . . . 0.0 111.96 -167.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.5 p -125.85 152.76 45.07 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -160.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.11 164.1 38.65 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.251 1.42 . . . . 0.0 114.523 169.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.46 142.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.85 1.66 . . . . 0.0 112.813 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.07 168.49 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 126.338 1.855 . . . . 0.0 111.105 170.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.3 t -72.16 129.73 39.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.688 -0.632 . . . . 0.0 109.709 158.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.01 -157.56 33.63 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.076 0.846 . . . . 0.0 113.461 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.0 tttp -68.57 -29.95 68.61 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.955 -0.732 . . . . 0.0 111.451 169.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.0 p -150.02 123.59 9.12 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.395 1.878 . . . . 0.0 108.027 -173.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.3 -121.44 24.07 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -170.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -107.59 172.98 6.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.422 1.106 . . . . 0.0 112.462 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.7 -170.94 12.28 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 127.336 2.398 . . . . 0.0 110.987 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.09 135.25 49.56 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.334 0.654 . . . . 0.0 111.512 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -96.96 144.12 27.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.688 1.195 . . . . 0.0 109.844 163.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -122.92 145.2 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.593 1.557 . . . . 0.0 110.605 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.1 t -97.09 103.03 14.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 152.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -90.77 97.82 11.41 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.957 0.884 . . . . 0.0 108.82 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.3 m -88.67 131.27 35.07 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.529 1.132 . . . . 0.0 109.974 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.83 159.58 31.98 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 122.419 1.011 . . . . 0.0 114.469 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.7 t -167.4 -175.5 2.9 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.928 1.291 . . . . 0.0 111.411 -162.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.3 p -60.17 -46.96 87.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.814 1.645 . . . . 0.0 111.846 169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -71.0 -4.57 25.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.195 1.798 . . . . 0.0 114.429 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.68 163.53 23.88 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 120.681 -1.262 . . . . 0.0 115.295 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -133.88 167.73 20.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.895 1.678 . . . . 0.0 109.933 174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -110.16 171.59 7.36 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.15 166.39 30.51 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -150.69 130.18 12.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.2 t -137.08 143.82 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -159.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.68 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -130.94 114.63 15.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.474 1.11 . . . . 0.0 110.552 -174.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.6 m -86.31 126.86 34.63 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.569 171.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -94.5 118.85 66.92 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 0.0 110.208 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -58.35 -34.41 98.64 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.0 2.466 . . . . 0.0 114.566 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -126.45 65.4 1.24 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.692 1.597 . . . . 0.0 111.38 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.15 2.48 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 120.998 -1.064 . . . . 0.0 110.817 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -155.45 71.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.44 1.896 . . . . 0.0 108.462 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -95.17 -37.22 11.15 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 113.14 -172.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 92.7 p 45.39 -67.74 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.926 3.29 . . . . 0.0 117.806 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -73.95 -23.03 59.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.88 1.672 . . . . 0.0 114.314 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -93.59 138.23 32.06 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.157 0.983 . . . . 0.0 112.328 -170.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.7 mt -121.19 -8.77 9.22 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -152.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -139.39 156.71 46.81 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 120.799 1.636 . . . . 0.0 113.523 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.6 tt -101.78 164.57 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.716 1.206 . . . . 0.0 109.332 161.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.4 t -147.69 141.75 26.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.488 1.115 . . . . 0.0 111.191 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.23 161.41 42.08 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.541 1.536 . . . . 0.0 110.672 165.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -99.33 121.54 41.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.291 0.237 . . . . 0.0 111.192 167.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 tt -151.63 133.66 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.052 -1.655 . . . . 0.0 114.774 -167.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -165.49 170.94 13.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.394 1.478 . . . . 0.0 113.331 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.4 t -86.47 154.11 21.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.99 2.116 . . . . 0.0 112.642 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.29 -12.33 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.056 1.342 . . . . 0.0 112.828 165.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.5 4.44 20.45 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.87 6.37 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.837 1.684 . . . . 0.0 115.354 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -64.65 143.65 57.78 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.518 2.159 . . . . 0.0 112.751 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.27 38.87 3.11 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.532 2.733 . . . . 0.0 110.137 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -79.56 150.68 31.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.21 1.804 . . . . 0.0 111.427 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -85.75 134.03 33.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.929 0.871 . . . . 0.0 112.625 -169.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 pt -134.79 171.36 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.509 1.523 . . . . 0.0 111.318 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -128.04 138.18 52.47 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.043 -1.036 . . . . 0.0 110.554 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -99.24 146.79 25.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.318 154.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.9 ttp -139.44 147.97 42.12 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.913 1.285 . . . . 0.0 111.775 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.7 mm -112.72 135.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.867 1.667 . . . . 0.0 108.458 166.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.34 127.47 52.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.294 1.037 . . . . 0.0 109.915 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.25 154.17 20.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.971 1.708 . . . . 0.0 111.001 172.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -74.69 152.01 39.18 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 120.018 1.281 . . . . 0.0 112.489 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 92.0 p -57.62 167.47 1.06 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.864 1.665 . . . . 0.0 114.375 168.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.9 pt -71.94 8.04 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 164.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.17 -14.67 15.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.711 1.604 . . . . 0.0 112.429 170.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.54 18.03 79.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.465 1.031 . . . . 0.0 114.094 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -146.32 132.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.432 2.293 . . . . 0.0 108.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.17 -178.45 46.94 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 115.176 0.83 . . . . 0.0 115.176 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.99 155.17 41.14 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.485 0.714 . . . . 0.0 111.788 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -137.25 -42.21 0.1 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.75 1.167 . . . . 0.0 115.199 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -154.02 147.04 24.53 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.912 1.356 . . . . 0.0 110.053 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -127.53 130.99 50.1 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.718 0.807 . . . . 0.0 112.953 -163.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -137.88 130.21 29.22 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.464 1.105 . . . . 0.0 113.075 -168.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.27 159.41 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -170.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.6 ' CE2' HD13 ' A' ' 118' ' ' ILE . 5.5 m-30 -87.04 -173.56 4.5 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.707 0.765 . . . . 0.0 111.158 150.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 75.2 m -141.53 123.33 15.26 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 119.568 -1.957 . . . . 0.0 111.463 147.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tt -150.01 153.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 123.212 0.605 . . . . 0.0 112.356 -144.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.2 136.37 20.74 Favored Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 125.954 1.702 . . . . 0.0 114.485 -172.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -88.66 159.09 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.028 3.152 . . . . 0.0 115.124 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -114.83 175.98 5.25 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.687 2.395 . . . . 0.0 111.286 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.9 p -96.87 0.32 48.97 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.6 p -133.58 152.64 51.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.407 1.483 . . . . 0.0 113.431 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.603 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -85.46 132.24 34.25 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 127.807 2.443 . . . . 0.0 110.14 -151.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -165.06 123.84 1.73 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.767 1.227 . . . . 0.0 112.426 -146.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.8 m -79.79 128.74 33.79 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.8 mt -118.07 91.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.487 1.515 . . . . 0.0 109.382 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -74.92 123.31 24.86 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 109.785 167.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.6 HD13 ' CE2' ' A' ' 105' ' ' TYR . 6.9 mt -129.02 125.72 22.92 Favored Pre-proline 0 N--CA 1.485 1.282 0 C-N-CA 124.565 1.146 . . . . 0.0 110.297 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.88 168.16 2.51 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.859 3.039 . . . . 0.0 113.991 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -57.07 -16.94 8.43 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 m -66.54 -21.51 66.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.71 1.604 . . . . 0.0 114.163 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 70.7 m -88.87 6.35 39.56 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -101.29 146.37 27.64 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -166.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -136.7 145.27 44.52 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.099 2.16 . . . . 0.0 111.647 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -95.86 154.62 17.13 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.363 1.065 . . . . 0.0 113.212 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 157.74 20.31 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.901 0.88 . . . . 0.0 109.981 158.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -139.34 -3.66 1.53 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.468 1.507 . . . . 0.0 113.844 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.58 -14.39 60.78 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.372 0.669 . . . . 0.0 111.325 166.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -139.86 124.94 18.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.124 2.17 . . . . 0.0 110.911 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -165.56 157.07 12.58 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 125.241 1.416 . . . . 0.0 110.162 171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -74.85 170.76 19.67 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.143 2.562 . . . . 0.0 113.902 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.05 -29.84 11.42 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.939 2.426 . . . . 0.0 113.129 168.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -93.36 39.5 2.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.517 2.008 . . . . 0.0 113.154 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 152.19 24.14 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.59 114.73 18.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 108.385 160.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.5 tpt -104.21 25.48 10.01 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.924 1.69 . . . . 0.0 113.269 -164.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 62.2 p -82.59 -23.34 34.46 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.95 12.88 75.52 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.319 0.963 . . . . 0.0 114.57 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.9 t -148.36 150.46 33.6 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.487 1.143 . . . . 0.0 112.388 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.3 tp -76.84 106.28 8.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.402 1.081 . . . . 0.0 108.197 168.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -114.2 114.47 26.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.629 1.172 . . . . 0.0 111.23 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.9 mp -84.38 0.85 47.8 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -162.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -76.51 -7.05 54.36 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -154.33 96.1 1.89 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.715 0.806 . . . . 0.0 113.043 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -125.53 141.04 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.936 2.094 . . . . 0.0 110.663 -175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -91.2 -61.11 1.73 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.439 1.096 . . . . 0.0 111.321 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 69.6 m -151.73 159.31 44.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.529 HD12 ' CG ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.86 143.54 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 126.75 2.02 . . . . 0.0 108.459 159.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -140.03 138.03 35.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.986 1.314 . . . . 0.0 110.586 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -130.66 130.3 43.73 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.86 1.264 . . . . 0.0 110.745 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 90.6 mtp -153.13 145.58 24.09 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -168.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -65.44 153.83 40.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 153.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.48 12.83 7.0 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.544 154.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -121.67 170.35 9.81 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.931 1.692 . . . . 0.0 112.767 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -121.42 36.16 4.69 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.847 1.659 . . . . 0.0 113.072 -168.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -136.13 157.56 46.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.934 1.294 . . . . 0.0 111.906 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 50.4 m -90.81 162.18 14.95 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 120.812 -1.18 . . . . 0.0 113.135 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -160.03 172.71 36.58 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.032 0.825 . . . . 0.0 113.2 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.33 139.11 53.55 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.296 1.038 . . . . 0.0 109.684 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -150.64 165.18 34.14 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -167.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.476 HG23 ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -126.31 148.18 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 126.556 1.942 . . . . 0.0 113.735 175.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.9 p -138.15 139.17 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.61 1.164 . . . . 0.0 112.437 172.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -131.49 175.57 9.04 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 124.655 1.182 . . . . 0.0 112.199 155.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.3 m120 69.64 45.38 0.79 Allowed 'General case' 0 CA--C 1.558 1.273 0 N-CA-C 120.302 3.445 . . . . 0.0 120.302 156.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 4.2 mt -70.55 125.31 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 121.786 2.085 . . . . 0.0 111.556 175.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -144.3 160.55 40.83 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.619 1.168 . . . . 0.0 113.53 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 20.7 tp -104.34 138.12 41.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.866 2.066 . . . . 0.0 109.103 166.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.9 mm -118.2 133.64 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.188 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.36 -74.55 0.59 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 125.408 1.48 . . . . 0.0 112.847 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -82.74 154.37 24.82 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.513 1.125 . . . . 0.0 113.565 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.5 tp -138.52 124.51 20.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.033 2.133 . . . . 0.0 108.876 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.569 1.548 . . . . 0.0 112.311 -176.613 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.16 129.07 12.53 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.725 0.81 . . . . 0.0 111.62 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 p -158.09 150.31 22.06 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.99 1.716 . . . . 0.0 111.173 -171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.13 -28.92 12.42 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.121 1.368 . . . . 0.0 112.563 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.32 129.49 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.407 1.483 . . . . 0.0 109.99 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.76 -55.38 0.73 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.539 1.543 . . . . 0.0 115.89 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -98.25 101.53 13.02 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.117 1.367 . . . . 0.0 113.596 -158.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -101.51 126.0 48.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.642 1.177 . . . . 0.0 110.495 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.5 mmm -76.17 142.2 41.63 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -110.75 -54.85 2.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.627 1.571 . . . . 0.0 111.96 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -156.94 141.23 16.52 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.094 1.358 . . . . 0.0 110.197 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -132.31 16.77 4.5 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.193 1.397 . . . . 0.0 112.443 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 59.85 14.48 4.24 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.343 2.257 . . . . 0.0 115.947 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -73.68 5.74 3.72 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -168.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.12 -141.42 3.44 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.101 1.81 . . . . 0.0 112.113 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.8 t -67.64 134.29 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.085 0.954 . . . . 0.0 110.112 174.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 tt -72.83 137.54 45.79 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.269 0.628 . . . . 0.0 111.895 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.98 41.95 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.626 1.57 . . . . 0.0 113.963 -172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -129.05 145.81 51.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.398 1.479 . . . . 0.0 111.852 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.05 109.75 3.32 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.168 1.366 . . . . 0.0 113.641 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.75 120.19 39.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.574 1.687 . . . . 0.0 111.167 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.683 ' CE1' HG23 ' A' ' 57' ' ' VAL . 30.3 p90 -150.06 157.23 42.92 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 112.437 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.0 p -160.32 170.31 21.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.402 1.481 . . . . 0.0 112.25 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -172.5 -171.42 37.33 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.889 -1.132 . . . . 0.0 115.013 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 43.31 54.56 5.08 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.914 1.686 . . . . 0.0 112.655 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.54 -18.15 48.05 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.582 1.086 . . . . 0.0 115.476 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 158.23 22.55 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.236 1.518 . . . . 0.0 114.068 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -136.81 142.45 42.92 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.733 2.013 . . . . 0.0 110.838 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.06 157.35 33.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.549 1.94 . . . . 0.0 111.555 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -150.79 136.4 18.02 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.661 1.985 . . . . 0.0 110.511 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.3 p -141.74 99.3 3.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.975 1.71 . . . . 0.0 110.916 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -124.05 167.52 14.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.409 1.884 . . . . 0.0 111.765 -171.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.63 143.98 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 O-C-N 120.843 -1.161 . . . . 0.0 113.127 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.2 -173.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 129.331 3.052 . . . . 0.0 111.014 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -82.62 146.77 28.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.153 -1.592 . . . . 0.0 112.464 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.18 170.26 24.41 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.025 0.821 . . . . 0.0 115.048 175.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -48.79 -27.78 3.21 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.247 1.819 . . . . 0.0 114.729 -175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.56 118.15 23.4 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 110.269 159.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.84 -109.03 2.41 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.207 1.384 . . . . 0.0 113.418 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -110.8 160.8 16.41 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.929 0.892 . . . . 0.0 110.968 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.62 -176.03 14.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 126.864 2.173 . . . . 0.0 111.682 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -130.2 125.6 35.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.125 0.97 . . . . 0.0 111.061 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -97.94 125.43 42.85 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.664 1.586 . . . . 0.0 112.352 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -116.2 141.34 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.356 -1.293 . . . . 0.0 111.222 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -144.84 147.84 33.3 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.897 1.679 . . . . 0.0 109.472 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -146.46 155.14 42.34 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.258 1.028 . . . . 0.0 113.254 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.9 m -114.71 122.97 48.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.455 1.502 . . . . 0.0 107.504 167.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -123.88 164.32 17.15 Favored Glycine 0 N--CA 1.474 1.203 0 C-N-CA 123.737 0.684 . . . . 0.0 114.545 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.8 t -154.08 165.9 34.73 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.861 1.664 . . . . 0.0 109.987 177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.3 p -54.31 -45.63 72.63 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -166.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.7 p-10 -97.96 -4.57 36.04 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.625 1.97 . . . . 0.0 114.535 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.92 162.97 52.13 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.932 1.253 . . . . 0.0 113.352 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -148.21 155.37 41.29 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -170.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -147.94 163.5 36.65 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 129.08 2.952 . . . . 0.0 108.568 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.57 27.2 0.1 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 119.094 2.397 . . . . 0.0 119.094 -162.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -44.25 128.0 5.88 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -152.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.683 HG23 ' CE1' ' A' ' 22' ' ' TYR . 45.8 t -90.75 141.02 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.74 1.155 . . . . 0.0 112.04 -169.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -121.97 131.68 54.13 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.673 0.789 . . . . 0.0 110.475 151.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 t -94.73 121.81 36.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.69 1.196 . . . . 0.0 110.646 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.24 119.73 71.83 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.153 1.381 . . . . 0.0 109.744 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -55.86 -34.98 93.12 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.419 2.746 . . . . 0.0 114.675 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -156.23 132.66 10.13 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.977 0.911 . . . . 0.0 111.381 163.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.06 25.4 6.91 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.885 1.707 . . . . 0.0 114.139 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.6 47.32 1.16 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.133 1.773 . . . . 0.0 113.845 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -76.43 -49.08 17.59 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.799 -1.188 . . . . 0.0 113.759 -166.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p 48.95 -63.6 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 129.532 3.133 . . . . 0.0 117.683 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -87.43 -19.52 27.93 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -172.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 16.3 m-90 -73.9 148.92 41.83 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 118.46 0.573 . . . . 0.0 111.1 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.41 -29.08 3.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.841 1.257 . . . . 0.0 114.368 -158.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -141.49 155.57 45.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.231 1.012 . . . . 0.0 111.371 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.5 tt -84.91 163.02 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 153.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.5 t -144.9 141.2 28.85 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.029 0.932 . . . . 0.0 110.702 165.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -152.01 160.76 43.38 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.324 1.049 . . . . 0.0 111.59 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.46 121.98 43.42 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.515 -0.741 . . . . 0.0 112.377 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 tt -147.24 132.8 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.752 -0.593 . . . . 0.0 112.301 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' CD2' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -167.58 159.75 12.37 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.672 1.589 . . . . 0.0 113.275 -175.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 t -78.36 138.69 38.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.43 1.492 . . . . 0.0 112.597 -173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.5 m -117.04 6.79 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.194 . . . . 0.0 112.445 167.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -105.88 152.07 23.74 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.66 1.584 . . . . 0.0 109.303 152.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.05 -10.36 56.19 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.492 -1.38 . . . . 0.0 115.086 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 53.0 m -58.95 161.47 4.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.609 1.964 . . . . 0.0 113.868 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.11 28.5 5.75 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.005 1.722 . . . . 0.0 111.753 170.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -59.53 133.1 55.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.874 1.269 . . . . 0.0 111.624 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.19 157.02 18.93 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -167.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 pt -139.76 166.78 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.603 1.161 . . . . 0.0 111.13 -166.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.0 mtm-85 -126.27 137.57 53.53 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.174 1.39 . . . . 0.0 110.863 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -96.97 137.45 36.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttp -137.09 141.84 42.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.467 0.651 . . . . 0.0 112.591 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 79.2 mt -126.04 137.2 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.036 2.134 . . . . 0.0 107.261 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.97 153.01 51.87 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.814 1.293 . . . . 0.0 113.323 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.96 156.93 19.14 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.565 1.946 . . . . 0.0 112.368 -160.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.17 137.01 52.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.228 -1.545 . . . . 0.0 114.264 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.3 t -57.4 136.24 56.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.339 1.456 . . . . 0.0 113.122 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.82 -22.04 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 174.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -101.28 -4.5 26.97 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.522 1.129 . . . . 0.0 113.363 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.69 0.16 88.94 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.702 1.144 . . . . 0.0 115.085 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.55 138.54 47.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 126.728 2.011 . . . . 0.0 108.027 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.74 -168.13 54.67 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.804 0.716 . . . . 0.0 114.11 -169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.64 153.8 31.94 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.318 1.447 . . . . 0.0 112.699 169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.24 108.62 3.2 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 157.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.592 ' H ' ' HB3' ' A' ' 135' ' ' ASP . 38.5 tt0 -83.62 147.24 27.83 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 110.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.77 160.28 41.5 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.626 1.679 . . . . 0.0 112.96 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -145.34 119.85 9.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.627 -2.533 . . . . 0.0 109.226 -148.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.45 149.76 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -166.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -138.22 133.2 32.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.313 1.845 . . . . 0.0 110.26 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.5 m -119.46 126.03 50.34 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.921 1.288 . . . . 0.0 112.777 -165.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -152.22 165.54 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.875 -162.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.6 p -113.65 146.69 36.0 Favored Pre-proline 0 N--CA 1.48 1.06 0 C-N-CA 127.138 2.175 . . . . 0.0 112.628 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -87.7 141.99 5.67 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.827 3.018 . . . . 0.0 114.218 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -95.41 171.47 8.68 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.673 1.589 . . . . 0.0 112.416 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 97.2 p -83.76 -6.92 59.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -170.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.0 p -157.11 161.23 39.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 120.952 1.706 . . . . 0.0 113.803 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.529 ' CD2' ' HE3' ' A' ' 76' ' ' LYS . 76.1 m95 -42.38 126.01 3.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.358 1.863 . . . . 0.0 112.868 -174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -154.11 118.47 4.84 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.822 2.049 . . . . 0.0 107.374 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -95.66 108.77 21.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.58 92.51 2.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 124.771 1.228 . . . . 0.0 109.449 -165.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -71.14 122.66 20.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.961 165.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.1 mt -128.11 117.66 20.51 Favored Pre-proline 0 N--CA 1.478 0.952 0 C-N-CA 125.373 1.469 . . . . 0.0 110.174 -174.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.93 170.18 18.33 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.951 3.101 . . . . 0.0 113.946 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.44 -24.02 28.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 170.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.3 p -79.38 -16.29 56.47 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.8 m -82.45 -15.97 50.6 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.577 1.081 . . . . 0.0 113.365 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -90.94 137.94 31.98 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.799 1.24 . . . . 0.0 111.441 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 91.2 mtm180 -133.31 156.2 48.03 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.202 1.401 . . . . 0.0 110.729 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.8 ttt-85 -76.71 144.84 39.08 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.714 0.806 . . . . 0.0 111.725 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 tpt180 -79.61 139.19 37.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.728 1.211 . . . . 0.0 109.606 166.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.59 -31.91 3.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -171.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -78.4 -13.16 59.97 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.521 -1.362 . . . . 0.0 112.052 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.75 142.8 45.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.382 2.273 . . . . 0.0 110.016 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -140.69 153.62 68.12 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 124.588 1.155 . . . . 0.0 111.673 156.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -67.53 170.11 14.36 Favored 'Trans proline' 0 CA--C 1.553 1.462 1 C-N-CA 125.394 4.063 . . . . 0.0 115.904 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -81.03 -24.93 4.37 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 124.303 3.335 . . . . 0.0 116.386 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -133.62 103.26 0.49 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.422 1.487 . . . . 0.0 110.768 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -123.71 165.19 17.67 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -149.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.592 ' HB3' ' H ' ' A' ' 101' ' ' GLU . 0.4 OUTLIER -90.73 159.33 16.4 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.079 1.752 . . . . 0.0 106.973 147.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptp -142.15 24.58 1.96 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 119.681 -1.887 . . . . 0.0 114.447 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.8 p -77.66 -12.81 60.01 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -169.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.82 5.16 60.49 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.054 1.297 . . . . 0.0 113.799 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.6 p -136.98 156.33 48.59 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.467 1.907 . . . . 0.0 110.439 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.35 110.23 21.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.252 1.421 . . . . 0.0 109.216 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -99.44 91.15 4.79 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.472 1.909 . . . . 0.0 112.03 -163.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.83 31.2 0.16 Allowed 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.027 -1.671 . . . . 0.0 114.129 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -118.94 3.21 11.54 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 156.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -144.42 28.43 1.33 Allowed 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 -164.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.0 mm -80.39 137.75 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.322 -1.486 . . . . 0.0 112.238 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.09 -58.95 1.95 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.763 1.225 . . . . 0.0 112.357 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -155.26 156.93 36.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.743 1.217 . . . . 0.0 112.692 -166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.75 152.97 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.206 1.402 . . . . 0.0 111.248 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' HE1' HG22 ' A' ' 57' ' ' VAL . 96.5 m-70 -146.27 143.5 29.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.024 0.93 . . . . 0.0 112.599 -166.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -100.98 129.87 46.88 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 162.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 25.6 ptm -145.46 172.84 12.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 122.169 0.985 . . . . 0.0 113.133 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -78.14 144.44 36.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.157 1.383 . . . . 0.0 113.022 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.44 1.84 11.79 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.393 1.077 . . . . 0.0 111.572 153.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.44 145.26 17.53 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.218 3.007 . . . . 0.0 108.011 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.66 6.09 23.48 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.239 1.415 . . . . 0.0 114.45 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -69.68 144.65 52.8 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.576 1.08 . . . . 0.0 109.941 165.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -67.34 153.68 43.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.014 1.326 . . . . 0.0 112.653 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.19 -179.89 40.92 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.134 0.814 . . . . 0.0 115.134 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -151.83 137.39 17.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.605 1.962 . . . . 0.0 112.029 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.45 167.0 25.52 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 174.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -126.16 138.37 54.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.76 1.224 . . . . 0.0 110.945 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.7 t -122.35 145.96 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.79 1.636 . . . . 0.0 111.581 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -152.99 -179.74 7.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.588 162.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 64.69 44.68 3.73 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 155.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.483 1.113 . . . . 0.0 111.21 -170.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -138.63 161.33 37.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.901 1.68 . . . . 0.0 113.297 -168.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.7 tp -111.94 136.05 51.77 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.357 2.663 . . . . 0.0 108.0 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.7 mm -114.65 126.89 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.267 1.027 . . . . 0.0 111.82 -166.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -102.91 -20.4 11.52 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 116.541 1.376 . . . . 0.0 116.541 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -103.38 163.67 12.12 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.566 1.546 . . . . 0.0 112.321 -176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 19.5 tp -140.11 69.23 1.35 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.831 1.252 . . . . 0.0 110.632 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 C--O 1.253 1.237 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -177.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 140.41 51.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.698 0.799 . . . . 0.0 111.948 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.1 m -75.27 -17.0 60.4 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.646 0.778 . . . . 0.0 112.212 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 146.2 31.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.003 1.321 . . . . 0.0 113.517 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 m -139.4 164.45 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 128.215 2.606 . . . . 0.0 110.194 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.5 82.56 0.88 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.314 0.959 . . . . 0.0 112.432 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -159.44 165.15 33.75 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.175 1.39 . . . . 0.0 112.734 -171.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -138.22 124.59 20.56 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.771 1.628 . . . . 0.0 110.164 173.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.6 tpp -73.07 142.65 47.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 112.396 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -98.74 -55.78 2.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.373 1.469 . . . . 0.0 111.2 165.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -145.75 150.09 35.6 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 122.449 1.119 . . . . 0.0 111.654 163.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -120.78 -2.66 9.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.068 2.147 . . . . 0.0 113.141 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 61.49 2.1 0.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.872 2.069 . . . . 0.0 116.535 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -26.5 68.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 121.281 1.855 . . . . 0.0 113.623 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.35 -129.1 3.95 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.177 1.846 . . . . 0.0 113.153 174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.74 145.52 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.354 1.462 . . . . 0.0 110.588 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 19' ' ' TRP . 9.9 tt -85.05 134.58 34.2 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.866 1.266 . . . . 0.0 111.113 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -128.27 35.93 4.35 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.368 2.267 . . . . 0.0 113.581 -168.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.49 ' H ' HD23 ' A' ' 17' ' ' LEU . 17.0 m95 -126.3 142.97 51.33 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.977 1.711 . . . . 0.0 109.534 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.83 162.06 33.77 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -141.76 156.95 45.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -143.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -155.59 158.12 37.88 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.0 p -160.56 167.72 26.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.789 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -141.99 -17.12 0.33 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 116.64 1.416 . . . . 0.0 116.64 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -136.29 88.04 2.35 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.107 1.363 . . . . 0.0 110.326 -167.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.78 -23.55 0.3 Allowed Glycine 0 CA--C 1.538 1.484 0 C-N-CA 127.551 2.5 . . . . 0.0 116.839 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.22 155.32 26.18 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.693 1.597 . . . . 0.0 111.507 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -154.36 133.4 12.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.726 1.61 . . . . 0.0 109.248 -171.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.9 p -137.48 152.43 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.752 1.221 . . . . 0.0 112.542 -167.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.8 p -162.8 154.1 17.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.683 1.593 . . . . 0.0 113.994 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -107.23 153.67 22.36 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.426 1.89 . . . . 0.0 111.85 167.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.54 163.58 32.18 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.818 2.047 . . . . 0.0 111.478 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -102.4 133.06 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.748 2.019 . . . . 0.0 109.217 174.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.8 m -146.5 168.47 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 126.153 1.781 . . . . 0.0 111.526 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 m -70.91 128.85 37.4 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.012 -1.68 . . . . 0.0 112.075 168.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.26 -176.16 14.27 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 125.088 1.327 . . . . 0.0 113.385 175.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -46.13 -33.78 3.78 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.252 1.421 . . . . 0.0 114.191 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 t -146.93 129.48 15.97 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.893 0.477 . . . . 0.0 110.873 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.56 -115.85 6.85 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.078 0.847 . . . . 0.0 111.538 -170.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -107.13 152.26 24.28 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.616 1.198 . . . . 0.0 112.223 172.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.96 -174.53 46.74 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.335 1.445 . . . . 0.0 111.363 163.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.9 tmm? -126.27 122.7 36.25 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.302 1.441 . . . . 0.0 108.85 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -99.17 137.02 38.28 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 109.632 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.61 133.65 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.737 0.815 . . . . 0.0 111.133 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -127.76 133.56 49.49 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.675 1.19 . . . . 0.0 110.575 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.08 149.3 34.81 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.2 m -94.29 128.73 40.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.745 1.618 . . . . 0.0 107.292 157.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.29 178.38 18.57 Favored Glycine 0 N--CA 1.472 1.049 0 CA-C-N 119.343 0.974 . . . . 0.0 113.607 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -134.29 159.81 39.83 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.9 p -83.4 -23.55 32.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.46 1.104 . . . . 0.0 113.491 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -137.98 9.68 2.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.283 1.833 . . . . 0.0 113.22 -173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.31 -148.83 16.37 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.676 1.132 . . . . 0.0 113.564 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.44 143.55 13.44 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.302 1.041 . . . . 0.0 113.057 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.41 167.84 22.62 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.738 1.615 . . . . 0.0 111.056 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.58 166.06 38.22 Favored Glycine 0 CA--C 1.541 1.669 0 O-C-N 120.629 -1.294 . . . . 0.0 114.858 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -162.03 146.64 12.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.326 1.451 . . . . 0.0 112.076 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 149' ' ' HIS . 38.2 t -144.03 129.01 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -154.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -100.45 121.23 41.2 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.202 1.801 . . . . 0.0 112.203 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.5 m -98.38 79.96 2.58 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.019 1.328 . . . . 0.0 110.485 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.52 149.15 95.72 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -170.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -62.74 -25.41 74.89 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.062 2.508 . . . . 0.0 116.018 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.22 138.08 29.41 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.778 1.631 . . . . 0.0 112.156 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.05 21.64 3.49 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.273 1.892 . . . . 0.0 114.151 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -130.33 70.12 1.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.459 . . . . 0.0 108.619 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -81.83 3.2 26.91 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.899 1.28 . . . . 0.0 113.196 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.4 p -41.76 -17.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 129.574 3.149 . . . . 0.0 117.684 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -74.02 -5.21 40.05 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.423 1.889 . . . . 0.0 114.53 170.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -131.17 172.53 12.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.646 1.578 . . . . 0.0 113.014 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.73 -35.96 5.84 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.583 1.553 . . . . 0.0 113.324 -171.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -143.14 160.34 40.61 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.047 1.339 . . . . 0.0 112.124 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.8 tt -92.95 162.61 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.831 0.852 . . . . 0.0 110.179 164.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -150.92 140.3 21.4 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.758 1.223 . . . . 0.0 111.334 167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -149.74 158.49 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.241 1.016 . . . . 0.0 112.432 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -99.92 122.06 42.27 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.681 -0.637 . . . . 0.0 112.159 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 tt -145.88 129.41 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -168.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HE3' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.83 158.25 39.13 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 175.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.9 t -53.8 129.97 35.32 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.981 2.912 . . . . 0.0 110.16 164.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 m -117.3 -13.19 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.097 0.959 . . . . 0.0 111.359 162.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -171.87 33.61 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.898 2.879 . . . . 0.0 109.549 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.5 78.6 0.22 Allowed Glycine 0 N--CA 1.47 0.934 0 O-C-N 120.194 -1.566 . . . . 0.0 113.074 -157.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.7 m -37.45 148.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.808 2.443 . . . . 0.0 116.79 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.96 30.54 0.13 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.331 2.253 . . . . 0.0 114.136 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 -64.71 163.39 14.05 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.294 1.438 . . . . 0.0 110.178 168.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -69.78 139.13 53.21 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.7 pt -133.29 160.99 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.386 1.874 . . . . 0.0 110.378 171.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -117.36 102.22 9.06 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -66.89 138.97 57.69 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 165.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 51.9 ttp -132.13 137.25 47.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.13 0.972 . . . . 0.0 111.341 172.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.3 mm -104.0 136.6 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.077 1.351 . . . . 0.0 108.43 167.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.9 116.29 32.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.126 0.971 . . . . 0.0 109.777 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -68.13 168.51 11.99 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.99 -0.444 . . . . 0.0 111.081 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -72.34 140.7 48.63 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.095 1.358 . . . . 0.0 113.034 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.0 t -66.79 134.16 51.59 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.418 0.687 . . . . 0.0 112.005 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -70.89 -17.8 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -103.33 -4.46 24.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.922 1.689 . . . . 0.0 113.15 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.18 14.63 82.11 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.312 0.958 . . . . 0.0 114.427 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.0 p -115.68 130.73 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.76 1.624 . . . . 0.0 110.393 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 54.22 -133.86 45.41 Favored Glycine 0 CA--C 1.538 1.513 0 O-C-N 121.333 -0.855 . . . . 0.0 114.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -98.16 167.27 10.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.641 1.577 . . . . 0.0 112.109 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.74 -126.21 5.75 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.543 1.544 . . . . 0.0 113.541 171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -74.31 137.27 42.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.624 -0.927 . . . . 0.0 111.321 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -101.46 129.93 47.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.583 0.753 . . . . 0.0 112.674 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -126.44 123.73 38.53 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.937 1.695 . . . . 0.0 110.94 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.03 134.51 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.786 1.234 . . . . 0.0 113.813 -162.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB3' HG22 ' A' ' 107' ' ' ILE . 19.4 m-85 -83.61 -176.95 6.54 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.618 1.967 . . . . 0.0 114.042 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.4 m -133.71 124.96 27.61 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.537 -0.727 . . . . 0.0 109.608 137.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 105' ' ' TYR . 2.1 tt -154.04 155.68 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.165 0.586 . . . . 0.0 112.547 -154.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.6 139.36 15.41 Favored Pre-proline 0 N--CA 1.482 1.154 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.5 -176.77 3.35 Favored 'Trans proline' 0 CA--C 1.547 1.146 1 C-N-CA 125.446 4.098 . . . . 0.0 114.427 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -106.49 -172.62 2.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 110.754 171.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.5 t -119.14 1.41 11.36 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.39 1.876 . . . . 0.0 113.419 172.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.8 p -136.37 159.56 41.38 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.841 2.056 . . . . 0.0 111.248 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -59.13 116.92 4.17 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.374 1.443 . . . . 0.0 110.819 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -152.4 126.02 8.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.756 2.423 . . . . 0.0 108.352 -160.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -101.86 108.0 19.34 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.072 0.939 . . . . 0.0 111.107 -169.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.6 mm -100.77 90.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 126.591 1.956 . . . . 0.0 109.844 -166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -82.93 125.93 31.93 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.986 0.914 . . . . 0.0 111.555 172.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mt -130.2 131.76 23.63 Favored Pre-proline 0 N--CA 1.481 1.123 0 C-N-CA 125.062 1.345 . . . . 0.0 110.682 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -83.91 171.26 10.68 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.865 3.044 . . . . 0.0 112.603 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -63.19 -17.45 62.43 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 120.749 -1.219 . . . . 0.0 113.927 170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.5 m -72.9 0.08 12.12 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.5 m -101.75 -0.31 34.61 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -155.9 174.36 15.44 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -139.65 164.42 29.98 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -154.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -76.75 139.15 40.32 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.572 1.549 . . . . 0.0 113.343 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -104.27 103.69 13.48 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.342 1.057 . . . . 0.0 112.16 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.8 mt -97.29 -24.0 15.88 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -162.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -72.35 -14.62 61.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.375 1.443 . . . . 0.0 111.629 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -140.16 87.57 2.16 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.121 1.368 . . . . 0.0 111.139 -173.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.94 140.83 10.75 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.655 -1.278 . . . . 0.0 111.175 156.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.22 163.13 30.24 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.279 3.319 . . . . 0.0 114.571 -167.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.36 -14.5 40.3 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.543 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.28 19.64 38.29 Favored Glycine 0 CA--C 1.54 1.64 0 C-N-CA 126.214 1.864 . . . . 0.0 114.871 166.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 149.79 12.52 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.254 1.527 . . . . 0.0 114.487 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.18 137.6 58.27 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 122.794 1.283 . . . . 0.0 109.714 154.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 69.6 mtm -105.68 13.14 30.23 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.426 2.29 . . . . 0.0 112.939 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -75.93 -18.17 59.46 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.84 9.05 55.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.932 1.253 . . . . 0.0 114.691 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.4 t -139.53 154.2 47.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.947 2.099 . . . . 0.0 111.038 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.24 126.21 31.84 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 109.141 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -120.42 96.58 5.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.295 1.438 . . . . 0.0 111.88 -170.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.9 mp -72.7 -7.2 49.32 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.044 -1.035 . . . . 0.0 112.928 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.09 -21.21 64.79 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.534 1.934 . . . . 0.0 112.963 161.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -140.9 49.88 1.66 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -148.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.5 mm -105.23 139.11 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 120.856 -1.152 . . . . 0.0 113.242 -173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -97.7 -57.36 2.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.571 1.548 . . . . 0.0 112.257 175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 p -159.4 167.94 27.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.021 1.728 . . . . 0.0 111.623 -170.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . 0.281 0.1 OUTLIER -124.57 151.53 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.235 -0.916 . . . . 0.0 111.245 171.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 57' ' ' VAL . 60.4 m-70 -138.01 150.93 47.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.205 1.802 . . . . 0.0 111.561 -163.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -108.79 137.04 47.36 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.621 1.168 . . . . 0.0 110.705 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.31 149.89 51.89 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.201 1.001 . . . . 0.0 112.516 172.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -88.96 134.71 33.88 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.545 1.138 . . . . 0.0 113.848 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -130.34 6.45 4.88 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.148 1.779 . . . . 0.0 113.901 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -151.98 161.91 41.9 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.776 1.631 . . . . 0.0 109.952 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -111.55 13.23 21.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.812 1.245 . . . . 0.0 114.248 -163.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -71.6 165.13 24.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.959 0.904 . . . . 0.0 111.398 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 75.4 m -104.16 145.71 29.81 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.906 1.682 . . . . 0.0 110.271 167.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.35 -177.58 47.22 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -138.63 143.01 39.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.31 1.444 . . . . 0.0 112.99 -172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.32 175.15 11.33 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 112.157 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.533 HG13 ' HE3' ' A' ' 76' ' ' LYS . 8.7 p -152.42 148.16 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 120.336 -1.477 . . . . 0.0 113.771 -166.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.9 t -135.14 150.08 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.63 1.572 . . . . 0.0 113.355 -171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -154.37 -178.91 7.47 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.857 1.663 . . . . 0.0 109.148 160.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 58.54 46.28 15.06 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 168.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.2 mt -84.78 104.34 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.932 -1.105 . . . . 0.0 109.965 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -140.18 173.93 11.02 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.745 1.618 . . . . 0.0 114.559 -165.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 72.1 mt -114.22 149.93 35.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.666 2.386 . . . . 0.0 111.773 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.0 mm -134.73 144.35 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 127.087 2.155 . . . . 0.0 110.813 -168.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.07 -7.57 37.89 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 126.352 1.929 . . . . 0.0 116.179 -174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -76.19 144.34 40.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.36 1.08 . . . . 0.0 110.955 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.6 20.53 14.9 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 123.278 1.513 . . . . 0.0 113.544 177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.044 2.538 . . . . 0.0 110.79 -161.794 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tmm? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 119.508 -0.282 . . . . 0.0 111.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.83 153.3 35.98 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.298 1.439 . . . . 0.0 112.843 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -79.04 156.61 28.3 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.013 0.925 . . . . 0.0 112.667 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.96 125.15 17.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 0.0 110.261 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 53.14 20.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.885 1.674 . . . . 0.0 114.438 -174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -59.33 2.68 Favored Glycine 0 N--CA 1.472 1.092 0 O-C-N 120.421 -1.425 . . . . 0.0 112.676 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.99 158.26 40.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.746 2.019 . . . . 0.0 110.609 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -146.53 138.63 24.88 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.111 1.364 . . . . 0.0 111.882 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.3 tpp -83.58 146.16 28.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.2 mt -108.73 -50.29 3.04 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.333 1.053 . . . . 0.0 110.734 158.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -152.46 127.47 9.69 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -115.29 11.45 16.17 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.458 1.903 . . . . 0.0 109.172 167.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 61.34 12.33 4.2 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.824 2.449 . . . . 0.0 115.732 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -78.16 -4.95 50.12 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 120.669 -1.269 . . . . 0.0 113.634 -175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -107.86 -138.18 8.56 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.305 1.907 . . . . 0.0 113.453 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.2 t -85.11 143.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.753 1.621 . . . . 0.0 111.488 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 tt -70.05 98.72 1.34 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.343 0.592 . . . . 0.0 110.43 175.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -94.27 -1.81 53.35 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.282 1.433 . . . . 0.0 114.347 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -83.25 142.5 31.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.793 1.637 . . . . 0.0 111.758 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.73 98.75 1.09 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.515 -0.603 . . . . 0.0 113.705 -169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -77.01 140.94 40.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.004 0.922 . . . . 0.0 111.406 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.47 153.73 17.81 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 112.952 -177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -153.11 161.86 41.98 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.59 -144.58 12.31 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.854 1.692 . . . . 0.0 114.27 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -70.49 -17.87 62.96 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -170.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.37 -25.25 0.04 OUTLIER Glycine 0 N--CA 1.477 1.411 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.2 152.2 41.17 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 120.191 1.995 . . . . 0.0 110.879 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -128.12 153.73 46.52 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.94 1.296 . . . . 0.0 112.401 -175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 m -144.04 149.13 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 125.769 1.628 . . . . 0.0 114.021 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -145.8 144.82 30.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.519 1.128 . . . . 0.0 110.715 162.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.8 m -127.7 133.95 49.58 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.476 1.111 . . . . 0.0 109.584 170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 161.64 40.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -171.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -81.87 141.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.69 1.596 . . . . 0.0 110.8 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.58 -170.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 127.191 2.196 . . . . 0.0 110.836 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 m -80.52 153.43 28.13 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 119.777 -1.827 . . . . 0.0 111.584 166.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.22 -177.04 23.83 Favored Glycine 0 N--CA 1.469 0.895 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -60.39 -27.21 67.25 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.732 1.613 . . . . 0.0 113.158 -176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.5 p -136.64 88.33 2.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.167 1.387 . . . . 0.0 107.634 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.37 -121.92 11.91 Favored Glycine 0 CA--C 1.535 1.329 0 O-C-N 121.567 -0.708 . . . . 0.0 112.567 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.5 157.05 17.25 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.308 -1.113 . . . . 0.0 111.847 178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.57 178.83 18.69 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.472 1.511 . . . . 0.0 112.076 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.0 ttm -128.66 135.5 49.37 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.721 0.808 . . . . 0.0 110.946 168.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -116.33 145.67 43.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.125 2.17 . . . . 0.0 110.733 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.72 141.32 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.966 1.306 . . . . 0.0 111.374 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -113.83 123.39 49.71 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.315 1.046 . . . . 0.0 111.616 175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -105.37 108.84 20.57 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.214 1.005 . . . . 0.0 110.159 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.8 m -111.5 100.79 9.29 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.909 1.283 . . . . 0.0 108.114 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -106.54 167.43 14.09 Favored Glycine 0 N--CA 1.474 1.177 0 N-CA-C 118.007 1.963 . . . . 0.0 118.007 -155.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -139.11 151.08 46.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.936 0.895 . . . . 0.0 111.645 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.9 p -58.82 -29.9 67.24 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -173.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -134.77 4.09 3.29 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.29 -157.8 30.79 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.336 1.446 . . . . 0.0 113.635 177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -152.22 126.42 9.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.612 ' H ' ' HE3' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -120.95 140.68 51.53 Favored 'General case' 0 CA--C 1.549 0.93 1 C-N-CA 133.189 4.596 . . . . 0.0 112.036 162.806 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.95 170.25 39.16 Favored Glycine 0 CA--C 1.544 1.865 0 C-N-CA 124.179 0.895 . . . . 0.0 114.979 174.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -155.65 132.12 10.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.18 1.392 . . . . 0.0 112.122 174.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.8 t -143.01 132.83 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -147.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -100.98 129.72 46.87 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.417 1.487 . . . . 0.0 110.836 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.0 m -109.32 118.66 37.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.878 1.271 . . . . 0.0 110.383 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -83.11 131.74 52.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.615 1.166 . . . . 0.0 110.908 -175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -62.42 -35.35 72.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.825 2.35 . . . . 0.0 112.567 168.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -149.49 133.52 17.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.058 2.143 . . . . 0.0 109.07 170.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.04 106.61 0.67 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 127.41 2.433 . . . . 0.0 107.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.98 33.63 1.01 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -152.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -93.34 14.99 16.7 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 119.185 -2.197 . . . . 0.0 115.784 -148.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.7 p -52.44 -33.87 46.06 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.71 -10.83 60.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.585 1.954 . . . . 0.0 115.3 177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -88.59 175.19 7.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.367 1.067 . . . . 0.0 111.325 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.31 -43.29 4.16 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.382 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -143.89 169.45 17.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.941 1.696 . . . . 0.0 111.112 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.0 tt -97.1 158.17 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.4 t -140.14 138.35 35.15 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.897 0.879 . . . . 0.0 110.671 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 164.85 26.8 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.238 0.615 . . . . 0.0 110.37 165.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -109.53 111.32 22.76 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 166.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.8 tt -122.79 137.98 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.759 1.224 . . . . 0.0 108.886 -164.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.589 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 15.1 mttm -145.92 162.03 38.71 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.628 -144.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t -128.26 142.27 51.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.493 1.139 . . . . 0.0 111.164 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.84 -32.54 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.504 1.521 . . . . 0.0 110.383 170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.25 54.04 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.255 2.222 . . . . 0.0 110.792 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.83 -105.69 0.31 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.472 1.034 . . . . 0.0 113.752 -168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 m -147.25 151.61 36.94 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -162.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.8 -4.02 50.98 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.914 1.685 . . . . 0.0 112.575 160.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.36 176.96 4.98 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.52 2.328 . . . . 0.0 111.09 170.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -84.59 173.35 10.86 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.083 1.753 . . . . 0.0 115.483 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.0 pt -134.23 172.85 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.517 2.327 . . . . 0.0 110.774 176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.5 mtt180 -134.14 152.26 51.75 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -109.92 153.06 25.03 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 126.352 1.861 . . . . 0.0 109.696 163.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.1 ttp -142.87 149.04 37.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.898 0.879 . . . . 0.0 111.7 170.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 76.5 mt -122.52 133.65 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.943 2.097 . . . . 0.0 107.604 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.83 111.32 23.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.579 1.152 . . . . 0.0 110.779 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -76.8 152.03 35.71 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.943 0.897 . . . . 0.0 110.848 174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -75.63 153.51 37.21 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.189 0.595 . . . . 0.0 112.493 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 86.0 p -72.35 159.93 33.2 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.66 1.584 . . . . 0.0 113.824 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.3 pt -68.89 -20.13 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 O-C-N 121.721 -0.612 . . . . 0.0 112.47 165.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -74.86 -6.7 50.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.421 1.488 . . . . 0.0 113.323 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.6 8.32 80.92 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.901 1.238 . . . . 0.0 114.904 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.8 t -129.06 125.71 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 126.605 1.962 . . . . 0.0 109.073 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 48.78 -151.99 2.89 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.571 1.388 . . . . 0.0 116.571 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -73.55 149.2 42.35 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.111 2.565 . . . . 0.0 114.733 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.39 -37.6 0.17 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.7 2.095 . . . . 0.0 114.731 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.63 144.62 42.0 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 120.478 2.139 . . . . 0.0 113.516 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -99.37 123.85 43.99 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.119 1.768 . . . . 0.0 111.211 168.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -126.88 128.05 45.88 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.047 1.739 . . . . 0.0 110.443 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.76 157.61 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -160.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -151.66 150.73 30.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.106 0.963 . . . . 0.0 111.644 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.0 t -137.04 143.99 42.97 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.97 165.65 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 128.855 2.862 . . . . 0.0 110.571 -167.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.6 p -94.65 154.06 40.08 Favored Pre-proline 0 N--CA 1.48 1.044 0 O-C-N 121.057 -1.027 . . . . 0.0 112.937 167.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -80.02 -169.98 0.91 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.085 3.19 . . . . 0.0 112.942 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -130.14 -153.9 0.6 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.932 2.493 . . . . 0.0 113.278 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.9 p -149.55 10.05 0.73 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 129.773 3.229 . . . . 0.0 113.916 167.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.5 p -169.82 124.49 0.79 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 129.578 3.151 . . . . 0.0 106.39 -170.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.589 ' CE3' ' HD3' ' A' ' 76' ' ' LYS 0.257 0.5 OUTLIER -25.07 112.47 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 130.535 3.534 . . . . 0.0 114.695 178.717 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -117.78 117.91 30.61 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.695 1.198 . . . . 0.0 111.781 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.2 m -77.49 125.32 29.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.158 0.983 . . . . 0.0 110.122 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.469 HG22 HD13 ' A' ' 118' ' ' ILE . 2.5 mt -129.29 98.67 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.127 0.971 . . . . 0.0 110.3 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -71.2 105.2 3.34 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.675 164.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 116' ' ' ILE . 1.2 mm -96.59 119.96 62.96 Favored Pre-proline 0 N--CA 1.476 0.845 0 O-C-N 121.291 -0.881 . . . . 0.0 108.942 172.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -76.96 164.48 29.73 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.971 1.78 . . . . 0.0 110.336 168.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -73.01 -7.74 52.59 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.038 -1.039 . . . . 0.0 112.857 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 94.4 p -79.84 -23.1 42.24 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.9 m -76.13 -27.47 57.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.097 0.862 . . . . 0.0 113.299 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -71.17 128.94 37.6 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.144 0.977 . . . . 0.0 111.11 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -117.76 157.58 26.28 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.688 1.995 . . . . 0.0 110.852 -172.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -79.71 146.14 32.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.366 -0.834 . . . . 0.0 110.454 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -80.44 122.49 27.04 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 166.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.86 -9.51 10.63 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 117.091 2.256 . . . . 0.0 117.091 -152.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.8 -9.5 34.32 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.815 1.246 . . . . 0.0 111.336 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -155.87 133.94 11.38 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.25 1.82 . . . . 0.0 111.527 -163.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -149.5 164.69 19.92 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.735 1.614 . . . . 0.0 111.092 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.03 153.53 68.32 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.287 2.658 . . . . 0.0 111.697 167.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.41 -23.87 23.28 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.357 3.371 . . . . 0.0 114.954 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -90.54 26.93 9.33 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.243 1.878 . . . . 0.0 115.997 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 140.07 52.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -171.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -69.97 -22.25 63.17 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.2 ttm 54.87 33.01 18.96 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.993 1.717 . . . . 0.0 113.314 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 98.6 p -72.72 -3.44 25.15 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.85 -4.06 40.16 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.97 1.271 . . . . 0.0 114.347 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.8 p -145.15 159.44 42.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 118.928 1.364 . . . . 0.0 113.363 -170.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -77.34 123.49 26.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.523 167.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -102.03 87.06 3.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.694 1.198 . . . . 0.0 109.612 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.8 mt -58.17 -22.47 51.55 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.985 0.914 . . . . 0.0 112.082 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -62.44 -16.29 54.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.692 1.197 . . . . 0.0 114.163 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -145.87 60.94 1.26 Allowed 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 120.101 1.318 . . . . 0.0 113.934 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 48.3 mm -99.46 140.35 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.847 1.259 . . . . 0.0 112.543 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -93.34 -56.25 3.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.291 1.436 . . . . 0.0 112.919 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 p -151.81 157.5 42.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.665 0.786 . . . . 0.0 112.644 -169.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.36 146.35 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.528 1.131 . . . . 0.0 110.875 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -135.75 131.84 36.06 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.079 1.351 . . . . 0.0 109.961 -160.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -82.21 146.08 29.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 155.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 66.9 mtp -139.65 146.34 39.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.644 1.688 . . . . 0.0 113.619 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.498 ' CG ' ' CZ3' ' A' ' 54' ' ' TRP . 53.0 p90 -51.05 139.6 17.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 112.995 -1.911 . . . . 0.0 112.514 158.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.53 5.61 2.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.536 1.134 . . . . 0.0 112.666 155.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -151.33 160.57 43.72 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.52 2.728 . . . . 0.0 106.806 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -120.37 5.62 10.69 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.14 137.73 41.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.467 1.03 . . . . 0.0 110.717 171.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.5 m -64.81 136.99 57.5 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.0 34.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.253 0.93 . . . . 0.0 114.596 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -125.65 139.22 53.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.967 1.707 . . . . 0.0 111.99 -174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -138.98 164.86 28.63 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.63 1.172 . . . . 0.0 112.938 -169.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 154.2 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.864 2.066 . . . . 0.0 111.838 -175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.75 145.26 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.754 1.622 . . . . 0.0 108.65 175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -151.0 136.97 18.21 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 116.785 -1.579 . . . . 0.0 112.477 159.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 68.77 126.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.043 1.737 . . . . 0.0 114.993 -156.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 93.8 mt -139.25 108.49 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 128.874 2.87 . . . . 0.0 107.04 162.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -139.22 152.79 47.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.646 1.579 . . . . 0.0 112.983 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.46 142.87 30.63 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.689 1.196 . . . . 0.0 109.767 167.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.9 mm -120.17 132.47 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.882 1.673 . . . . 0.0 109.092 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.29 -128.51 3.37 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.374 0.988 . . . . 0.0 113.625 -173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.24 156.14 39.67 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.02 1.328 . . . . 0.0 112.877 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.4 pp -124.57 130.97 53.45 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.247 1.419 . . . . 0.0 110.729 174.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.423 2.289 . . . . 0.0 112.701 -173.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.64 -10.1 0.62 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.605 1.562 . . . . 0.0 114.944 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.7 t -90.78 139.62 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.149 1.34 . . . . 0.0 112.809 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.47 -7.25 21.06 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.85 1.26 . . . . 0.0 113.702 170.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.08 -47.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 127.211 2.204 . . . . 0.0 113.758 -161.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.65 133.87 3.07 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.809 2.623 . . . . 0.0 110.977 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -119.45 138.7 52.95 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -172.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -134.2 140.16 46.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.002 2.121 . . . . 0.0 110.344 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.8 mmt -79.65 152.69 29.85 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.5 mt -108.03 -57.86 2.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.436 1.895 . . . . 0.0 109.806 159.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -150.81 119.4 6.5 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.586 1.154 . . . . 0.0 110.629 167.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -99.16 19.5 15.17 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.797 0.839 . . . . 0.0 110.945 168.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 60.94 8.31 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.612 2.365 . . . . 0.0 115.637 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -72.41 -16.03 61.84 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.9 -138.61 7.74 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 126.408 1.956 . . . . 0.0 112.715 170.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.47 138.24 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 126.452 1.901 . . . . 0.0 111.083 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.14 131.46 48.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.117 1.767 . . . . 0.0 111.471 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' ND2' ' CE2' ' A' ' 19' ' ' TRP . 2.7 p-10 -133.36 33.96 3.54 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -166.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.739 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 61.0 m95 -136.4 132.08 35.02 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -160.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.91 153.23 48.38 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.179 1.371 . . . . 0.0 113.931 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 138.66 15.49 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.229 1.014 . . . . 0.0 111.571 168.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -161.16 161.3 30.96 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.51 161.0 43.38 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 167.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -134.58 167.73 23.8 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.842 1.21 . . . . 0.0 114.586 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 52.97 13.04 0.32 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.953 2.901 . . . . 0.0 117.179 173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.06 -8.18 5.72 Favored Glycine 0 CA--C 1.537 1.42 0 N-CA-C 116.32 1.288 . . . . 0.0 116.32 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 160.14 26.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.768 1.784 . . . . 0.0 110.883 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -147.62 89.7 1.79 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -163.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.2 p -66.01 157.67 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.863 1.665 . . . . 0.0 113.594 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.2 m -161.42 130.74 4.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.898 2.079 . . . . 0.0 109.038 161.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.5 m -127.28 134.3 50.06 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.964 0.906 . . . . 0.0 111.084 -173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.94 167.54 21.94 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.425 1.49 . . . . 0.0 112.661 -177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.93 146.18 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.686 1.194 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.2 m -137.11 171.91 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.684 1.593 . . . . 0.0 112.076 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.4 m -76.63 120.81 22.34 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.968 -1.083 . . . . 0.0 110.344 158.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -96.27 -164.84 33.58 Favored Glycine 0 N--CA 1.472 1.047 0 C-N-CA 125.364 1.459 . . . . 0.0 114.107 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -65.57 -22.13 66.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.726 0.81 . . . . 0.0 113.029 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.6 t -153.19 138.2 17.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.052 1.341 . . . . 0.0 108.111 162.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.57 -126.07 40.17 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.536 0.588 . . . . 0.0 112.354 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -100.57 168.47 9.69 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.432 1.093 . . . . 0.0 111.944 177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.0 -162.44 9.56 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.631 3.015 . . . . 0.0 110.334 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.2 ttp -136.52 142.41 43.47 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.182 1.393 . . . . 0.0 111.261 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.39 152.11 30.44 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.395 1.478 . . . . 0.0 112.331 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.59 141.21 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.314 1.046 . . . . 0.0 111.721 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.1 t -131.12 142.69 50.28 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.591 1.957 . . . . 0.0 111.47 -166.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 54' ' ' TRP . 14.5 m-85 -141.11 142.29 34.12 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -175.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.1 m -91.11 131.9 36.39 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.497 133.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.17 167.26 30.22 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.329 1.422 . . . . 0.0 112.716 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.0 t -135.15 173.19 12.0 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 121.182 2.491 . . . . 0.0 116.071 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.8 p -82.06 -31.76 30.69 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -127.19 -0.33 6.43 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -170.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 49' ' ' THR . . . -103.11 -144.56 14.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.389 0.995 . . . . 0.0 113.77 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -161.66 153.37 19.04 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.468 2.307 . . . . 0.0 107.928 174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 46' ' ' TYR 0.266 0.0 OUTLIER -110.55 -175.05 2.62 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.84 1.256 . . . . 0.0 107.846 172.486 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 167.52 -175.14 42.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 118.175 2.03 . . . . 0.0 118.175 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -155.15 152.58 29.6 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.433 1.893 . . . . 0.0 109.995 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 149' ' ' HIS . 49.0 t -128.86 132.05 67.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 119.425 1.011 . . . . 0.0 111.752 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.739 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -141.2 120.0 12.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.357 -177.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.0 t -103.53 113.98 27.9 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.46 1.504 . . . . 0.0 107.218 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.28 133.76 94.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -166.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -59.22 -33.84 98.13 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.558 2.172 . . . . 0.0 112.663 171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -135.72 121.18 19.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.901 2.081 . . . . 0.0 110.628 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.69 13.46 24.94 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.516 1.055 . . . . 0.0 115.598 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -128.17 116.11 19.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.895 1.678 . . . . 0.0 108.284 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.58 13.63 7.54 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.832 1.253 . . . . 0.0 111.625 177.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.7 p -47.42 -27.91 1.89 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.576 2.35 . . . . 0.0 115.85 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -76.34 -14.87 60.07 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.321 2.248 . . . . 0.0 114.245 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -128.26 177.99 6.55 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 113.093 -167.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.03 -39.15 4.29 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 117.725 2.491 . . . . 0.0 117.725 -155.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -143.69 167.77 21.49 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 121.782 2.083 . . . . 0.0 112.637 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 tt -95.08 158.38 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.397 0.679 . . . . 0.0 110.344 160.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -147.95 142.83 26.85 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.755 1.222 . . . . 0.0 109.758 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.04 165.25 30.45 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 109.803 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.99 114.13 26.63 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 163.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.9 tt -162.66 119.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.794 -1.191 . . . . 0.0 113.746 -161.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -175.2 174.41 2.41 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.331 -157.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -77.48 164.51 25.37 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.838 2.055 . . . . 0.0 111.241 176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.78 -17.03 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.614 1.566 . . . . 0.0 112.144 166.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -165.36 121.59 1.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 6.91 87.76 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 118.023 1.969 . . . . 0.0 118.023 157.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -137.4 115.62 11.75 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.724 1.762 . . . . 0.0 114.024 -172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.08 13.61 9.74 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.725 2.01 . . . . 0.0 111.874 162.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.55 151.76 43.56 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 112.659 -176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -77.85 139.99 39.33 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.81 165.74 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.719 1.608 . . . . 0.0 110.149 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 -100.19 119.36 38.23 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 165.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.87 144.65 52.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 155.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.15 139.62 51.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.06 1.344 . . . . 0.0 110.188 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.41 137.01 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.63 1.572 . . . . 0.0 109.243 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.82 117.7 34.96 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.024 1.329 . . . . 0.0 111.169 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -82.72 151.18 26.31 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.545 1.138 . . . . 0.0 109.821 168.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -70.94 147.64 48.51 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.413 -1.429 . . . . 0.0 113.67 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.1 t -81.86 141.87 33.03 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.357 2.263 . . . . 0.0 113.601 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 42.4 pt -77.42 -0.6 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 O-C-N 121.467 -0.771 . . . . 0.0 113.078 168.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 -105.3 -10.55 16.96 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.767 1.627 . . . . 0.0 112.477 166.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.84 17.65 79.97 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.901 1.239 . . . . 0.0 114.663 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.42 149.77 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.059 1.343 . . . . 0.0 111.963 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 63.73 -161.09 36.47 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 122.038 0.799 . . . . 0.0 114.24 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -79.98 4.22 17.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -173.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.09 -100.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 C-N-CA 127.171 2.32 . . . . 0.0 114.017 -175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -111.94 131.7 55.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.536 0.735 . . . . 0.0 110.308 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -112.79 119.12 36.93 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.642 0.777 . . . . 0.0 112.342 -161.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -125.14 134.12 52.56 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.679 1.192 . . . . 0.0 112.531 -163.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.5 m -138.18 150.52 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -172.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' A' ' 118' ' ' ILE . 12.7 m-85 -87.9 176.23 7.44 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.489 -0.757 . . . . 0.0 110.1 152.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.0 m -112.92 130.58 56.06 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 121.772 -0.58 . . . . 0.0 109.825 140.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tt -150.42 141.64 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.524 0.678 . . . . 0.0 112.419 -157.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.5 p -125.34 129.92 24.3 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.959 1.704 . . . . 0.0 111.567 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.98 145.09 15.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.653 2.902 . . . . 0.0 112.88 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.4 160.46 19.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 112.754 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 99.6 p -91.48 9.78 30.49 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.646 1.579 . . . . 0.0 114.645 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.3 p -135.76 142.7 45.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.75 2.42 . . . . 0.0 109.579 177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.635 ' CE3' ' HE2' ' A' ' 76' ' ' LYS 0.314 1.7 t-105 -69.29 119.4 13.5 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 128.087 2.555 . . . . 0.0 105.228 -178.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.5 mmmm -162.16 140.68 9.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.516 1.926 . . . . 0.0 112.234 -156.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.6 m -79.62 133.64 36.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.436 1.094 . . . . 0.0 111.763 172.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.6 mm -124.46 90.61 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.668 1.987 . . . . 0.0 109.22 -175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.28 134.85 55.52 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 120.885 -1.135 . . . . 0.0 110.988 161.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 105' ' ' TYR . 17.8 mt -135.03 124.19 16.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.236 1.014 . . . . 0.0 109.808 168.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -79.17 172.47 14.72 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.987 3.125 . . . . 0.0 111.83 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -75.65 -10.01 59.07 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.136 -1.602 . . . . 0.0 113.657 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 13.3 p -75.1 -7.13 52.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.752 1.221 . . . . 0.0 114.032 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.6 m -89.72 -16.08 31.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -77.58 142.01 39.21 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.681 1.193 . . . . 0.0 113.648 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -123.41 153.03 40.96 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.158 1.383 . . . . 0.0 111.036 165.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -73.57 136.67 44.02 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.327 1.051 . . . . 0.0 110.802 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -73.6 123.62 24.36 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.17 0.988 . . . . 0.0 109.989 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.3 mt -113.44 -19.28 11.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.26 1.391 . . . . 0.0 114.041 -167.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -71.01 -15.23 62.55 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.227 1.011 . . . . 0.0 112.011 168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -157.17 135.29 11.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.526 1.93 . . . . 0.0 110.921 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -162.84 158.48 18.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 149.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.53 163.31 27.58 Favored 'Trans proline' 0 CA--C 1.546 1.107 0 C-N-CA 124.107 3.205 . . . . 0.0 113.912 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.23 -20.24 12.86 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.26 3.307 . . . . 0.0 114.496 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -86.63 26.18 6.73 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.228 1.394 . . . . 0.0 116.293 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.84 152.67 45.16 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.897 1.279 . . . . 0.0 113.575 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.74 128.04 32.89 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.143 156.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.8 tpp -78.31 30.77 0.18 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.96 1.304 . . . . 0.0 114.172 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 80.9 p -86.53 -18.4 31.65 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.244 1.817 . . . . 0.0 115.5 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 52.2 27.44 23.62 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.028 0.823 . . . . 0.0 113.714 -167.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.7 m -145.12 138.25 26.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.55 1.54 . . . . 0.0 111.517 -170.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -79.82 129.44 34.49 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.618 0.767 . . . . 0.0 112.667 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.21 96.4 6.45 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.222 1.409 . . . . 0.0 110.257 -174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.38 28.27 0.12 Allowed 'General case' 0 N--CA 1.478 0.967 0 O-C-N 121.021 -1.049 . . . . 0.0 113.523 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -102.73 -25.1 13.66 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.034 2.534 . . . . 0.0 111.852 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -145.9 66.51 1.21 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.789 1.235 . . . . 0.0 113.927 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.4 mm -94.41 144.47 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.369 1.467 . . . . 0.0 111.107 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -103.68 -57.8 1.98 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.113 0.965 . . . . 0.0 113.484 177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 p -153.92 165.02 37.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -163.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.516 HD11 ' CG ' ' A' ' 58' ' ' TYR . 5.2 pt -135.85 140.62 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.625 1.57 . . . . 0.0 109.401 -174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.469 ' CE1' HG13 ' A' ' 57' ' ' VAL . 89.7 m-70 -152.24 171.22 18.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.773 1.229 . . . . 0.0 112.35 -165.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -123.65 144.58 49.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.037 1.335 . . . . 0.0 113.982 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 60.6 mtt -141.43 151.42 43.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.034 1.333 . . . . 0.0 114.235 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 85.8 m-85 -116.4 82.52 1.8 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.633 1.573 . . . . 0.0 113.677 -151.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.31 -1.78 5.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.109 1.764 . . . . 0.0 115.066 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.71 156.08 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.803 1.241 . . . . 0.0 110.101 168.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -86.33 25.71 1.16 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.914 1.285 . . . . 0.0 113.192 -166.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -104.44 175.52 5.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.053 1.741 . . . . 0.0 114.215 -163.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 43.6 m -129.98 157.12 43.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.173 1.789 . . . . 0.0 112.553 -163.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 168.46 -178.67 41.88 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.183 0.897 . . . . 0.0 113.24 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -126.15 143.79 51.0 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.399 1.08 . . . . 0.0 112.116 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -137.13 159.73 41.04 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.122 1.369 . . . . 0.0 113.773 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.47 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.619 1.967 . . . . 0.0 114.428 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.1 137.31 52.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.939 1.696 . . . . 0.0 112.603 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -135.92 -177.76 4.84 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.201 1.0 . . . . 0.0 111.47 152.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.59 34.93 2.6 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 151.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.6 mt -74.98 118.34 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.152 -0.967 . . . . 0.0 109.782 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -150.07 164.41 35.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.21 1.804 . . . . 0.0 113.444 -168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 53.6 mt -111.07 140.49 45.57 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.176 1.791 . . . . 0.0 110.782 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.82 128.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.147 1.779 . . . . 0.0 109.198 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.4 -129.15 0.18 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.282 1.896 . . . . 0.0 117.162 -156.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.06 160.85 28.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.62 1.168 . . . . 0.0 112.632 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.7 tp -147.07 33.72 0.9 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.501 1.12 . . . . 0.0 111.676 -169.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.197 2.599 . . . . 0.0 114.744 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.503 0.192 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.07 165.42 11.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.726 1.611 . . . . 0.0 113.129 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.4 p -83.44 -174.24 5.17 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.452 1.901 . . . . 0.0 112.54 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.03 13.88 3.72 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.864 1.666 . . . . 0.0 115.185 174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.96 163.12 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.923 1.289 . . . . 0.0 112.373 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.35 98.74 0.4 Allowed Glycine 0 C--N 1.336 0.542 0 C-N-CA 126.198 1.856 . . . . 0.0 112.138 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -114.96 160.69 19.26 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.84 1.656 . . . . 0.0 113.621 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -124.95 119.47 28.84 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.315 1.446 . . . . 0.0 108.176 153.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -76.76 143.32 39.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.219 0.533 . . . . 0.0 111.77 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -110.04 -50.24 2.99 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.697 1.599 . . . . 0.0 110.336 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -146.51 164.12 33.55 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.89 1.329 . . . . 0.0 112.895 175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -150.33 1.61 0.47 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.818 2.447 . . . . 0.0 113.667 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . 0.294 0.0 OUTLIER 10.47 -118.32 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 1 C-N-CA 135.846 5.659 . . . . 0.0 119.589 179.974 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . 0.257 2.9 pm0 29.41 20.41 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.961 1 C-N-CA 132.56 4.344 . . . . 0.0 118.146 -153.904 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.52 -137.66 2.33 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 124.658 1.123 . . . . 0.0 110.373 165.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.06 118.84 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 162.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.1 tp -81.35 144.87 31.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 122.073 0.939 . . . . 0.0 112.542 -169.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 12.2 p-10 -121.17 22.94 10.76 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -153.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.695 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 78.1 m95 -137.41 152.54 49.73 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.054 1.742 . . . . 0.0 111.43 -163.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.21 70.82 2.61 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.232 0.92 . . . . 0.0 114.493 -162.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 56' ' ' THR . 5.9 m -74.89 147.76 40.74 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.36 159.42 35.82 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.793 1.237 . . . . 0.0 113.081 -171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 p -159.9 161.04 34.25 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 166.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.36 165.31 34.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.4 1.476 . . . . 0.0 114.435 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 45.28 47.58 10.34 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 127.383 2.273 . . . . 0.0 114.79 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.65 -5.62 82.28 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 116.306 1.282 . . . . 0.0 116.306 168.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.08 163.36 25.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.587 1.194 . . . . 0.0 110.613 165.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -150.65 150.54 31.26 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.421 1.088 . . . . 0.0 110.374 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -138.19 135.59 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.943 1.297 . . . . 0.0 110.431 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -141.56 131.14 23.96 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.777 0.831 . . . . 0.0 109.44 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 p -107.19 128.14 54.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.834 1.654 . . . . 0.0 110.529 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 169.16 15.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.135 2.174 . . . . 0.0 111.267 -176.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -100.33 136.41 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.268 1.427 . . . . 0.0 110.873 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.08 -159.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 127.757 2.423 . . . . 0.0 110.709 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.5 m -94.94 150.78 19.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.117 1.767 . . . . 0.0 112.25 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.89 -168.36 16.76 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.63 1.11 . . . . 0.0 115.8 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt -77.6 -20.5 53.86 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.296 1.439 . . . . 0.0 113.767 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.4 p -122.12 85.22 2.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.461 1.504 . . . . 0.0 107.801 169.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.8 -106.74 0.94 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.042 1.306 . . . . 0.0 112.107 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -73.7 165.88 24.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.222 0.609 . . . . 0.0 110.765 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.11 170.54 22.15 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.266 1.889 . . . . 0.0 112.048 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -114.51 130.05 56.71 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 111.177 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -112.07 131.51 55.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.636 1.174 . . . . 0.0 111.813 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.39 138.89 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.286 1.034 . . . . 0.0 110.196 164.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.1 t -107.13 119.92 40.7 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 148.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -95.87 146.39 24.61 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.152 0.981 . . . . 0.0 111.427 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -110.49 144.48 39.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 142.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -124.47 153.55 17.7 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.786 1.184 . . . . 0.0 111.544 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.7 p -132.93 171.79 13.47 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.326 1.063 . . . . 0.0 111.675 175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.8 p -70.37 -37.43 74.58 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 -170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -137.91 13.97 2.89 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.6 -146.63 3.23 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 121.075 -1.015 . . . . 0.0 113.592 168.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -158.52 150.03 21.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.158 1.383 . . . . 0.0 109.435 167.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.29 128.68 6.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.068 1.747 . . . . 0.0 107.174 -172.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.82 -161.26 33.65 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 -174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 1.2 t -152.9 163.51 39.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.15 0.98 . . . . 0.0 111.806 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.552 HG13 ' CE1' ' A' ' 149' ' ' HIS . 84.7 t -134.6 137.65 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -173.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.695 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -125.07 120.02 30.28 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.884 0.85 . . . . 0.0 111.33 -178.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.5 t -95.75 129.99 42.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.386 1.474 . . . . 0.0 109.562 172.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.6 mt -90.66 123.19 65.82 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.731 1.212 . . . . 0.0 111.013 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -63.32 -30.82 73.6 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.489 2.793 . . . . 0.0 113.713 172.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -141.32 124.35 16.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.578 1.551 . . . . 0.0 111.405 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.86 17.2 20.41 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.898 1.713 . . . . 0.0 115.385 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.48 27.27 5.38 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -167.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . 0.257 0.1 OUTLIER -77.48 42.38 0.35 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -168.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.1 p -61.69 -12.57 17.02 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.233 -1.542 . . . . 0.0 115.162 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -81.49 6.04 15.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.001 2.12 . . . . 0.0 115.042 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.01 159.41 35.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.48 1.512 . . . . 0.0 111.905 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.85 -22.28 8.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -168.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.9 mttt -147.77 162.69 38.71 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.212 1.405 . . . . 0.0 111.787 -175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 tt -98.42 161.96 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.895 0.878 . . . . 0.0 109.802 155.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.6 t -149.2 138.2 21.32 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.414 1.086 . . . . 0.0 111.618 172.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.86 168.17 20.44 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.846 1.658 . . . . 0.0 109.463 168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -105.29 127.14 52.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.15 -0.452 . . . . 0.0 112.163 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -151.15 128.75 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 119.927 -1.733 . . . . 0.0 114.929 -167.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -163.47 177.1 9.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.679 1.192 . . . . 0.0 113.787 -179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.7 t -73.3 167.81 20.46 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.961 2.105 . . . . 0.0 112.386 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.96 10.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 163.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -134.1 22.29 3.8 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.12 -12.44 24.82 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.814 1.674 . . . . 0.0 114.955 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.2 m -61.64 145.4 52.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 118.291 1.046 . . . . 0.0 111.8 178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.93 31.81 4.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.995 1.718 . . . . 0.0 112.684 -172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -60.39 142.73 54.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.646 1.579 . . . . 0.0 112.283 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -83.75 155.49 23.03 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.762 0.825 . . . . 0.0 113.068 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.2 pt -146.17 166.49 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 111.703 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -125.55 147.07 49.4 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.386 1.075 . . . . 0.0 110.189 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 107' ' ' ILE . 25.3 m-85 -104.07 146.66 28.41 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.803 0.841 . . . . 0.0 110.257 165.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 ttt -128.08 137.64 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.477 1.911 . . . . 0.0 109.794 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 69.8 mt -126.58 134.23 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.923 1.689 . . . . 0.0 107.841 169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.12 111.44 23.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.907 0.883 . . . . 0.0 111.424 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.29 164.47 22.75 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 159.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -93.42 163.39 13.6 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.043 0.937 . . . . 0.0 113.519 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.3 t -74.71 157.35 35.43 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.852 0.861 . . . . 0.0 110.682 171.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.4 pt -102.69 -2.95 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.242 1.017 . . . . 0.0 112.772 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -133.49 5.74 3.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.843 1.257 . . . . 0.0 114.041 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.89 32.3 81.45 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 120.979 -1.076 . . . . 0.0 112.396 -169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -121.67 128.76 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 127.65 2.38 . . . . 0.0 108.053 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.75 -130.18 30.73 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -163.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -137.75 -24.39 1.03 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 0.0 114.001 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 130.51 177.66 15.01 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 129.462 3.411 . . . . 0.0 113.033 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.61 119.65 10.89 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.85 -0.794 . . . . 0.0 111.614 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -94.64 126.01 39.67 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.315 1.446 . . . . 0.0 111.969 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -125.84 134.67 51.58 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.201 1.8 . . . . 0.0 111.954 -172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.25 154.73 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -138.83 145.03 39.56 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 119.665 1.121 . . . . 0.0 110.748 171.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.2 m -104.51 128.84 52.55 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.222 1.809 . . . . 0.0 113.214 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 87' ' ' PHE . 1.9 tt -163.75 154.18 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 122.097 0.951 . . . . 0.0 113.462 -144.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.4 p -136.01 152.15 75.07 Favored Pre-proline 0 N--CA 1.47 0.561 0 C-N-CA 126.034 1.734 . . . . 0.0 112.771 -176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -81.32 -175.92 2.86 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 124.512 3.475 . . . . 0.0 111.708 167.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -125.51 -167.85 1.75 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.268 1.427 . . . . 0.0 111.343 166.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 77.9 p -104.21 -14.57 15.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.433 1.893 . . . . 0.0 113.7 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -100.84 144.01 30.31 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.965 1.706 . . . . 0.0 111.374 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.617 ' HA ' ' HD2' ' A' ' 76' ' ' LYS 0.371 2.1 t90 -68.32 126.02 28.28 Favored 'General case' 0 N--CA 1.416 -2.149 0 C-N-CA 126.886 2.074 . . . . 0.0 108.524 175.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -163.72 127.4 2.71 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.227 1.811 . . . . 0.0 112.64 -149.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -80.06 129.55 34.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.49 0.662 . . . . 0.0 111.774 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -121.52 97.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.252 1.421 . . . . 0.0 108.707 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -72.87 127.35 32.3 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.752 164.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -103.17 116.96 61.44 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 159.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -75.77 158.31 39.21 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.506 1.471 . . . . 0.0 110.282 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -67.4 -7.35 24.4 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.4 p -85.41 -17.38 36.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.083 1.353 . . . . 0.0 114.357 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.6 m -91.56 -15.14 29.13 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -74.03 152.78 39.92 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.542 1.137 . . . . 0.0 111.502 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ppt_? -132.54 156.73 46.29 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.987 0.915 . . . . 0.0 111.33 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.95 151.23 22.43 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.63 79.84 1.4 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.443 1.897 . . . . 0.0 110.69 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.52 -31.77 47.72 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.971 -1.08 . . . . 0.0 112.562 -164.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 30.5 p-10 -74.67 -11.16 60.11 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.689 1.596 . . . . 0.0 114.651 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.61 -11.81 20.64 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.234 1.568 . . . . 0.0 115.234 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -117.84 156.52 49.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 125.839 1.656 . . . . 0.0 113.204 -168.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.61 148.45 20.43 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 123.241 2.628 . . . . 0.0 112.799 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -9.35 18.28 Favored 'Trans proline' 0 CA--C 1.54 0.801 1 C-N-CA 125.974 4.45 . . . . 0.0 115.816 -168.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.83 47.27 0.22 Allowed Glycine 0 CA--C 1.538 1.53 0 C-N-CA 127.378 2.418 . . . . 0.0 115.656 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -142.21 169.16 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -141.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -64.9 103.71 0.75 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 144.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.96 35.87 2.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.647 1.579 . . . . 0.0 111.355 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 93.9 p -73.0 -28.35 62.33 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -160.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 66.84 14.9 63.84 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-N 118.426 0.557 . . . . 0.0 113.453 -165.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -134.62 130.29 36.21 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.93 1.692 . . . . 0.0 110.944 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.0 tp -79.72 108.99 13.71 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -98.35 106.77 19.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.297 1.439 . . . . 0.0 110.604 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.2 52.6 2.37 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 122.859 1.314 . . . . 0.0 111.024 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -120.11 -22.9 6.48 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.309 1.844 . . . . 0.0 111.922 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -149.5 48.48 0.96 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.04 1.736 . . . . 0.0 113.621 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -77.18 134.28 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 120.5 -1.375 . . . . 0.0 111.718 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.94 -56.81 2.94 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.586 1.555 . . . . 0.0 112.818 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 p -154.76 161.02 41.67 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -166.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.585 HD11 ' CG ' ' A' ' 58' ' ' TYR . 3.1 pt -128.81 139.67 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 127.084 2.154 . . . . 0.0 108.826 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.552 ' CE1' HG13 ' A' ' 57' ' ' VAL . 33.5 m-70 -150.12 149.6 30.5 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.054 0.942 . . . . 0.0 111.529 -158.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -92.21 159.16 15.77 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.953 -0.467 . . . . 0.0 111.916 161.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.7 148.71 45.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.208 1.003 . . . . 0.0 111.869 174.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.37 68.81 0.68 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.82 1.295 . . . . 0.0 112.275 -151.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.96 -4.26 27.43 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.729 171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -129.92 148.25 51.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.684 1.129 . . . . 0.0 113.403 172.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.86 31.24 6.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.933 2.093 . . . . 0.0 111.811 -166.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -136.56 172.96 12.23 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.13 1.372 . . . . 0.0 113.93 -167.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -93.55 159.54 15.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.143 1.777 . . . . 0.0 113.102 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.07 164.1 26.21 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.9 1.238 . . . . 0.0 112.486 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.7 136.52 52.97 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.54 1.136 . . . . 0.0 110.683 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.84 154.54 43.49 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.766 0.827 . . . . 0.0 112.642 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.419 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -118.52 145.19 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.696 1.598 . . . . 0.0 112.781 174.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.51 151.22 35.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.708 157.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -132.56 164.87 25.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.684 145.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 69.29 136.01 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.234 2.214 . . . . 0.0 115.993 173.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.3 mt -136.68 117.37 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.648 1.579 . . . . 0.0 108.775 165.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -150.45 158.75 44.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 45.7 mt -94.94 144.73 25.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.743 2.017 . . . . 0.0 109.829 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.4 mm -127.49 141.15 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.751 1.221 . . . . 0.0 111.482 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -105.33 -15.14 20.33 Favored Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.809 1.484 . . . . 0.0 116.809 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 153.88 28.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.63 1.172 . . . . 0.0 112.959 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.7 tp -151.88 42.48 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.171 0.986 . . . . 0.0 112.397 -173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 C--O 1.251 1.148 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.586 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.52 154.06 29.1 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.579 0.752 . . . . 0.0 112.218 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.3 m -157.43 1.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.383 1.473 . . . . 0.0 114.256 170.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -146.61 -35.55 0.26 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.54 150.88 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.184 1.794 . . . . 0.0 110.6 -172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.21 15.1 67.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.847 0.737 . . . . 0.0 113.804 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -146.72 158.88 44.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.99 2.116 . . . . 0.0 111.889 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -146.61 140.33 25.97 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.177 0.991 . . . . 0.0 111.241 164.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.9 tpt -73.35 147.28 44.53 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -103.72 -55.74 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.843 1.257 . . . . 0.0 110.613 166.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.36 141.88 20.79 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.565 1.075 . . . . 0.0 113.555 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -106.14 -6.27 18.72 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.305 1.842 . . . . 0.0 113.048 173.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 64.86 -4.88 0.43 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.239 2.616 . . . . 0.0 116.868 -169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.83 -13.59 62.26 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.252 -1.53 . . . . 0.0 113.364 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.7 -116.89 1.22 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.65 2.072 . . . . 0.0 113.596 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.05 133.43 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tt -77.94 106.16 9.61 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 162.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -117.03 15.21 15.1 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.11 1.764 . . . . 0.0 114.203 -167.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -83.12 137.48 34.06 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.92 105.66 1.35 Allowed Glycine 0 C--N 1.341 0.854 0 C-N-CA 123.933 0.778 . . . . 0.0 112.948 -167.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -88.47 154.98 19.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -156.88 159.06 37.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.036 1.334 . . . . 0.0 112.26 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.9 p -161.89 149.16 14.25 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.41 173.54 15.63 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 161.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.61 -5.82 36.34 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.325 -1.691 . . . . 0.0 113.943 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.03 -2.37 86.08 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.856 1.217 . . . . 0.0 115.624 168.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.81 165.44 28.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.15 1.975 . . . . 0.0 112.955 -178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -147.35 141.13 25.72 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.863 1.665 . . . . 0.0 109.046 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -135.87 133.59 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.639 1.175 . . . . 0.0 111.991 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.6 m -143.19 116.24 8.88 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.562 0.745 . . . . 0.0 112.929 -168.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 17.9 p -91.38 147.75 22.81 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.682 1.993 . . . . 0.0 112.31 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.17 163.45 36.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.175 2.19 . . . . 0.0 111.848 174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 mt -104.29 138.38 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.625 1.57 . . . . 0.0 111.411 172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.28 -171.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.503 2.721 . . . . 0.0 110.968 -175.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.7 m -77.14 139.02 39.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.291 -1.506 . . . . 0.0 110.695 163.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -109.35 -159.31 18.61 Favored Glycine 0 N--CA 1.47 0.942 0 C-N-CA 124.125 0.869 . . . . 0.0 113.592 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -68.99 -28.81 66.95 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.214 -0.58 . . . . 0.0 111.009 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -155.38 137.08 14.31 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.196 0.998 . . . . 0.0 108.487 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.15 -131.27 48.3 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 121.864 0.702 . . . . 0.0 112.048 -163.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -87.81 171.05 10.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 112.567 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.36 168.8 25.68 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 126.537 2.018 . . . . 0.0 111.124 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.5 ttp -104.81 133.2 50.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.43 0.615 . . . . 0.0 110.172 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -107.18 141.33 38.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.944 1.297 . . . . 0.0 109.198 165.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.48 135.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.825 1.25 . . . . 0.0 110.592 176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.2 m -122.76 147.44 46.5 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.3 1.84 . . . . 0.0 110.553 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CE2' ' NE1' ' A' ' 54' ' ' TRP . 8.9 p90 -147.85 145.34 28.66 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 167.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -97.09 128.86 44.43 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 160.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.01 170.38 26.47 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-N 119.471 1.032 . . . . 0.0 115.133 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.543 HG23 ' H ' ' A' ' 52' ' ' GLY . 7.2 t -144.66 168.05 21.09 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -154.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 m -80.44 -37.53 31.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.805 1.242 . . . . 0.0 112.183 167.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -94.88 -20.93 19.01 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 49' ' ' THR . . . -107.65 -150.27 15.88 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.135 1.35 . . . . 0.0 113.796 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -163.22 151.33 13.63 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.996 1.718 . . . . 0.0 109.962 -173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.485 ' NE1' ' CE2' ' A' ' 46' ' ' TYR . 0.5 OUTLIER -154.2 164.54 38.37 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.606 0.762 . . . . 0.0 110.952 179.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.17 171.85 44.95 Favored Glycine 0 N--CA 1.473 1.149 0 O-C-N 120.488 -1.383 . . . . 0.0 114.248 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.8 t -156.96 138.43 13.95 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.919 0.888 . . . . 0.0 112.517 168.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.7 t -139.16 131.09 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -151.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -117.32 132.75 56.54 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.421 1.489 . . . . 0.0 112.1 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.3 t -90.63 122.68 33.63 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.365 0.602 . . . . 0.0 110.758 172.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.28 133.42 68.24 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.108 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -62.92 -32.3 76.85 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.856 2.37 . . . . 0.0 113.718 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -125.85 177.08 6.51 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.808 2.443 . . . . 0.0 111.08 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 171.06 83.44 0.05 OUTLIER Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -170.22 43.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.557 2.343 . . . . 0.0 108.771 -162.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.547 ' HE1' ' CD1' ' A' ' 89' ' ' ILE . 4.8 m95 -70.87 6.55 1.47 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -152.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.8 p -57.41 -31.65 66.06 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -153.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -90.26 0.63 57.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.86 1.264 . . . . 0.0 114.308 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -94.84 162.73 13.63 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.106 1.363 . . . . 0.0 110.64 165.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -127.46 -24.38 3.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.188 1.395 . . . . 0.0 112.715 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -141.61 156.11 45.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.56 1.144 . . . . 0.0 112.228 -171.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -94.72 158.79 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 109.535 158.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.8 t -145.97 131.68 18.95 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.926 0.89 . . . . 0.0 109.758 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.94 157.82 43.74 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.593 1.157 . . . . 0.0 111.505 169.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -94.45 121.03 35.56 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.917 -0.489 . . . . 0.0 111.915 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.2 tt -149.54 134.2 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.686 -1.259 . . . . 0.0 113.347 -169.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.614 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -166.15 167.9 15.85 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.525 1.13 . . . . 0.0 113.648 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.6 t -87.22 147.96 25.35 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 127.114 2.166 . . . . 0.0 113.914 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 m -111.91 -6.1 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.109 1.363 . . . . 0.0 112.425 164.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -101.26 -21.99 14.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.399 1.88 . . . . 0.0 113.117 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.83 5.92 58.48 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.845 1.688 . . . . 0.0 116.919 168.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.5 m -81.8 0.69 38.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -163.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . 54.91 10.18 0.36 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.454 2.702 . . . . 0.0 116.871 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -73.54 141.86 46.69 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.785 1.634 . . . . 0.0 112.608 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -75.07 147.19 40.85 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -163.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.6 pt -135.93 174.15 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.545 1.938 . . . . 0.0 110.482 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -130.02 149.57 51.68 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.525 -0.735 . . . . 0.0 112.782 166.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -99.35 153.38 19.02 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.788 1.635 . . . . 0.0 109.26 162.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -162.17 141.6 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.577 -0.702 . . . . 0.0 110.03 -168.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.547 ' CD1' ' HE1' ' A' ' 65' ' ' TRP . 2.1 tt -121.47 141.58 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.46 139.86 42.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.753 0.821 . . . . 0.0 111.476 -176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -78.01 160.7 27.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.389 1.076 . . . . 0.0 111.275 163.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.43 158.13 26.04 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.92 -1.112 . . . . 0.0 113.254 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -70.19 141.91 52.5 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.622 1.569 . . . . 0.0 112.845 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 pt -66.97 -18.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.648 1.179 . . . . 0.0 112.999 169.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -101.77 -10.86 19.56 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.98 1.712 . . . . 0.0 113.126 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.96 6.72 39.25 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 123.761 0.696 . . . . 0.0 113.856 -165.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.36 142.43 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 128.042 2.537 . . . . 0.0 109.38 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 64.2 -137.01 40.28 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.018 0.818 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -116.25 161.99 18.15 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.494 1.117 . . . . 0.0 111.904 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.56 -160.33 14.83 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.941 1.734 . . . . 0.0 113.946 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.84 118.4 13.58 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.086 -1.243 . . . . 0.0 112.7 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -93.62 136.6 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.158 -0.964 . . . . 0.0 113.59 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.68 122.69 33.63 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.571 1.549 . . . . 0.0 111.923 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.8 m -129.0 154.35 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -154.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -145.64 125.95 13.92 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.765 2.026 . . . . 0.0 110.615 171.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.9 m -114.89 133.39 56.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.295 1.438 . . . . 0.0 112.654 -167.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.05 159.4 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.123 1.369 . . . . 0.0 114.134 -164.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -93.72 137.31 23.26 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.774 1.23 . . . . 0.0 111.103 159.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -87.6 144.04 6.44 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.953 2.435 . . . . 0.0 112.406 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.04 178.04 8.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.181 0.992 . . . . 0.0 110.795 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -103.72 5.44 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.499 2.319 . . . . 0.0 114.351 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 82.3 p -122.06 143.16 49.68 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 123.261 1.505 . . . . 0.0 114.536 -176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.358 2.0 t90 -75.09 115.55 14.84 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 128.915 2.886 . . . . 0.0 107.706 -171.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.66 131.39 4.72 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.32 3.048 . . . . 0.0 110.024 -157.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 59.6 m -93.12 106.68 18.6 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.188 0.995 . . . . 0.0 110.33 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mt -94.21 97.08 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 C-N-CA 126.218 1.807 . . . . 0.0 109.856 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -74.33 126.31 30.38 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.691 168.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 21.1 mt -134.16 122.41 16.14 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.67 1.188 . . . . 0.0 109.38 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -78.46 159.76 28.95 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.13 1.887 . . . . 0.0 112.113 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -64.11 -12.37 38.73 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.253 -0.904 . . . . 0.0 112.438 169.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.9 m -68.21 -14.66 63.15 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.45 1.1 . . . . 0.0 113.821 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.7 m -93.33 -3.23 53.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -96.62 142.6 28.48 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.112 -0.993 . . . . 0.0 112.812 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -131.56 163.83 27.18 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.951 1.701 . . . . 0.0 110.948 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -72.96 135.1 44.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.347 0.659 . . . . 0.0 109.943 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -71.55 130.65 41.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.583 1.083 . . . . 0.0 108.106 167.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.58 -15.19 2.79 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -163.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.17 -9.9 59.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.395 1.478 . . . . 0.0 112.191 163.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.45 127.72 8.43 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.735 2.014 . . . . 0.0 110.686 -174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -151.38 155.42 34.47 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.222 1.409 . . . . 0.0 110.847 158.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.66 157.11 9.05 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 125.093 3.862 . . . . 0.0 111.999 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -65.11 -28.29 56.79 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.293 2.662 . . . . 0.0 113.786 -175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.61 15.16 43.03 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.132 1.349 . . . . 0.0 115.708 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.39 147.99 50.25 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 119.357 1.579 . . . . 0.0 112.531 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.41 -12.28 59.85 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.7 ptt? 47.19 33.23 2.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.229 2.612 . . . . 0.0 114.169 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 82.7 p -77.47 -16.79 58.55 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.13 1.57 27.42 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.141 0.877 . . . . 0.0 113.506 -169.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.7 m -123.71 143.41 50.3 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 127.4 2.28 . . . . 0.0 110.106 -171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.5 tp -80.72 106.24 12.58 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.886 1.274 . . . . 0.0 109.588 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.62 85.11 3.52 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.995 1.318 . . . . 0.0 110.418 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' HB2' ' H ' ' A' ' 65' ' ' TRP . 1.8 pp -58.48 -20.67 47.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 113.251 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.81 -9.15 41.96 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.815 1.646 . . . . 0.0 112.667 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -144.9 47.79 1.32 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.241 1.417 . . . . 0.0 112.818 -168.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.3 146.74 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.616 1.567 . . . . 0.0 113.355 -171.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -115.55 -57.84 2.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.862 2.465 . . . . 0.0 113.553 -165.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 p -160.94 164.49 31.09 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -162.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.4 pt -117.97 156.62 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.318 1.047 . . . . 0.0 111.305 165.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -137.31 144.87 42.84 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.487 1.115 . . . . 0.0 110.804 -170.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -78.31 136.84 37.81 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 148.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 91.2 mtp -128.05 142.64 51.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.753 0.821 . . . . 0.0 111.383 170.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.28 141.12 37.32 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.684 0.794 . . . . 0.0 111.983 172.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.03 17.5 3.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.981 1.313 . . . . 0.0 112.292 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -149.51 173.02 14.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.156 2.583 . . . . 0.0 109.616 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -118.12 19.48 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -172.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -116.03 174.24 6.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.943 1.297 . . . . 0.0 111.974 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.4 m -70.25 170.96 10.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 127.282 2.233 . . . . 0.0 113.932 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.89 163.23 30.78 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.203 0.841 . . . . 0.0 115.203 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -137.94 135.05 35.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.918 1.687 . . . . 0.0 111.651 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 56.0 p90 -154.42 166.36 33.49 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.4 146.93 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 127.276 2.23 . . . . 0.0 113.985 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.4 p -138.73 138.63 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.301 1.44 . . . . 0.0 112.793 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -134.49 175.15 9.78 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 155.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 60.36 58.2 2.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.4 mt -88.15 118.35 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 120.662 -1.274 . . . . 0.0 111.328 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -149.45 165.66 31.45 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 114.551 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.93 149.09 26.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.835 1.254 . . . . 0.0 111.293 167.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mm -129.45 146.2 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.809 2.043 . . . . 0.0 110.558 -173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.24 -6.97 0.72 Allowed Glycine 0 CA--C 1.54 1.607 0 N-CA-C 117.59 1.796 . . . . 0.0 117.59 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -111.71 160.46 17.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.237 1.519 . . . . 0.0 114.089 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 18.7 tp -86.83 40.75 0.92 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.36 1.864 . . . . 0.0 112.346 -175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.713 1.605 . . . . 0.0 111.718 177.082 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.02 124.86 16.05 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -93.03 161.33 14.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.837 2.055 . . . . 0.0 110.995 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.3 172.16 16.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.2 -36.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.779 1.631 . . . . 0.0 111.108 162.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.28 43.77 0.36 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.377 1.465 . . . . 0.0 114.307 -174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.28 150.84 40.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.03 1.332 . . . . 0.0 112.389 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -143.63 143.96 31.69 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.807 0.843 . . . . 0.0 111.575 161.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 tpp -74.85 145.15 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.321 1.048 . . . . 0.0 112.36 -173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -108.23 -62.17 1.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.671 0.788 . . . . 0.0 111.459 163.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -156.46 127.75 7.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 172.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -106.0 19.74 20.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.558 1.143 . . . . 0.0 111.934 169.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 62.31 11.81 4.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.615 2.366 . . . . 0.0 115.411 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -73.76 -15.94 61.18 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.946 1.462 . . . . 0.0 114.946 -169.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 -126.56 2.42 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 127.066 2.27 . . . . 0.0 113.524 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.87 141.49 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.358 1.863 . . . . 0.0 109.824 170.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.3 tp -69.54 146.92 51.45 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 7.0 p-10 -149.96 34.28 0.67 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -160.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.735 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 66.8 m95 -137.82 139.91 40.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.37 1.068 . . . . 0.0 113.456 -166.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.03 161.32 54.13 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.241 1.401 . . . . 0.0 115.063 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -145.61 146.14 31.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.379 1.472 . . . . 0.0 110.585 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -158.51 154.1 26.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.821 1.248 . . . . 0.0 112.706 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.0 p -154.58 162.67 41.03 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.301 1.04 . . . . 0.0 113.561 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.92 160.97 28.73 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.065 1.317 . . . . 0.0 114.112 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . 0.255 1.5 mp0 33.34 59.49 0.48 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.948 2.499 . . . . 0.0 116.234 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.87 -8.35 79.92 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.385 1.469 . . . . 0.0 115.751 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.22 163.29 28.01 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 118.602 1.201 . . . . 0.0 111.956 170.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -139.57 141.49 37.21 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.808 1.243 . . . . 0.0 112.76 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.56 153.41 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 128.128 2.571 . . . . 0.0 108.794 163.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.7 m -167.13 103.45 0.54 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 120.593 -1.317 . . . . 0.0 112.01 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.8 p -86.93 134.0 33.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.089 1.756 . . . . 0.0 114.726 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -137.85 172.93 12.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.59 1.956 . . . . 0.0 111.826 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.9 mm -111.78 142.51 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.835 1.654 . . . . 0.0 110.724 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -148.3 171.86 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.18 1.792 . . . . 0.0 112.213 -171.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 m -70.35 125.66 27.42 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 120.345 -1.472 . . . . 0.0 111.409 161.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.03 -177.16 17.78 Favored Glycine 0 N--CA 1.469 0.865 0 C-N-CA 125.402 1.477 . . . . 0.0 114.164 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.55 -34.65 18.1 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.862 1.665 . . . . 0.0 113.005 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 t -147.93 130.24 15.64 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.383 0.673 . . . . 0.0 110.481 170.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.61 -122.74 31.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.312 0.482 . . . . 0.0 112.216 -167.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.85 165.7 10.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.211 1.004 . . . . 0.0 110.876 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.35 173.98 16.46 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 127.449 2.452 . . . . 0.0 111.601 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.3 ttp -106.43 129.48 54.4 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.827 0.851 . . . . 0.0 109.6 165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -100.9 148.66 24.72 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.727 1.611 . . . . 0.0 110.688 172.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 148.63 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 163.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 t -88.45 124.95 34.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.031 149.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.2 m-30 -111.52 103.69 12.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 110.341 172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.5 m -107.83 105.04 14.67 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.626 1.17 . . . . 0.0 109.687 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.96 175.24 50.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.023 0.82 . . . . 0.0 113.684 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 t -154.46 176.5 12.28 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.546 1.138 . . . . 0.0 110.22 159.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.2 p -56.54 -40.94 75.96 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 120.213 1.37 . . . . 0.0 113.996 -174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -127.61 17.86 6.89 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.414 1.086 . . . . 0.0 113.343 -173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.72 -163.41 39.22 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.06 1.314 . . . . 0.0 113.82 176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -162.83 141.15 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.569 1.148 . . . . 0.0 112.292 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -147.34 158.52 44.0 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.513 1.051 . . . . 0.0 112.764 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.63 -175.55 44.94 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.393 0.997 . . . . 0.0 114.369 176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 153.74 45.67 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 127.099 2.16 . . . . 0.0 111.293 -175.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 149' ' ' HIS . 47.3 t -120.76 146.35 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 120.271 1.396 . . . . 0.0 108.283 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.735 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.04 127.44 16.86 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.566 0.698 . . . . 0.0 111.177 178.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -103.03 115.02 29.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.974 1.71 . . . . 0.0 108.962 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.6 mt -73.07 133.03 81.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.394 1.078 . . . . 0.0 113.088 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -56.69 -26.71 66.88 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.883 3.055 . . . . 0.0 114.781 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -144.24 123.23 12.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.606 1.562 . . . . 0.0 110.789 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.02 25.88 9.14 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 125.878 1.704 . . . . 0.0 114.208 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -134.38 103.71 5.83 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.108 1.363 . . . . 0.0 113.411 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.59 48.22 0.95 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.6 p -58.97 -17.41 24.52 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -80.27 -15.2 57.5 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 120.085 1.311 . . . . 0.0 113.534 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -94.14 150.63 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.354 1.061 . . . . 0.0 112.099 -167.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -111.12 -33.15 6.55 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.803 0.841 . . . . 0.0 113.102 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -144.0 158.36 43.75 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.413 1.085 . . . . 0.0 112.527 -174.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.5 tt -92.13 161.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.878 0.871 . . . . 0.0 109.293 154.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.2 t -136.75 139.76 42.09 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.779 1.231 . . . . 0.0 110.534 168.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -144.42 171.36 14.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.72 0.808 . . . . 0.0 110.125 158.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -117.33 121.37 40.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.416 0.286 . . . . 0.0 110.704 172.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 tt -123.16 140.89 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.449 1.499 . . . . 0.0 110.864 -164.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.569 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 6.8 mttm -154.22 166.78 32.05 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -149.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -125.43 154.06 42.55 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.546 1.138 . . . . 0.0 113.252 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.7 p -127.06 9.48 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 127.242 2.217 . . . . 0.0 110.588 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -127.76 159.79 33.7 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.113 2.565 . . . . 0.0 111.401 168.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.8 -13.32 63.58 Favored Glycine 0 CA--C 1.537 1.456 0 O-C-N 120.291 -1.505 . . . . 0.0 114.859 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.0 m -68.09 151.38 47.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 112.308 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.91 29.21 0.82 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.81 153.53 41.61 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.097 -1.002 . . . . 0.0 112.764 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.57 154.9 24.76 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.18 171.37 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 127.063 2.145 . . . . 0.0 110.771 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -119.33 156.61 29.72 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.919 1.288 . . . . 0.0 113.719 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -127.73 157.57 39.97 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.534 2.334 . . . . 0.0 111.223 -176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.0 ttm -149.7 137.74 20.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.491 1.116 . . . . 0.0 111.556 177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.07 141.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 126.294 1.837 . . . . 0.0 107.462 166.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.52 132.25 38.95 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -95.52 178.01 5.63 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.76 1.224 . . . . 0.0 112.833 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -89.39 168.87 11.87 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.274 1.43 . . . . 0.0 114.476 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.9 t -57.1 157.52 5.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.622 1.969 . . . . 0.0 112.974 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.7 -12.2 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 163.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -105.19 -1.82 24.92 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.946 1.298 . . . . 0.0 113.314 168.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.84 -5.26 76.22 Favored Glycine 0 N--CA 1.478 1.483 0 N-CA-C 116.06 1.184 . . . . 0.0 116.06 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.07 158.53 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 127.088 2.155 . . . . 0.0 110.96 167.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.12 -15.5 63.09 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 118.756 2.262 . . . . 0.0 118.756 -160.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -94.67 111.41 23.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.063 1.932 . . . . 0.0 113.549 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.43 175.2 34.14 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 127.723 2.582 . . . . 0.0 112.835 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -55.5 136.21 50.07 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -109.45 134.07 52.31 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.291 1.436 . . . . 0.0 111.464 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -130.42 126.3 36.66 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.866 1.666 . . . . 0.0 110.48 -171.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.12 157.41 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -160.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -154.04 163.6 39.82 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.252 1.821 . . . . 0.0 111.593 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -128.01 144.1 51.1 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 120.096 1.316 . . . . 0.0 113.357 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 155.45 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 125.009 1.323 . . . . 0.0 114.278 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -118.27 146.12 38.71 Favored Pre-proline 0 N--CA 1.483 1.196 0 C-N-CA 126.882 2.073 . . . . 0.0 113.293 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -94.8 176.13 1.05 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.732 3.622 . . . . 0.0 114.262 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.84 169.57 20.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.256 1.423 . . . . 0.0 111.54 157.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.5 m -67.29 -27.97 67.62 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.644 1.178 . . . . 0.0 112.791 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 p -86.01 111.18 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 123.131 1.443 . . . . 0.0 108.882 162.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.569 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -30.31 114.07 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.645 3.178 . . . . 0.0 112.708 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -120.83 125.42 47.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.587 1.155 . . . . 0.0 111.505 -168.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -92.88 125.41 37.47 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.756 0.822 . . . . 0.0 110.908 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 mt -120.13 96.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.495 1.118 . . . . 0.0 109.763 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.91 110.54 6.49 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.623 158.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.5 mt -104.96 114.63 63.56 Favored Pre-proline 0 N--CA 1.477 0.882 0 O-C-N 121.271 -0.893 . . . . 0.0 108.886 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -73.05 155.28 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.547 1.498 . . . . 0.0 110.84 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -65.83 -7.56 16.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 p -85.78 -23.03 27.4 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.036 1.334 . . . . 0.0 114.027 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 39.3 m -81.22 -20.26 41.46 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.77 141.2 49.73 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.864 -1.147 . . . . 0.0 111.846 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 149.86 41.34 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.076 1.35 . . . . 0.0 112.606 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -81.43 134.62 35.57 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 tpt85 -74.9 64.48 1.3 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.472 1.909 . . . . 0.0 112.685 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.12 -31.79 71.63 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 -157.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -86.49 3.53 43.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -116.09 -8.4 11.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.252 2.221 . . . . 0.0 113.339 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -69.97 137.36 87.36 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 -157.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -60.26 164.36 12.84 Favored 'Trans proline' 0 CA--C 1.552 1.381 0 C-N-CA 124.621 3.547 . . . . 0.0 115.365 176.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.84 -25.18 0.31 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.638 2.892 . . . . 0.0 115.908 -170.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.55 59.5 4.92 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 126.011 1.767 . . . . 0.0 110.77 -172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.1 139.09 53.23 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -145.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -80.63 8.54 7.7 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -157.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.9 tpt 58.43 10.16 1.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.301 1.84 . . . . 0.0 115.835 174.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.9 p -79.4 -21.2 45.98 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 57.68 24.31 52.76 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.818 -168.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 m -146.8 141.71 26.97 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.343 1.457 . . . . 0.0 112.032 -165.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -79.13 116.45 19.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.86 1.264 . . . . 0.0 111.273 167.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.54 102.62 14.56 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.221 1.008 . . . . 0.0 111.085 -172.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.02 -12.13 61.41 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 118.346 -0.835 . . . . 0.0 113.116 -172.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -81.14 -0.69 41.35 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.261 1.025 . . . . 0.0 113.184 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -143.99 33.78 1.24 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -163.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.3 mm -82.3 135.37 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 111.38 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -96.42 -50.8 4.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.369 1.468 . . . . 0.0 112.486 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.2 p -161.84 167.24 25.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.498 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -126.03 149.47 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.861 1.264 . . . . 0.0 108.753 170.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.571 ' CE1' HG13 ' A' ' 57' ' ' VAL . 54.8 m-70 -140.94 147.03 38.17 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.385 1.074 . . . . 0.0 110.415 -177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.96 142.19 45.94 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 63.8 mtt -145.56 156.86 43.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.94 0.876 . . . . 0.0 112.943 -170.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.7 152.15 36.31 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.95 21.91 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.941 1.297 . . . . 0.0 111.595 165.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -137.92 153.06 49.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.98 1.712 . . . . 0.0 112.584 -164.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -112.74 -22.42 10.71 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.441 1.496 . . . . 0.0 110.767 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -65.93 175.59 1.95 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.934 2.094 . . . . 0.0 113.149 166.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.15 160.65 26.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.74 1.616 . . . . 0.0 111.273 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 175.38 171.66 39.56 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 121.409 -0.807 . . . . 0.0 114.47 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -118.09 134.63 54.81 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.035 1.334 . . . . 0.0 110.769 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -144.72 158.58 43.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.559 1.143 . . . . 0.0 112.413 -164.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.32 153.29 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.662 1.585 . . . . 0.0 109.626 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.52 155.7 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.886 1.274 . . . . 0.0 111.624 165.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -146.35 172.74 13.05 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 164.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 58.57 59.65 2.85 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 167.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.63 122.94 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.131 -1.606 . . . . 0.0 111.509 174.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -142.95 167.14 22.77 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.161 1.385 . . . . 0.0 114.35 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.43 144.55 29.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.382 1.473 . . . . 0.0 110.466 161.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.5 mm -124.68 128.93 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.541 1.536 . . . . 0.0 110.434 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.8 -12.01 64.76 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.923 1.249 . . . . 0.0 115.331 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -98.11 151.21 20.62 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.021 1.328 . . . . 0.0 113.67 -174.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.1 pp -98.65 32.78 2.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.697 1.599 . . . . 0.0 113.076 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.908 1.683 . . . . 0.0 113.247 -175.833 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 150.38 39.85 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 m 59.18 -3.12 0.09 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.062 2.145 . . . . 0.0 116.335 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.79 160.25 21.26 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.315 1.446 . . . . 0.0 112.091 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -136.32 156.65 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.223 1.409 . . . . 0.0 112.198 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.25 91.48 0.54 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.079 1.323 . . . . 0.0 112.975 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.72 162.7 25.97 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.072 1.349 . . . . 0.0 113.509 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -140.39 143.7 35.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.831 2.052 . . . . 0.0 110.502 171.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.4 ttp -81.16 149.76 28.98 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.9 mt -116.99 -52.33 2.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.095 1.358 . . . . 0.0 111.849 162.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.92 127.81 6.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.962 0.905 . . . . 0.0 112.421 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.47 8.89 7.12 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.646 1.578 . . . . 0.0 111.546 177.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 67.88 2.46 3.1 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 166.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -69.58 -9.69 55.08 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.69 -138.07 9.84 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.615 1.579 . . . . 0.0 113.046 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.0 t -85.87 142.58 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.043 1.737 . . . . 0.0 111.309 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.01 102.91 0.66 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.599 1.159 . . . . 0.0 110.727 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.5 35.49 1.64 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.038 1.735 . . . . 0.0 112.899 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -116.77 149.83 39.27 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.271 1.428 . . . . 0.0 110.589 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.42 90.0 0.46 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 124.146 0.879 . . . . 0.0 113.93 -168.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -92.07 144.22 25.66 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -159.02 174.29 15.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 112.918 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.5 p -156.97 158.82 37.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 171.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.38 172.49 47.73 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 123.862 0.744 . . . . 0.0 112.167 156.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.78 -22.95 26.99 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 -168.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.39 -4.13 37.8 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.161 1.362 . . . . 0.0 115.684 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.98 168.37 10.59 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.805 1.303 . . . . 0.0 110.503 172.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -161.38 127.86 3.89 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.529 0.731 . . . . 0.0 109.127 -167.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 p -124.74 155.96 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -164.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -153.5 137.98 16.77 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.489 1.515 . . . . 0.0 111.402 174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.78 118.32 16.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.623 1.169 . . . . 0.0 110.603 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -126.56 163.87 22.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.434 1.894 . . . . 0.0 113.245 -167.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.4 mm -97.61 144.36 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.07 1.348 . . . . 0.0 111.219 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.6 m -148.16 -176.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.819 2.048 . . . . 0.0 110.833 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -73.38 145.27 46.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 119.859 -1.776 . . . . 0.0 110.98 165.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 113' ' ' TRP . . . -148.38 -170.44 16.27 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 121.326 -0.859 . . . . 0.0 115.037 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HE2' ' CE3' ' A' ' 113' ' ' TRP . 67.5 mmtt -51.95 -28.84 17.95 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.6 1.96 . . . . 0.0 114.608 -164.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 t -153.09 132.21 12.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.996 0.918 . . . . 0.0 109.699 165.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.59 -125.3 38.11 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.428 0.537 . . . . 0.0 111.76 -169.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.41 159.69 14.77 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.142 0.973 . . . . 0.0 112.803 177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.54 -174.34 19.33 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 126.407 1.956 . . . . 0.0 111.003 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.8 ttp -129.59 135.21 48.28 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.438 1.095 . . . . 0.0 110.567 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.89 144.69 47.27 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.642 1.577 . . . . 0.0 110.873 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.48 138.61 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.77 0.828 . . . . 0.0 110.945 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.2 t -133.4 138.77 46.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.064 1.346 . . . . 0.0 109.98 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.491 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 5.2 p90 -141.36 157.43 45.2 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -101.44 135.05 43.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.833 2.053 . . . . 0.0 108.162 158.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.76 176.63 16.2 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 120.356 1.435 . . . . 0.0 114.976 -174.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.1 t -136.45 163.85 29.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 174.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.1 p -88.06 -23.07 23.85 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.779 1.232 . . . . 0.0 113.508 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.08 -26.8 18.97 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 49' ' ' THR . . . -115.36 -139.23 6.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.905 0.764 . . . . 0.0 114.466 -172.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -159.51 158.74 32.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 127.333 2.253 . . . . 0.0 108.724 -177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.491 ' CD1' ' CE2' ' A' ' 46' ' ' TYR 0.263 0.0 OUTLIER -123.11 -172.99 2.61 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.209 1.403 . . . . 0.0 108.382 173.246 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.64 147.72 11.22 Favored Glycine 0 N--CA 1.474 1.194 0 O-C-N 119.536 -1.977 . . . . 0.0 115.665 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 t -156.34 136.28 12.69 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.043 1.337 . . . . 0.0 111.586 158.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -137.63 138.24 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -159.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -111.94 134.45 53.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.072 1.349 . . . . 0.0 111.285 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.8 t -100.52 123.55 44.88 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.422 1.089 . . . . 0.0 110.409 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.82 142.76 57.01 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.707 1.203 . . . . 0.0 111.048 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.9 -37.92 18.47 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.688 2.259 . . . . 0.0 110.836 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -159.69 156.01 27.05 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.707 2.403 . . . . 0.0 108.029 158.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -115.31 87.57 0.44 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 170.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -128.04 3.89 5.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -166.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -93.36 52.65 1.79 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.249 1.42 . . . . 0.0 113.669 -151.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.7 t -72.87 41.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.292 1.837 . . . . 0.0 115.92 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -136.28 18.55 3.17 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.574 2.349 . . . . 0.0 112.504 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -101.13 144.47 29.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.372 -0.83 . . . . 0.0 112.177 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.7 -40.91 6.4 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.739 1.615 . . . . 0.0 110.884 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -133.58 158.99 41.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 111.657 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 tt -85.95 163.98 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 153.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.3 t -146.02 139.36 26.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 111.034 169.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.47 157.14 43.45 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.735 . . . . 0.0 112.331 163.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' CG ' ' HE3' ' A' ' 37' ' ' LYS . 16.5 m-20 -95.09 112.16 23.9 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 167.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.78 142.08 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.949 0.9 . . . . 0.0 112.596 -167.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.97 166.37 28.84 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.852 1.426 . . . . 0.0 114.852 167.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 t -84.78 123.26 30.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.467 1.907 . . . . 0.0 109.836 172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.313 1.1 p -106.76 1.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.797 1.639 . . . . 0.0 111.901 172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -71.11 -35.47 71.8 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.103 -0.998 . . . . 0.0 110.886 142.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.98 -30.18 9.87 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.064 1.792 . . . . 0.0 113.781 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.9 m -78.6 150.32 32.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.182 0.993 . . . . 0.0 112.967 174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.2 52.05 2.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.063 2.145 . . . . 0.0 111.239 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -58.48 120.83 9.52 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.663 1.985 . . . . 0.0 110.211 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.21 160.94 16.71 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.944 1.831 . . . . 0.0 115.944 -167.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 pt -154.08 173.69 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.72 1.608 . . . . 0.0 111.119 -160.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.99 134.13 55.29 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.316 1.047 . . . . 0.0 109.133 163.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -93.43 149.1 21.49 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 160.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -141.64 146.32 36.04 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.187 0.995 . . . . 0.0 112.558 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.95 135.88 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.738 1.615 . . . . 0.0 109.866 168.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -99.09 130.72 45.43 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.61 1.164 . . . . 0.0 111.09 168.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -81.99 168.47 17.81 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.463 0.705 . . . . 0.0 111.146 166.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -92.85 160.66 14.83 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.99 -1.069 . . . . 0.0 112.325 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -87.65 144.97 26.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.025 0.93 . . . . 0.0 113.491 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.5 pt -92.29 -12.8 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.847 1.259 . . . . 0.0 112.805 164.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -92.28 -4.98 53.22 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.237 1.415 . . . . 0.0 112.741 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.83 84.15 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.129 1.347 . . . . 0.0 114.669 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.4 t -77.5 165.55 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.628 1.971 . . . . 0.0 110.295 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.74 -21.15 54.56 Favored Glycine 0 CA--C 1.537 1.419 0 N-CA-C 117.683 1.833 . . . . 0.0 117.683 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.49 154.84 44.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.574 1.549 . . . . 0.0 112.096 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.75 -130.91 7.14 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.187 2.327 . . . . 0.0 112.604 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.55 156.34 35.15 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.588 -0.948 . . . . 0.0 111.547 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -128.46 120.65 27.26 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.145 0.978 . . . . 0.0 112.15 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -123.41 131.4 53.63 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.314 1.846 . . . . 0.0 112.181 -160.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.1 m -141.8 137.1 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.277 1.031 . . . . 0.0 113.197 -166.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -76.88 -179.08 5.22 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.952 1.701 . . . . 0.0 111.965 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.9 m -139.51 109.21 6.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.737 0.815 . . . . 0.0 109.421 147.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.1 tt -149.88 160.32 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 O-C-N 121.507 -0.746 . . . . 0.0 112.507 -151.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -152.06 143.69 16.1 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.41 171.37 17.77 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 125.166 3.911 . . . . 0.0 113.263 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -110.21 173.57 6.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.854 1.262 . . . . 0.0 113.131 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 p -73.06 -20.24 61.01 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.427 ' O ' ' HE2' ' A' ' 114' ' ' LYS . 99.6 p -146.95 160.13 42.72 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.422 1.489 . . . . 0.0 110.828 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.512 ' CE3' ' HE2' ' A' ' 37' ' ' LYS 0.261 3.7 m0 -60.82 120.07 9.42 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -164.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -128.14 141.58 51.44 Favored 'General case' 0 CA--C 1.511 -0.519 0 C-N-CA 126.862 2.065 . . . . 0.0 109.814 179.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 m -89.73 95.15 10.12 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.816 1.322 . . . . 0.0 109.799 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.35 93.79 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.009 0.909 . . . . 0.0 109.918 -170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -83.05 86.52 6.99 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.633 1.173 . . . . 0.0 110.826 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.59 122.44 62.6 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 121.135 -0.978 . . . . 0.0 111.758 -172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -82.37 165.33 16.55 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.61 2.873 . . . . 0.0 112.804 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -66.6 -4.04 7.78 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.4 m -75.33 -22.85 57.33 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.568 -1.333 . . . . 0.0 112.64 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.9 m -74.41 -7.35 52.63 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.04 164.48 34.51 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.37 164.8 36.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -164.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -66.44 126.96 30.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.748 0.819 . . . . 0.0 109.468 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -62.13 138.81 58.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.423 1.489 . . . . 0.0 110.461 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -98.21 -39.57 8.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -80.89 -14.82 57.67 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.145 -0.972 . . . . 0.0 113.068 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -142.92 134.34 26.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.924 2.09 . . . . 0.0 110.373 -173.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -141.55 155.56 66.98 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.63 1.572 . . . . 0.0 109.987 159.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.94 157.83 23.19 Favored 'Trans proline' 0 CA--C 1.55 1.301 0 C-N-CA 123.119 2.546 . . . . 0.0 113.635 171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.19 -21.27 18.01 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.889 3.06 . . . . 0.0 114.326 -174.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -115.56 38.57 3.04 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.134 1.826 . . . . 0.0 114.318 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.57 156.68 2.47 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -175.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.66 152.61 37.54 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 156.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -88.23 2.1 53.03 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -165.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.2 p -81.73 -17.92 46.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -165.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 62.78 12.08 39.94 Favored Glycine 0 N--CA 1.479 1.502 0 CA-C-N 120.712 1.597 . . . . 0.0 113.44 -172.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.4 m -141.87 145.08 34.22 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.766 2.426 . . . . 0.0 108.39 -163.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.5 tp -85.77 111.35 20.07 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.279 0.632 . . . . 0.0 109.916 -174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -93.63 89.41 6.22 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.066 1.346 . . . . 0.0 110.237 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.79 -16.73 12.35 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.022 -1.049 . . . . 0.0 113.39 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.96 -6.63 56.73 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.787 1.235 . . . . 0.0 114.255 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -146.94 46.2 1.17 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.341 1.057 . . . . 0.0 113.014 -166.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.5 mm -94.87 135.86 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.67 1.588 . . . . 0.0 112.337 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.83 -60.06 2.12 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.663 1.185 . . . . 0.0 112.33 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.6 p -163.17 167.06 22.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 111.972 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.7 149.26 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.205 1.002 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -137.98 153.83 49.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.054 0.942 . . . . 0.0 112.328 -175.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -95.02 139.31 31.56 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.29 1.036 . . . . 0.0 109.099 162.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 54.8 mtt -138.03 159.88 40.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.692 1.597 . . . . 0.0 112.139 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 48.5 m-85 -125.06 125.36 43.68 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.96 -1.087 . . . . 0.0 113.54 -152.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.5 10.38 6.69 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.361 1.464 . . . . 0.0 112.976 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 137.41 32.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 122.295 1.045 . . . . 0.0 111.197 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -109.58 2.56 20.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.86 -158.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.53 178.38 1.28 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.251 1.42 . . . . 0.0 112.11 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.7 m -83.2 144.25 29.92 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.842 151.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.34 166.88 36.69 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.692 0.678 . . . . 0.0 114.534 -174.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -142.46 139.02 31.41 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.151 1.38 . . . . 0.0 111.602 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -142.85 162.04 36.53 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.276 1.43 . . . . 0.0 112.218 -177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.0 p -158.54 144.71 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.26 159.9 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -132.68 179.68 6.0 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.515 0.726 . . . . 0.0 111.205 141.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 63.28 49.79 3.16 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 163.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.74 115.96 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.44 -1.412 . . . . 0.0 109.594 172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -146.94 162.88 37.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.296 1.438 . . . . 0.0 113.86 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.6 mt -94.19 144.78 25.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.877 2.071 . . . . 0.0 109.759 168.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.07 124.61 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.718 1.607 . . . . 0.0 109.34 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.92 -160.95 29.76 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.032 1.301 . . . . 0.0 115.305 -173.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.53 163.1 11.62 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.382 1.073 . . . . 0.0 112.996 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 41.3 tp -140.55 85.3 1.99 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.676 1.19 . . . . 0.0 108.95 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.218 0 C-N-CA 125.676 1.59 . . . . 0.0 115.177 -152.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.651 0.262 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.32 134.09 55.39 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.027 -1.046 . . . . 0.0 113.778 -175.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -153.71 121.24 5.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 126.584 1.954 . . . . 0.0 110.387 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.64 -170.82 3.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.271 1.028 . . . . 0.0 112.116 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -75.23 138.08 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.42 -0.8 . . . . 0.0 110.326 161.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.01 3.51 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -153.75 130.21 10.61 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 120.556 2.178 . . . . 0.0 111.698 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -137.83 127.96 25.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.98 0.912 . . . . 0.0 111.727 171.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.3 mtp -93.16 141.66 28.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.474 1.11 . . . . 0.0 111.194 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.2 mt -110.95 -49.65 3.01 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.162 0.985 . . . . 0.0 113.503 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -143.42 105.58 4.4 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.044 0.938 . . . . 0.0 110.989 -171.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.33 -6.88 57.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.484 1.514 . . . . 0.0 112.743 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 62.46 20.35 11.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.984 2.114 . . . . 0.0 115.873 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -76.2 -4.85 44.04 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -172.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.96 -138.65 10.39 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.441 1.496 . . . . 0.0 111.928 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.85 154.79 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.391 1.076 . . . . 0.0 109.116 158.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tt -61.21 110.42 1.39 Allowed 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.725 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.521 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 8.9 p-10 -90.1 32.13 0.94 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.882 1.673 . . . . 0.0 114.608 -161.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.728 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 77.7 m95 -141.24 159.05 43.04 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.124 2.169 . . . . 0.0 111.234 -160.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.86 153.48 52.73 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.4 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.64 135.6 21.22 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.332 1.066 . . . . 0.0 110.256 169.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' HG23 ' A' ' 57' ' ' VAL . 41.2 p90 -161.98 164.61 28.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -166.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.9 p -154.71 160.38 41.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.529 1.132 . . . . 0.0 112.909 172.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.34 145.79 16.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.76 1.172 . . . . 0.0 113.343 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 48.53 40.99 16.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 127.416 2.286 . . . . 0.0 116.596 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.8 -13.02 6.14 Favored Glycine 0 N--CA 1.473 1.147 0 O-C-N 120.865 -1.147 . . . . 0.0 115.633 158.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.05 173.85 11.38 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 118.381 1.091 . . . . 0.0 112.0 173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -163.21 143.59 9.1 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.573 1.149 . . . . 0.0 110.196 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 m -126.91 129.9 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.678 1.191 . . . . 0.0 112.882 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.1 m -142.68 127.29 17.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.589 1.156 . . . . 0.0 113.269 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.2 p -124.92 129.29 50.07 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -160.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -124.71 175.29 7.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 129.76 3.224 . . . . 0.0 112.254 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.1 mt -111.0 141.1 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.472 1.109 . . . . 0.0 111.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.42 -160.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 128.258 2.623 . . . . 0.0 109.691 174.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.1 t -106.1 156.83 18.03 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.189 -1.569 . . . . 0.0 112.223 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.63 -171.19 31.53 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -62.0 -18.19 59.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -165.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.0 t -134.11 108.62 8.42 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.317 0.58 . . . . 0.0 109.827 165.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.14 -112.58 3.35 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.096 1.331 . . . . 0.0 113.356 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -78.18 172.87 12.91 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.233 1.013 . . . . 0.0 111.723 177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.06 158.82 17.73 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 156.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -111.6 119.11 37.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.007 1.403 . . . . 0.0 110.109 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -92.51 128.0 38.21 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.234 1.014 . . . . 0.0 110.885 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.74 140.45 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.123 0.969 . . . . 0.0 111.056 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.8 t -122.17 130.52 53.29 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.179 1.391 . . . . 0.0 109.025 163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.513 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.7 p90 -128.78 146.84 50.8 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.254 0.621 . . . . 0.0 112.559 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 m -95.67 132.45 40.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 157.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.86 171.31 20.74 Favored Glycine 0 N--CA 1.479 1.503 0 CA-C-N 120.553 1.524 . . . . 0.0 113.773 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 52' ' ' GLY . 5.1 t -127.72 155.16 44.43 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 p -72.46 -28.42 62.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.515 1.926 . . . . 0.0 113.803 170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -117.29 -13.05 10.44 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -163.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 49' ' ' THR . . . -126.07 -129.06 3.26 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.327 0.967 . . . . 0.0 114.972 -171.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -160.96 160.35 30.66 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.91 1.684 . . . . 0.0 110.554 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -119.36 -179.03 3.73 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 126.554 1.942 . . . . 0.0 107.097 167.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.79 176.48 34.9 Favored Glycine 0 N--CA 1.474 1.188 0 CA-C-N 122.6 2.455 . . . . 0.0 119.008 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.98 145.96 25.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.79 2.436 . . . . 0.0 109.629 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 149' ' ' HIS . 87.5 t -108.62 136.41 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.728 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -127.65 124.78 38.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.729 0.776 . . . . 0.0 110.378 162.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 t -104.65 128.1 52.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.131 0.972 . . . . 0.0 109.88 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.4 119.87 69.65 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.937 1.295 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -56.6 -36.53 98.08 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.003 2.468 . . . . 0.0 112.425 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -159.61 147.62 17.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 129.944 3.298 . . . . 0.0 106.641 164.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.57 44.51 1.24 Allowed Glycine 0 N--CA 1.472 1.04 0 C-N-CA 125.453 1.502 . . . . 0.0 112.639 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.68 48.5 1.07 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.783 1.233 . . . . 0.0 114.061 -171.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -74.55 7.64 2.83 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -171.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.1 p -58.53 -11.04 2.55 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.4 pttm -91.15 11.93 21.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.796 2.838 . . . . 0.0 114.944 173.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -133.01 175.0 9.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 127.202 2.201 . . . . 0.0 111.716 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.81 -37.3 3.95 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -143.21 165.64 26.9 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.185 1.394 . . . . 0.0 112.326 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.68 158.19 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.317 1.447 . . . . 0.0 110.632 162.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.9 t -134.21 139.36 45.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.536 1.534 . . . . 0.0 109.187 164.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.02 166.44 24.65 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 122.047 0.927 . . . . 0.0 110.031 162.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 114' ' ' LYS 0.281 8.5 m-20 -99.99 132.67 45.21 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.384 -172.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' H ' ' N ' ' A' ' 115' ' ' THR . 19.1 tt -171.32 133.04 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 127.142 2.177 . . . . 0.0 112.1 176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HB3' ' HE2' ' A' ' 114' ' ' LYS . 53.2 tttm -146.69 141.15 26.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.489 -1.382 . . . . 0.0 112.664 -171.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -76.06 113.51 13.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.292 0.637 . . . . 0.0 110.74 173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.6 -19.5 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-O 121.037 0.446 . . . . 0.0 111.71 154.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -166.81 98.43 0.55 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.058 0.943 . . . . 0.0 112.16 -165.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.96 -105.23 0.19 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.784 0.707 . . . . 0.0 111.505 172.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.2 m -164.88 163.41 21.05 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 128.825 2.85 . . . . 0.0 107.973 178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.56 41.17 0.25 Allowed 'General case' 0 CA--C 1.554 1.118 0 O-C-N 120.273 -1.517 . . . . 0.0 112.717 168.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -112.2 155.16 24.45 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.268 2.627 . . . . 0.0 109.759 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.19 168.99 12.91 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.2 pt -123.88 164.12 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 127.049 2.14 . . . . 0.0 108.571 154.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -129.13 156.94 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.76 0.824 . . . . 0.0 112.264 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -126.64 155.27 42.83 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.788 1.635 . . . . 0.0 110.969 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -135.64 141.83 45.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.245 1.818 . . . . 0.0 110.057 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 60.5 mt -130.78 136.22 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 108.79 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.2 123.58 48.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.923 0.889 . . . . 0.0 111.356 168.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -66.99 171.86 5.05 Favored 'General case' 0 CA--C 1.553 1.095 0 O-C-N 121.736 -0.603 . . . . 0.0 111.184 163.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -85.84 149.39 25.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.462 -1.399 . . . . 0.0 112.149 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.6 t -73.57 149.86 41.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.675 1.59 . . . . 0.0 113.629 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.3 pt -93.37 -21.13 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.683 0.793 . . . . 0.0 112.634 160.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -80.62 -7.03 59.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.446 1.898 . . . . 0.0 113.104 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.43 17.32 78.01 Favored Glycine 0 CA--C 1.533 1.207 0 O-C-N 121.625 -0.672 . . . . 0.0 113.509 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.25 169.87 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.237 1.815 . . . . 0.0 109.257 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.23 -18.89 65.64 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 -173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -142.57 152.5 42.64 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.721 1.76 . . . . 0.0 113.237 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.37 -147.23 21.52 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 127.737 2.589 . . . . 0.0 112.396 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.64 154.99 34.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.346 -1.09 . . . . 0.0 112.874 174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -116.25 127.81 55.06 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.369 1.068 . . . . 0.0 113.371 -169.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -135.06 137.6 43.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.319 1.447 . . . . 0.0 111.872 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.58 157.19 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.437 1.095 . . . . 0.0 113.742 -166.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.26 142.31 21.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.536 1.134 . . . . 0.0 111.605 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 m -121.8 130.81 53.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.059 1.344 . . . . 0.0 111.774 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.94 162.8 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.515 1.526 . . . . 0.0 112.934 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.2 p -93.28 148.57 35.85 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.132 0.973 . . . . 0.0 111.671 162.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.86 174.87 1.51 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.995 3.13 . . . . 0.0 113.578 165.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -101.76 179.0 4.47 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 122.675 1.226 . . . . 0.0 110.071 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.1 p -116.53 -5.61 11.69 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 127.06 2.144 . . . . 0.0 113.029 174.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 -20.78 17.84 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -168.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -179.8 169.99 1.27 Allowed 'General case' 0 CA--C 1.502 -0.9 1 C-N-CA 134.147 4.979 . . . . 0.0 110.872 174.127 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -70.66 100.64 1.89 Allowed 'General case' 0 N--CA 1.415 -2.211 1 N-CA-C 99.987 -4.079 . . . . 0.0 99.987 172.303 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' H ' ' A' ' 75' ' ' ILE . 16.0 m -152.35 125.89 8.84 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.99 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.9 mm -129.32 135.71 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.701 1.2 . . . . 0.0 109.172 137.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -107.0 135.67 48.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.459 1.103 . . . . 0.0 111.432 158.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.36 133.17 11.88 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.441 1.097 . . . . 0.0 111.729 -169.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -88.71 163.08 6.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.063 3.176 . . . . 0.0 112.175 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -60.62 -16.31 37.18 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 170.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 p -81.29 -20.8 40.05 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.914 1.286 . . . . 0.0 114.03 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.6 m -82.31 -23.24 35.25 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -73.41 134.45 44.01 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.699 1.2 . . . . 0.0 111.159 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 159.36 25.96 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.226 1.81 . . . . 0.0 110.25 -174.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -72.65 130.84 41.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.712 -0.618 . . . . 0.0 110.239 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.4 tpp85 -73.66 122.04 21.68 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 164.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 11.1 mt -119.43 -11.68 9.47 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.397 1.079 . . . . 0.0 112.677 -164.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.85 -15.4 60.23 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.85 0.86 . . . . 0.0 111.762 162.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -153.4 137.16 16.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.612 1.165 . . . . 0.0 112.389 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -139.16 149.21 60.23 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.884 1.274 . . . . 0.0 110.377 162.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -57.4 157.46 22.1 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.618 2.879 . . . . 0.0 113.294 168.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.59 -33.55 13.25 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.691 2.261 . . . . 0.0 113.984 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.66 3.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.08 1.324 . . . . 0.0 114.173 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -66.29 158.86 27.96 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.36 7.88 10.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 -164.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 ttt 64.85 2.31 1.69 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 165.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 51.8 p -82.67 -36.27 26.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.254 1.388 . . . . 0.0 114.378 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.48 1.29 81.84 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.524 1.059 . . . . 0.0 114.322 -170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.4 m -116.55 150.25 38.28 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.898 1.679 . . . . 0.0 109.736 174.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.0 tp -80.79 111.79 17.57 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.029 1.332 . . . . 0.0 109.16 171.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.67 102.5 10.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.317 0.647 . . . . 0.0 111.482 -165.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.8 33.01 0.42 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.944 1.297 . . . . 0.0 114.071 -166.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -102.16 -26.23 13.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.423 1.089 . . . . 0.0 112.154 163.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.12 93.79 2.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 119.511 1.05 . . . . 0.0 112.582 -170.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.6 mm -126.25 140.33 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.607 1.963 . . . . 0.0 111.48 -174.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.65 -56.32 2.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.642 1.577 . . . . 0.0 113.251 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 p -156.51 162.62 39.94 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -166.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.471 HD11 ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -127.69 137.87 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 128.034 2.534 . . . . 0.0 109.309 175.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.489 ' CE1' HG13 ' A' ' 57' ' ' VAL . 66.9 m-70 -142.41 156.3 45.19 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.161 0.984 . . . . 0.0 111.841 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.89 141.79 33.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.68 1.192 . . . . 0.0 111.768 177.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 55.2 mtt -136.51 155.58 49.77 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.413 1.485 . . . . 0.0 112.151 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 63.0 m-85 -138.08 137.21 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -158.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.96 20.43 3.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.806 1.242 . . . . 0.0 113.129 -177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -137.66 128.21 26.68 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.334 -0.854 . . . . 0.0 111.543 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -91.16 -3.86 56.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -167.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -69.08 160.71 30.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.741 0.817 . . . . 0.0 112.505 166.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.3 m -77.65 168.12 20.47 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.982 2.113 . . . . 0.0 111.61 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.1 167.33 40.49 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 116.453 1.341 . . . . 0.0 116.453 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -131.33 140.16 49.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.466 1.906 . . . . 0.0 111.141 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.24 160.12 29.53 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.933 0.893 . . . . 0.0 111.745 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.7 t -98.74 149.05 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.702 1.201 . . . . 0.0 110.222 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 82.4 t -131.8 144.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.672 1.989 . . . . 0.0 110.739 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -158.11 -172.45 3.91 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 119.534 1.061 . . . . 0.0 113.086 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 62.11 56.07 2.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 118.463 2.764 . . . . 0.0 118.463 143.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.45 117.35 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 O-C-N 120.86 -1.15 . . . . 0.0 110.297 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.33 149.97 51.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.82 1.248 . . . . 0.0 113.001 171.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 145.37 24.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.41 1.484 . . . . 0.0 109.966 162.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.79 141.71 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.319 1.847 . . . . 0.0 109.539 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.95 -144.77 5.17 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.804 1.669 . . . . 0.0 113.459 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.47 152.43 51.79 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.222 1.409 . . . . 0.0 112.49 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.28 27.66 1.13 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -169.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.484 1.245 0 C-N-CA 126.091 1.756 . . . . 0.0 112.544 174.799 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tmm? . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.59 38.99 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.394 1.078 . . . . 0.0 113.833 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -93.12 -26.12 17.58 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.081 1.352 . . . . 0.0 114.104 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.21 -173.29 2.54 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.203 1.801 . . . . 0.0 110.109 162.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER 60.93 8.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.94 36.5 1.68 Allowed Glycine 0 N--CA 1.472 1.048 0 C-N-CA 125.906 1.717 . . . . 0.0 113.99 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.51 127.16 31.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.38 1.072 . . . . 0.0 111.306 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -128.35 128.63 44.9 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.813 1.645 . . . . 0.0 109.559 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.4 tpp -78.52 132.39 37.19 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.128 0.571 . . . . 0.0 110.615 -175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.7 mt -94.77 -50.42 5.16 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.229 1.011 . . . . 0.0 109.941 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -156.94 123.58 5.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.405 1.082 . . . . 0.0 111.995 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -117.32 22.68 12.31 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.464 1.106 . . . . 0.0 111.406 171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.51 2.4 0.67 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.407 3.083 . . . . 0.0 117.76 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -64.31 -18.27 64.45 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.039 -1.038 . . . . 0.0 113.394 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.54 -139.27 4.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 126.463 1.982 . . . . 0.0 114.144 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.2 t -117.03 143.11 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.196 2.198 . . . . 0.0 110.111 173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 tt -61.39 131.29 49.77 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -171.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP 0.34 0.0 OUTLIER -115.5 18.3 16.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -173.741 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.746 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 67.5 m95 -118.51 150.19 40.03 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 120.735 -1.228 . . . . 0.0 112.699 -162.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.77 152.27 52.54 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 121.714 -0.616 . . . . 0.0 112.11 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.5 133.18 11.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.188 0.994 . . . . 0.0 110.062 159.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.452 ' CE1' ' HA3' ' A' ' 55' ' ' GLY . 6.7 p90 -155.75 164.28 38.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.856 0.862 . . . . 0.0 113.149 -170.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -160.18 153.43 21.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.979 1.312 . . . . 0.0 112.246 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -149.73 5.84 0.72 Allowed Glycine 0 N--CA 1.478 1.452 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -143.79 61.88 1.37 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.887 1.675 . . . . 0.0 111.584 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.0 -1.55 84.27 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.043 1.782 . . . . 0.0 116.828 170.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.62 177.36 6.37 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.007 1.404 . . . . 0.0 111.124 170.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -164.47 136.31 4.55 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.847 1.659 . . . . 0.0 109.039 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.98 138.86 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.954 1.252 . . . . 0.0 111.437 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.1 t -140.84 141.99 34.63 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.121 1.369 . . . . 0.0 112.039 172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 p -116.94 141.46 48.2 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.54 1.536 . . . . 0.0 112.307 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.32 164.67 27.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.406 1.482 . . . . 0.0 111.548 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 mt -106.44 133.59 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.966 1.307 . . . . 0.0 110.925 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.0 -163.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.243 1.817 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.9 m -91.54 151.94 20.53 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.912 1.685 . . . . 0.0 112.237 167.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.45 -144.78 6.82 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.655 1.121 . . . . 0.0 115.483 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -81.42 -28.29 34.33 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.803 0.841 . . . . 0.0 110.699 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -153.21 143.46 22.38 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.364 1.466 . . . . 0.0 110.554 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.72 -105.04 1.04 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.347 1.927 . . . . 0.0 113.317 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -107.2 172.22 6.95 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.221 1.009 . . . . 0.0 113.104 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.65 172.71 22.1 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.343 1.925 . . . . 0.0 110.476 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 131.81 56.85 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.058 0.943 . . . . 0.0 111.052 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.39 139.06 34.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.449 1.1 . . . . 0.0 109.909 168.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.7 p -109.19 136.58 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.257 1.023 . . . . 0.0 109.089 160.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.0 t -123.46 147.86 46.76 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.776 1.63 . . . . 0.0 109.053 167.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.488 ' CE2' ' HA3' ' A' ' 48' ' ' GLY . 4.9 p90 -144.04 148.94 35.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.6 m -83.62 133.34 34.84 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 150.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA3' ' CE2' ' A' ' 46' ' ' TYR . . . -134.8 158.92 23.73 Favored Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.749 1.159 . . . . 0.0 115.63 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 p -124.32 157.86 33.97 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 m -78.21 -28.25 47.99 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.607 1.163 . . . . 0.0 113.039 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -139.43 13.28 2.57 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.69 -146.17 15.77 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 121.102 -0.999 . . . . 0.0 113.128 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -155.75 145.27 21.03 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 123.233 1.492 . . . . 0.0 111.641 170.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.542 ' CZ2' ' HB3' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -118.79 -173.8 2.56 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 128.005 2.522 . . . . 0.0 106.232 167.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.452 ' HA3' ' CE1' ' A' ' 22' ' ' TYR . . . -173.44 157.63 26.4 Favored Glycine 0 N--CA 1.472 1.081 0 O-C-N 119.076 -2.265 . . . . 0.0 116.105 -172.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -155.02 140.24 17.57 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.046 1.738 . . . . 0.0 110.177 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' A' ' 149' ' ' HIS . 48.4 t -133.77 142.14 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 122.016 -0.428 . . . . 0.0 111.723 -173.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.746 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.1 OUTLIER -144.42 124.61 13.71 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.236 -171.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 t -101.42 116.58 33.1 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.893 1.677 . . . . 0.0 108.682 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.82 126.45 89.53 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.49 1.116 . . . . 0.0 112.88 -172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -55.74 -36.06 94.43 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.387 2.725 . . . . 0.0 113.387 170.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.0 110.81 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.012 1.725 . . . . 0.0 108.764 172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.49 23.67 21.89 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.693 1.616 . . . . 0.0 112.666 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -127.93 116.42 20.07 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.064 1.345 . . . . 0.0 109.5 170.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -134.58 7.32 3.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.221 1.809 . . . . 0.0 113.002 -172.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -55.82 -25.23 40.77 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -101.04 4.24 42.14 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.422 1.889 . . . . 0.0 114.398 173.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -108.8 172.01 7.09 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.514 2.326 . . . . 0.0 112.508 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -97.38 -68.3 0.81 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.638 1.175 . . . . 0.0 113.317 -170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -142.82 158.57 43.5 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -166.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.98 165.61 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.152 1.381 . . . . 0.0 109.719 158.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -152.53 156.72 39.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 158.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.27 165.33 28.71 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.018 1.327 . . . . 0.0 111.876 161.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -108.62 120.87 43.7 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.718 -0.614 . . . . 0.0 110.712 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -144.33 131.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -160.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -137.11 161.86 34.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.083 1.353 . . . . 0.0 113.929 176.043 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.9 141.66 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.455 -2.157 . . . . 0.0 110.888 152.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.14 -0.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.705 0.802 . . . . 0.0 111.782 172.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -163.81 -32.13 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.548 1.139 . . . . 0.0 111.446 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.59 4.65 26.89 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.475 1.512 . . . . 0.0 116.441 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m 60.3 -175.69 0.11 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.321 1.849 . . . . 0.0 115.019 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.82 54.03 3.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.102 1.361 . . . . 0.0 112.822 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -100.18 148.3 24.76 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.614 1.166 . . . . 0.0 111.652 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -77.6 132.68 38.4 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.34 -0.85 . . . . 0.0 112.552 -174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 pt -129.14 171.61 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 127.592 2.357 . . . . 0.0 111.034 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -131.38 147.53 52.57 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -113.62 159.11 19.99 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.063 1.745 . . . . 0.0 111.469 174.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.9 ttm -141.47 129.9 22.5 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.953 1.301 . . . . 0.0 111.59 170.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.3 mm -96.02 133.86 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.082 1.353 . . . . 0.0 108.589 163.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.27 116.91 31.17 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.875 0.87 . . . . 0.0 113.044 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -86.79 147.6 25.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.386 1.875 . . . . 0.0 111.42 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -77.66 146.21 36.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.342 1.057 . . . . 0.0 111.823 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 135' ' ' ASP . 42.9 t -60.09 147.77 38.23 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.502 1.521 . . . . 0.0 112.779 170.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 pt -59.71 -23.41 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.493 -0.754 . . . . 0.0 112.531 165.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -86.06 -13.07 48.46 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.52 1.128 . . . . 0.0 112.702 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.96 -5.25 34.27 Favored Glycine 0 N--CA 1.475 1.286 0 C-N-CA 125.091 1.329 . . . . 0.0 115.901 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.37 142.4 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.039 1.336 . . . . 0.0 110.183 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.96 4.07 25.32 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 117.152 1.621 . . . . 0.0 117.152 -172.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -143.41 159.27 42.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.857 1.663 . . . . 0.0 110.457 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.41 -43.34 0.18 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.729 -0.607 . . . . 0.0 114.286 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -127.13 134.5 50.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.972 0.909 . . . . 0.0 110.064 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -140.08 133.14 29.49 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.102 -0.999 . . . . 0.0 112.016 -161.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -121.79 121.29 36.88 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.921 1.689 . . . . 0.0 108.912 -164.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.91 140.23 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -156.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 145.41 46.35 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.262 1.425 . . . . 0.0 111.24 -174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -124.46 127.79 48.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.544 1.138 . . . . 0.0 111.126 168.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.31 143.96 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.651 1.581 . . . . 0.0 113.472 -161.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 22.1 p -95.94 144.62 28.15 Favored Pre-proline 0 N--CA 1.475 0.805 0 O-C-N 121.019 -1.051 . . . . 0.0 112.486 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -80.67 175.42 10.08 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 124.657 3.571 . . . . 0.0 112.264 173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -123.46 -174.05 2.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.572 1.549 . . . . 0.0 110.495 170.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.0 m -112.64 -5.26 13.98 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.252 2.221 . . . . 0.0 112.458 173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.8 p -104.74 137.86 41.91 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.399 2.28 . . . . 0.0 113.012 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.725 ' CE3' ' HE3' ' A' ' 76' ' ' LYS 0.321 2.1 t90 -89.19 107.09 18.86 Favored 'General case' 0 N--CA 1.425 -1.725 0 C-N-CA 128.708 2.803 . . . . 0.0 105.559 -167.148 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmmm -162.82 140.58 8.12 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 130.052 3.341 . . . . 0.0 109.813 -157.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.9 m -84.32 127.08 33.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.639 1.176 . . . . 0.0 113.356 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.1 mt -92.87 114.85 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.352 1.061 . . . . 0.0 108.216 163.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -105.14 119.69 39.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.428 1.091 . . . . 0.0 112.383 164.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.4 153.51 47.59 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.574 1.15 . . . . 0.0 111.592 164.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -89.79 -109.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.252 2.635 . . . . 0.0 112.27 -158.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -58.12 9.19 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.053 1.341 . . . . 0.0 113.918 150.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 58.7 m 60.88 67.8 0.79 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 147.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 123' ' ' PHE 0.464 13.6 m 61.41 14.27 5.66 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 155.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 122' ' ' SER . 0.1 OUTLIER 48.44 5.29 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.297 1 N-CA-C 123.977 4.806 . . . . 0.0 123.977 115.56 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -106.0 119.5 39.36 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.738 2.063 . . . . 0.0 112.679 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ptt-85 -73.88 135.59 43.36 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.759 1.163 . . . . 0.0 113.37 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.7 tpt85 -75.88 66.34 2.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.401 1.88 . . . . 0.0 113.252 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.06 -16.88 61.38 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -79.57 -18.96 50.55 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.545 1.066 . . . . 0.0 113.509 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.16 -2.9 3.95 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.058 1.873 . . . . 0.0 116.058 -148.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -101.48 135.92 19.73 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.893 -1.129 . . . . 0.0 112.714 -163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.07 161.27 15.62 Favored 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.065 3.177 . . . . 0.0 113.237 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -89.36 -24.18 0.72 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.984 3.122 . . . . 0.0 116.244 -169.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.48 44.55 3.22 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 126.06 1.79 . . . . 0.0 113.202 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -151.61 179.9 7.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.979 2.512 . . . . 0.0 110.437 -150.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.513 ' H ' ' HA ' ' A' ' 93' ' ' SER . 5.6 t70 -64.71 120.75 13.02 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.053 -1.03 . . . . 0.0 108.34 152.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -131.74 46.76 2.61 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.588 1.555 . . . . 0.0 109.566 165.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 55.6 p -75.84 -10.45 59.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.23 6.88 62.1 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.447 1.023 . . . . 0.0 113.51 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.9 t -142.2 147.49 36.65 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.337 1.455 . . . . 0.0 111.582 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 140' ' ' LEU . 1.7 pt? -83.2 112.14 19.57 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.282 1.833 . . . . 0.0 111.808 -170.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.24 82.18 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.299 0.571 . . . . 0.0 111.549 -171.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.94 11.58 0.38 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -85.21 -9.73 57.44 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.723 -1.236 . . . . 0.0 112.59 162.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -150.62 40.33 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -151.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -92.13 147.05 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.897 1.679 . . . . 0.0 111.696 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -109.64 -51.39 2.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.647 1.179 . . . . 0.0 113.587 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 92.7 p -150.13 164.43 35.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -165.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.526 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.5 pt -123.17 140.43 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 126.004 1.722 . . . . 0.0 108.712 174.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' CE1' HG13 ' A' ' 57' ' ' VAL . 80.6 m-70 -140.98 155.12 46.28 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.217 1.407 . . . . 0.0 111.408 -167.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -112.16 149.49 32.15 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 51.2 mtm -138.65 149.86 45.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.506 1.522 . . . . 0.0 111.282 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 54' ' ' TRP . 59.7 m-85 -128.22 65.43 1.39 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -142.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.2 3.75 4.28 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.32 142.31 50.08 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.375 1.47 . . . . 0.0 110.5 173.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -130.72 -33.66 1.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.609 1.164 . . . . 0.0 112.931 -150.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.11 138.58 49.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.827 0.851 . . . . 0.0 110.811 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.0 m -65.25 129.47 39.83 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.295 0.638 . . . . 0.0 110.542 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.71 -170.69 36.0 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 -166.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -143.34 150.76 39.62 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.532 1.533 . . . . 0.0 114.24 -170.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -143.44 161.01 39.5 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.698 1.999 . . . . 0.0 111.46 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.415 HG23 ' HE2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -131.36 143.36 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.95 1.3 . . . . 0.0 113.454 176.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.01 147.32 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 113.537 170.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -130.96 -177.0 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.98 0.912 . . . . 0.0 111.522 152.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.45 37.18 0.58 Allowed 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 150.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.7 mt -78.17 114.2 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.249 1.02 . . . . 0.0 111.789 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 171.07 14.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.075 1.35 . . . . 0.0 112.421 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 pp -135.74 160.51 38.32 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.421 1.088 . . . . 0.0 111.433 160.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.24 128.26 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.338 1.055 . . . . 0.0 112.276 -171.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.04 165.01 23.73 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.963 1.268 . . . . 0.0 113.502 175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -79.69 157.68 27.15 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.442 1.497 . . . . 0.0 114.716 -170.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 27.7 tp -75.26 93.49 2.86 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.112 1.365 . . . . 0.0 109.933 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.76 1.624 . . . . 0.0 111.505 -165.047 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mtp . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.44 167.33 20.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.465 0.706 . . . . 0.0 111.843 170.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 t -114.32 124.94 53.24 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.232 -0.918 . . . . 0.0 109.15 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.49 158.15 44.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.139 0.975 . . . . 0.0 112.898 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.33 157.34 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.812 1.645 . . . . 0.0 111.229 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.89 78.72 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.884 175.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -131.77 145.09 51.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.425 1.612 . . . . 0.0 114.175 -177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -140.31 138.8 35.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.861 0.864 . . . . 0.0 112.266 160.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.9 tpp -79.97 135.87 36.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.03 0.932 . . . . 0.0 111.947 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.2 mt -93.19 -75.64 0.49 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.686 0.794 . . . . 0.0 112.356 166.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -134.51 145.87 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.942 1.297 . . . . 0.0 111.479 -173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -142.73 12.8 1.89 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.19 10.92 1.86 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.816 2.446 . . . . 0.0 117.042 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -73.08 -46.66 50.24 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.738 -1.226 . . . . 0.0 110.099 168.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.56 -145.93 5.85 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.494 1.997 . . . . 0.0 113.546 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.4 t -71.7 134.38 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.21 1.404 . . . . 0.0 111.422 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tt -82.27 114.14 20.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.782 0.833 . . . . 0.0 110.459 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -113.28 41.12 2.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.76 2.424 . . . . 0.0 113.011 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.4 125.83 41.34 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.209 1.403 . . . . 0.0 111.192 -174.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 88.06 0.65 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.413 1.006 . . . . 0.0 113.841 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -76.55 154.03 34.89 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.576 1.151 . . . . 0.0 113.019 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -160.76 156.56 25.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.639 1.176 . . . . 0.0 113.593 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 p -149.02 136.36 20.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.157 1.383 . . . . 0.0 109.871 156.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.07 -30.73 4.99 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 116.796 1.479 . . . . 0.0 116.796 -167.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -161.13 134.09 6.32 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.386 1.874 . . . . 0.0 108.631 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.77 -33.89 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.473 2.463 . . . . 0.0 115.553 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.24 164.3 14.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.145 1.378 . . . . 0.0 112.519 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.85 92.0 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.547 1.139 . . . . 0.0 110.703 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -72.46 155.02 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 125.108 1.363 . . . . 0.0 112.678 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.71 128.64 13.47 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.598 1.559 . . . . 0.0 107.841 173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.6 m -128.47 130.15 47.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.521 0.728 . . . . 0.0 109.735 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.88 158.42 43.81 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.846 1.259 . . . . 0.0 112.092 -169.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.8 mt -109.52 120.36 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.163 1.385 . . . . 0.0 109.941 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.28 -173.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.215 1.806 . . . . 0.0 110.992 -163.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.3 m -87.85 129.53 35.18 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.356 1.462 . . . . 0.0 111.006 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.38 -172.68 12.78 Favored Glycine 0 N--CA 1.474 1.207 0 C-N-CA 125.408 1.48 . . . . 0.0 115.344 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -46.7 -29.66 1.99 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.213 1.805 . . . . 0.0 115.182 -173.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.6 p -141.99 117.97 10.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.503 1.521 . . . . 0.0 107.916 171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.73 -117.22 6.26 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 118.845 0.748 . . . . 0.0 112.327 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -84.63 158.69 20.78 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.161 0.981 . . . . 0.0 112.558 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.78 175.27 19.49 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 128.006 2.717 . . . . 0.0 110.389 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -117.84 122.26 42.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.98 0.89 . . . . 0.0 110.131 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -103.5 136.13 43.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.035 1.334 . . . . 0.0 109.954 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.24 127.91 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.076 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 p -144.02 135.11 25.49 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.261 1.424 . . . . 0.0 111.017 -169.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.512 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 12.0 p90 -148.06 155.12 41.12 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -170.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.1 m -86.62 134.24 33.64 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 108.733 156.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -140.53 167.76 25.43 Favored Glycine 0 N--CA 1.48 1.572 0 CA-C-N 120.846 1.657 . . . . 0.0 115.943 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 52' ' ' GLY . 3.1 t -148.24 161.75 40.87 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -162.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 p -69.69 -39.59 76.85 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.274 1.43 . . . . 0.0 113.794 172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -103.85 -16.45 15.38 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 49' ' ' THR . . . -89.33 -152.06 25.51 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 114.994 0.757 . . . . 0.0 114.994 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -164.85 144.94 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.567 1.547 . . . . 0.0 111.951 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.512 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.4 OUTLIER -156.87 151.19 25.25 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.592 1.557 . . . . 0.0 110.687 -176.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.68 -176.06 46.25 Favored Glycine 0 N--CA 1.48 1.628 0 O-C-N 120.562 -1.336 . . . . 0.0 115.564 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -157.74 150.57 22.98 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.95 109.67 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -158.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -81.84 118.24 22.75 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.525 1.53 . . . . 0.0 113.101 -171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.5 t -96.19 79.16 3.15 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.476 1.111 . . . . 0.0 111.227 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.82 134.58 83.16 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 118.561 -0.733 . . . . 0.0 110.937 171.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -52.97 -27.29 35.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.565 3.51 . . . . 0.0 117.434 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -152.19 140.04 19.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.036 0.935 . . . . 0.0 112.564 172.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.93 49.29 0.86 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.345 2.402 . . . . 0.0 113.617 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.64 93.18 2.92 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.264 1.425 . . . . 0.0 109.921 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.82 51.65 1.24 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.504 1.922 . . . . 0.0 110.997 -176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.8 p -53.94 -36.7 63.08 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.119 1.768 . . . . 0.0 115.268 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -10.78 59.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -87.34 152.97 21.83 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.152 0.887 . . . . 0.0 111.025 -172.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 -29.42 6.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.116 0.966 . . . . 0.0 113.435 -167.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -142.88 165.03 28.47 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.94 1.296 . . . . 0.0 111.497 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.693 HD11 HD12 ' A' ' 118' ' ' ILE . 33.1 pt -69.54 174.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.667 0.746 . . . . 0.0 110.7 149.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.5 p -132.98 137.91 46.69 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 118.085 -1.446 . . . . 0.0 112.222 114.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -123.81 151.98 42.75 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 159.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -96.22 115.35 27.29 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.807 -0.558 . . . . 0.0 111.182 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.6 tt -146.76 132.54 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.675 -1.266 . . . . 0.0 114.277 -166.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.454 ' CE ' HG13 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -154.84 166.65 32.84 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 176.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 t -60.19 152.28 25.0 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 126.13 1.772 . . . . 0.0 110.898 168.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 m -121.01 16.01 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.48 1.112 . . . . 0.0 111.572 165.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.93 -172.98 3.18 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 128.464 2.706 . . . . 0.0 110.2 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.36 12.83 68.92 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.458 1.98 . . . . 0.0 114.83 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.7 m -141.57 151.1 42.9 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.958 1.703 . . . . 0.0 111.945 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -134.18 71.2 1.45 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.492 1.917 . . . . 0.0 111.033 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.43 156.06 35.74 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.049 2.14 . . . . 0.0 114.447 -171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.99 132.99 44.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 122.442 1.115 . . . . 0.0 112.28 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.2 pt -136.94 156.65 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 126.712 2.005 . . . . 0.0 110.644 -171.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -132.24 110.08 10.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.532 1.133 . . . . 0.0 109.474 -173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.41 163.5 14.16 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.243 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -136.39 155.87 49.43 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.39 137.65 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 149.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.02 115.68 31.06 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 159.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -73.17 160.76 31.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.534 -0.729 . . . . 0.0 111.363 171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.43 151.58 47.16 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.248 173.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 t -74.49 154.99 38.45 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.972 0.909 . . . . 0.0 113.384 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.2 pt -90.26 -14.2 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 161.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -100.75 -11.68 19.71 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.43 -9.97 67.04 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.195 1.379 . . . . 0.0 114.985 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 98' ' ' GLY . 11.2 p -71.41 169.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.615 1.566 . . . . 0.0 111.498 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' HG22 ' A' ' 97' ' ' VAL . . . -66.4 -12.9 59.55 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.248 1.659 . . . . 0.0 117.248 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -135.63 153.61 51.59 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.379 1.589 . . . . 0.0 113.568 178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.06 -130.41 3.97 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.843 2.163 . . . . 0.0 112.427 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.24 139.8 50.18 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.379 0.672 . . . . 0.0 111.408 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -123.28 125.24 44.68 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -162.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -133.7 132.82 41.09 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.072 1.749 . . . . 0.0 112.114 -160.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.16 152.2 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -164.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.849 ' CD2' HD12 ' A' ' 107' ' ' ILE . 15.9 m-30 -91.54 -179.68 5.43 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.875 2.47 . . . . 0.0 114.403 166.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.5 m -143.02 132.17 23.14 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.625 0.77 . . . . 0.0 111.673 126.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.849 HD12 ' CD2' ' A' ' 105' ' ' TYR . 16.1 mt -149.49 169.75 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 127.91 2.484 . . . . 0.0 110.843 -163.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 p -137.21 153.74 75.16 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.746 2.019 . . . . 0.0 111.6 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -84.69 172.16 9.2 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 123.922 3.081 . . . . 0.0 113.262 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -95.61 -167.65 1.64 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.558 1.143 . . . . 0.0 110.277 166.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.9 m -109.94 -9.15 14.78 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.234 2.214 . . . . 0.0 114.562 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.3 m -141.11 162.74 34.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.765 1.226 . . . . 0.0 111.361 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.4 ' CE2' ' HE3' ' A' ' 76' ' ' LYS . 81.3 m95 -54.26 127.01 25.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.142 0.977 . . . . 0.0 112.167 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -159.23 114.63 2.5 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.895 2.478 . . . . 0.0 108.945 -161.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 95.3 m -84.14 101.84 12.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.19 0.996 . . . . 0.0 110.02 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.29 105.9 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 122.158 0.98 . . . . 0.0 109.817 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -78.03 99.16 5.99 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.963 166.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HD11 ' A' ' 71' ' ' ILE . 5.9 mt -98.38 124.88 45.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 O-C-N 120.796 -1.19 . . . . 0.0 109.703 169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -86.58 168.53 8.43 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.43 2.753 . . . . 0.0 113.802 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -52.67 -27.91 19.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.4 m -70.91 -24.11 62.4 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.025 -1.047 . . . . 0.0 113.665 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.0 m -71.98 -12.24 61.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -86.04 132.55 34.03 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.826 1.65 . . . . 0.0 112.15 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -123.58 157.42 33.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.4 1.08 . . . . 0.0 111.915 161.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -70.62 135.04 48.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.801 1.24 . . . . 0.0 110.807 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.62 121.65 13.87 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.946 0.899 . . . . 0.0 108.845 173.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -39.17 10.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -159.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -87.28 -10.94 51.07 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.524 -0.735 . . . . 0.0 112.656 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -141.16 141.34 34.13 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.254 1.421 . . . . 0.0 111.185 -176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -143.45 150.0 49.69 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.514 1.525 . . . . 0.0 110.009 162.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -60.41 146.63 96.34 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.937 2.425 . . . . 0.0 111.697 163.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -65.92 -19.83 58.16 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.934 3.089 . . . . 0.0 113.634 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.77 20.73 43.26 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.319 1.914 . . . . 0.0 115.234 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.3 138.88 12.19 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 174.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.98 161.25 19.08 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.739 154.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 38.0 ttp -122.86 30.13 6.54 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.298 1.839 . . . . 0.0 112.511 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 p -69.05 -0.31 5.58 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 119.992 -1.692 . . . . 0.0 115.306 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.2 0.01 69.39 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.119 1.342 . . . . 0.0 114.42 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -160.77 165.35 30.5 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.931 1.292 . . . . 0.0 112.56 -174.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.66 118.05 16.16 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.279 0.561 . . . . 0.0 110.672 161.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -109.16 110.48 21.71 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.276 1.43 . . . . 0.0 110.574 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.3 mp -79.18 -2.98 43.44 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -158.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -72.13 -13.11 61.48 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.106 -0.996 . . . . 0.0 113.558 168.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.8 63.39 0.99 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.27 1.028 . . . . 0.0 112.154 -158.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 35.4 mm -112.19 142.58 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 127.052 2.141 . . . . 0.0 111.746 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -90.51 -56.82 3.05 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.164 0.986 . . . . 0.0 112.372 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 46.9 p -165.57 177.09 7.62 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.727 1.611 . . . . 0.0 111.704 -169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.54 148.2 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.333 1.053 . . . . 0.0 108.821 169.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -116.97 147.77 42.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.778 0.831 . . . . 0.0 110.154 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -105.36 128.83 53.69 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.034 0.933 . . . . 0.0 109.381 157.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.5 mtt -143.08 175.34 9.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 123.188 1.47 . . . . 0.0 111.633 173.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -83.39 147.84 27.65 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.993 1.717 . . . . 0.0 113.689 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -133.73 26.15 4.01 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.487 1.515 . . . . 0.0 110.918 158.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -143.04 -177.7 5.47 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.7 2.4 . . . . 0.0 109.516 175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -132.64 23.98 4.35 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -93.21 165.64 12.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.509 1.524 . . . . 0.0 111.08 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 68.6 m -72.35 164.9 25.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.217 1.007 . . . . 0.0 110.869 153.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -179.64 173.13 44.95 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 120.827 -1.17 . . . . 0.0 115.422 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -143.64 134.28 25.02 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.493 1.517 . . . . 0.0 112.947 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -150.27 174.77 12.46 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.943 1.297 . . . . 0.0 113.339 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.454 HG13 ' CE ' ' A' ' 76' ' ' LYS . 7.7 p -152.9 146.38 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.873 1.269 . . . . 0.0 112.727 -170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.8 150.69 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.001 1.32 . . . . 0.0 113.772 -171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.87 177.69 11.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.664 1.586 . . . . 0.0 110.124 168.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 58.33 56.13 4.62 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 15.6 mm -79.01 100.4 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.486 -0.759 . . . . 0.0 110.068 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -112.96 162.16 16.18 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.923 -1.11 . . . . 0.0 113.053 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 95.9 mt -95.24 144.9 25.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.871 1.269 . . . . 0.0 109.742 159.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 44.6 mm -127.3 132.66 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.669 1.587 . . . . 0.0 111.095 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.86 172.97 52.19 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.56 1.552 . . . . 0.0 114.778 -175.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.38 171.85 2.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.806 1.642 . . . . 0.0 114.055 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.815 HD13 ' H ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -79.43 36.15 0.3 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.708 2.403 . . . . 0.0 113.534 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.793 2.037 . . . . 0.0 112.507 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.99 159.79 33.62 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.834 0.854 . . . . 0.0 112.258 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t -61.04 135.12 57.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.858 1.263 . . . . 0.0 112.877 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.22 -8.92 58.33 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.83 153.92 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.31 1.444 . . . . 0.0 111.901 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.8 -21.42 3.2 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.848 1.213 . . . . 0.0 115.479 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.11 160.79 38.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 112.783 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -143.93 140.78 29.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.682 1.993 . . . . 0.0 109.846 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.8 tpp -90.91 129.99 36.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.981 1.312 . . . . 0.0 111.935 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.07 -46.78 8.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.566 1.547 . . . . 0.0 111.704 174.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.52 137.24 11.15 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.915 1.686 . . . . 0.0 110.467 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.37 18.3 11.4 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.6 1.16 . . . . 0.0 112.22 171.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 61.96 22.06 12.78 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.658 2.383 . . . . 0.0 115.646 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.42 -1.35 53.28 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 120.497 -1.377 . . . . 0.0 112.991 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.71 -160.73 9.45 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 126.709 2.1 . . . . 0.0 112.922 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.81 134.52 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.214 -1.168 . . . . 0.0 110.756 -175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.0 tt -69.05 129.26 39.42 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.81 0.844 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' CZ2' ' A' ' 19' ' ' TRP . 2.6 p-10 -119.33 32.41 6.12 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -171.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.742 ' CZ2' ' CE2' ' A' ' 58' ' ' TYR . 65.5 m95 -134.37 142.6 47.25 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.092 1.357 . . . . 0.0 111.94 -163.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.43 160.71 45.98 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.033 0.825 . . . . 0.0 114.389 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 m -140.03 144.92 37.14 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.787 1.235 . . . . 0.0 110.242 164.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -144.86 149.83 36.04 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.534 1.534 . . . . 0.0 111.492 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -162.94 -174.62 3.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.341 1.457 . . . . 0.0 110.993 174.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 173.59 -7.5 0.03 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 116.703 1.441 . . . . 0.0 116.703 168.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -126.3 66.84 1.22 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.587 1.555 . . . . 0.0 111.759 -172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.51 5.61 87.99 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.795 1.664 . . . . 0.0 115.964 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.43 166.85 17.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.368 1.467 . . . . 0.0 113.584 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -159.06 144.63 16.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.151 1.78 . . . . 0.0 110.552 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -104.07 128.63 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.397 1.079 . . . . 0.0 108.732 167.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.8 m -122.97 106.9 11.25 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.998 0.817 . . . . 0.0 110.714 175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p -99.39 111.03 23.47 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.502 1.521 . . . . 0.0 113.432 -169.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 164.49 26.79 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.7 138.98 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.022 1.329 . . . . 0.0 110.584 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.0 m -147.93 174.31 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.275 2.23 . . . . 0.0 110.937 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -63.47 138.31 58.47 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.048 -1.033 . . . . 0.0 111.066 164.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.9 179.06 16.71 Favored Glycine 0 N--CA 1.468 0.786 0 C-N-CA 125.266 1.412 . . . . 0.0 114.817 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -61.3 -32.87 72.73 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.691 1.197 . . . . 0.0 112.316 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -141.16 121.18 13.69 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.468 1.107 . . . . 0.0 109.173 170.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.4 -125.1 38.5 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 -170.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.7 156.8 18.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.525 0.678 . . . . 0.0 110.882 174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.04 -177.39 34.84 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.941 1.257 . . . . 0.0 110.269 167.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.4 tpt -128.67 128.3 43.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.337 0.568 . . . . 0.0 110.584 160.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -99.58 138.22 36.97 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.116 1.766 . . . . 0.0 111.275 -175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.88 115.22 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 150.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 m -82.05 108.8 15.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 148.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -77.02 149.87 35.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.422 1.089 . . . . 0.0 110.065 178.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.0 m -120.16 120.81 37.27 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 138.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.4 162.21 26.1 Favored Glycine 0 N--CA 1.476 1.328 0 CA-C-N 120.005 1.275 . . . . 0.0 112.964 -173.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.2 p -147.65 171.1 16.15 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 -161.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.5 p -66.81 -49.57 65.37 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.117 1.767 . . . . 0.0 113.562 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.65 6.31 39.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.18 -167.14 43.19 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -158.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -157.89 114.91 2.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.377 2.271 . . . . 0.0 107.967 -173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.439 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 9.1 p90 -160.21 148.37 16.74 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.527 1.931 . . . . 0.0 109.495 -173.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.21 -177.93 41.0 Favored Glycine 0 CA--C 1.541 1.693 0 CA-C-N 121.236 1.835 . . . . 0.0 115.032 -171.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.79 148.37 37.04 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.013 1.325 . . . . 0.0 113.771 -170.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.461 HG13 ' CE1' ' A' ' 149' ' ' HIS . 86.3 t -112.95 145.73 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.042 0.837 . . . . 0.0 109.135 -174.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.742 ' CE2' ' CZ2' ' A' ' 19' ' ' TRP . 0.0 OUTLIER -143.03 129.17 19.75 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.454 168.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -114.02 102.61 10.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 110.659 -173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.96 124.89 90.63 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.263 1.425 . . . . 0.0 112.336 -172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -66.23 -36.14 29.63 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.476 2.784 . . . . 0.0 112.476 163.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.51 87.61 2.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.537 1.935 . . . . 0.0 109.909 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.76 21.09 46.72 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.38 1.467 . . . . 0.0 114.439 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -120.2 113.7 20.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.994 1.718 . . . . 0.0 111.169 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -136.1 8.17 3.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.988 1.315 . . . . 0.0 113.43 -173.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.8 p -52.85 -19.35 2.46 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -100.27 10.98 40.44 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 172.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 19.1 m0 -117.29 165.89 12.93 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.614 1.966 . . . . 0.0 111.03 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.25 -38.21 5.81 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -155.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -152.04 167.01 29.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.667 1.587 . . . . 0.0 112.293 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 tt -95.52 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.184 0.994 . . . . 0.0 109.166 151.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.1 t -140.6 143.56 35.33 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.528 -0.733 . . . . 0.0 110.18 163.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 118' ' ' ILE . 5.8 p90 -142.55 164.18 30.81 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.74 0.816 . . . . 0.0 110.561 165.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -113.81 117.0 30.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.875 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.19 135.65 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.971 -1.08 . . . . 0.0 111.586 -160.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' HD3' ' CE3' ' A' ' 113' ' ' TRP . 12.3 mttm -153.37 163.33 40.11 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -138.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.4 t -121.1 147.21 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.456 1.902 . . . . 0.0 109.885 175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.04 2.91 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.542 1.137 . . . . 0.0 113.047 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -141.38 -70.69 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.012 0.925 . . . . 0.0 110.481 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.24 5.08 0.04 OUTLIER Glycine 0 CA--C 1.532 1.121 0 N-CA-C 116.88 1.512 . . . . 0.0 116.88 -175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.3 p -70.87 117.97 13.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.752 1.776 . . . . 0.0 111.427 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.56 -3.99 11.29 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -72.53 162.26 29.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.282 1.433 . . . . 0.0 113.223 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.27 168.26 19.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 40.9 pt -134.3 163.16 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.822 2.049 . . . . 0.0 110.36 165.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.36 137.88 41.59 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.2 1.4 . . . . 0.0 110.956 -174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -100.96 140.83 34.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.117 169.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.8 ttp -133.3 138.37 46.38 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.622 0.769 . . . . 0.0 109.943 160.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.1 mt -118.13 145.84 23.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 126.466 1.906 . . . . 0.0 107.671 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.73 140.36 52.42 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.579 0.752 . . . . 0.0 112.237 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -83.9 161.27 20.91 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.783 1.633 . . . . 0.0 111.308 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -61.69 146.89 47.76 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.389 -1.444 . . . . 0.0 113.009 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.7 t -82.84 145.56 29.4 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.0 pt -85.12 -8.83 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.455 1.102 . . . . 0.0 113.695 169.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.96 -22.75 12.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.501 1.121 . . . . 0.0 113.222 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.65 22.53 15.98 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 118.865 0.757 . . . . 0.0 114.752 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 p -86.72 160.63 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.674 1.19 . . . . 0.0 109.815 165.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.37 -14.86 58.12 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 116.702 1.441 . . . . 0.0 116.702 -168.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -142.2 154.66 44.98 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.897 2.079 . . . . 0.0 111.263 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.56 -113.23 3.34 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.514 2.007 . . . . 0.0 111.749 175.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.84 138.05 46.09 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.478 -1.013 . . . . 0.0 111.407 166.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -91.94 144.21 25.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.619 1.168 . . . . 0.0 111.64 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -141.97 123.23 14.75 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.884 1.274 . . . . 0.0 110.655 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.04 154.29 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 -165.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 118' ' ' ILE . 13.8 t80 -152.65 176.67 11.5 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.497 1.919 . . . . 0.0 110.052 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.9 m -149.66 145.5 26.76 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 120.096 1.316 . . . . 0.0 112.344 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.62 156.69 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.168 1.387 . . . . 0.0 113.124 -168.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -123.24 152.29 63.71 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.48 1.912 . . . . 0.0 112.584 178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -93.71 171.01 1.94 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 125.18 3.92 . . . . 0.0 113.733 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.42 162.06 35.41 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.932 1.293 . . . . 0.0 111.333 163.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.4 m -75.57 -17.4 60.06 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.274 1.43 . . . . 0.0 114.187 -173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.9 p -115.91 117.67 30.82 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.975 1.71 . . . . 0.0 106.586 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.597 ' CE3' ' HD3' ' A' ' 76' ' ' LYS . 1.1 m95 -20.27 116.91 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 131.245 3.818 . . . . 0.0 114.4 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -121.31 121.23 37.23 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.611 2.364 . . . . 0.0 110.473 -166.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.0 m -96.34 114.37 26.04 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.924 1.29 . . . . 0.0 112.077 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 118' ' ' ILE . 2.7 mt -114.31 99.69 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 123.01 1.386 . . . . 0.0 111.005 -173.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -79.2 99.77 7.17 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.654 1.581 . . . . 0.0 110.103 174.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 116' ' ' ILE . 0.8 OUTLIER -89.18 119.43 69.73 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 118.871 0.76 . . . . 0.0 109.83 175.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -82.52 164.84 16.41 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.415 2.077 . . . . 0.0 111.163 167.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -81.37 15.24 2.08 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.157 -0.964 . . . . 0.0 113.123 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.3 p -98.31 -34.21 10.77 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.374 1.87 . . . . 0.0 113.223 170.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.0 m -73.3 -14.56 61.33 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -171.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.26 157.79 33.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.415 1.086 . . . . 0.0 111.51 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.83 140.77 49.42 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -80.41 127.6 32.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.494 2.317 . . . . 0.0 111.924 174.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.89 154.39 20.56 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.171 1.789 . . . . 0.0 112.727 169.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.08 -35.87 14.35 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -137.75 -21.19 1.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.264 1.426 . . . . 0.0 113.406 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -71.04 82.5 0.68 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.825 1.25 . . . . 0.0 113.423 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.07 152.13 9.57 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 125.271 1.428 . . . . 0.0 112.041 165.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -61.75 156.97 45.03 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.637 2.224 . . . . 0.0 111.833 171.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -66.37 -11.01 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.94 3.094 . . . . 0.0 113.749 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.69 18.9 12.97 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 126.608 2.051 . . . . 0.0 116.231 169.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.68 161.32 3.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.091 1.756 . . . . 0.0 115.025 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.47 138.7 31.28 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.936 0.874 . . . . 0.0 111.044 158.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -86.61 12.48 10.47 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.6 p -70.24 -12.21 61.43 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 119.659 -1.901 . . . . 0.0 114.785 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 61.57 14.99 45.19 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.836 1.208 . . . . 0.0 114.007 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -150.71 151.99 33.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.335 1.854 . . . . 0.0 109.157 -169.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.3 131.68 37.15 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.933 1.242 . . . . 0.0 111.493 173.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.94 113.68 23.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.634 1.174 . . . . 0.0 110.086 -174.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.15 47.93 1.4 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 122.732 1.253 . . . . 0.0 112.284 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -129.98 -9.38 4.37 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.093 2.557 . . . . 0.0 111.343 170.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -144.78 23.28 1.58 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.96 1.304 . . . . 0.0 113.118 -154.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.5 mm -81.1 136.56 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 120.899 -1.126 . . . . 0.0 111.16 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -100.49 -55.07 2.69 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.412 1.485 . . . . 0.0 112.732 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.4 p -149.9 158.45 44.18 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -168.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.557 HD11 ' CG ' ' A' ' 58' ' ' TYR . 4.0 pt -131.54 140.72 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.468 1.907 . . . . 0.0 108.174 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CE1' HG13 ' A' ' 57' ' ' VAL . 69.3 m-70 -142.49 135.58 28.54 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.961 -1.087 . . . . 0.0 111.879 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.74 120.27 26.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.06 160.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 14.6 mmt -124.05 170.54 10.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.855 2.062 . . . . 0.0 111.533 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -94.09 144.5 25.43 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.646 1.178 . . . . 0.0 113.6 -172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.54 20.14 1.05 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.474 1.91 . . . . 0.0 112.13 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.18 173.59 16.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.406 2.282 . . . . 0.0 110.108 -156.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.06 -13.14 2.14 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.36 149.03 49.87 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.129 0.972 . . . . 0.0 111.926 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -121.26 171.36 8.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.697 1.599 . . . . 0.0 111.768 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 150.24 -156.7 26.86 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.476 0.95 . . . . 0.0 115.476 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -129.75 124.13 32.71 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.679 1.592 . . . . 0.0 112.245 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.31 151.54 42.08 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.923 0.889 . . . . 0.0 112.168 -173.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 59.3 t -123.89 154.75 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.704 1.602 . . . . 0.0 110.679 -169.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.47 149.54 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.369 1.468 . . . . 0.0 109.24 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -142.63 169.06 18.27 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.382 -0.824 . . . . 0.0 111.839 159.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 62.7 65.08 0.85 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 169.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 17.6 mt -80.98 113.17 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 119.569 -1.957 . . . . 0.0 110.549 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -141.83 152.8 44.01 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -174.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.4 136.74 40.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.576 1.55 . . . . 0.0 110.847 172.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 33.6 mm -112.27 120.85 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.133 1.373 . . . . 0.0 111.475 -170.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -99.99 -0.9 56.1 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.226 1.869 . . . . 0.0 115.746 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.12 167.92 9.82 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.103 1.761 . . . . 0.0 113.5 -176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.3 pp -140.06 30.46 2.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.309 1.844 . . . . 0.0 113.613 172.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 127.877 2.471 . . . . 0.0 112.433 -174.087 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmt? . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.58 34.32 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.667 1.587 . . . . 0.0 110.849 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -131.09 9.6 4.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.598 1.159 . . . . 0.0 113.98 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.09 -178.62 5.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.539 1.936 . . . . 0.0 112.088 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.4 t 63.86 -76.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 127.326 2.25 . . . . 0.0 115.034 168.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.29 -51.74 30.86 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.316 0.96 . . . . 0.0 111.59 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -142.3 127.72 18.9 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.342 1.857 . . . . 0.0 109.218 168.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -84.34 116.34 22.97 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.139 -0.976 . . . . 0.0 109.37 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtp -92.32 130.91 37.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 111.823 -173.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.5 mt -108.19 -53.67 2.6 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.717 1.607 . . . . 0.0 113.764 -168.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.657 ' HA ' ' CE2' ' A' ' 13' ' ' PHE 0.342 1.8 t70 -124.99 150.26 46.88 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.966 166.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HA ' ' H ' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -174.94 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.171 2.988 . . . . 0.0 116.887 169.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 11' ' ' ASP . 3.3 p90 -147.13 2.63 0.78 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.062 -1.649 . . . . 0.0 114.924 -148.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 54.94 -55.97 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 129.063 2.945 . . . . 0.0 118.431 161.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 -97.3 0.72 Allowed Glycine 0 N--CA 1.465 0.569 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -161.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.94 -66.15 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 112.657 -1.771 . . . . 0.0 108.981 144.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 19' ' ' TRP . 7.7 tt -150.46 97.4 2.52 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.773 2.429 . . . . 0.0 109.861 165.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.81 28.67 0.41 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.451 ' H ' HD23 ' A' ' 17' ' ' LEU . 9.4 m0 -112.97 179.56 3.93 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.365 1.866 . . . . 0.0 109.566 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.82 44.58 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-O 118.131 -1.372 . . . . 0.0 110.235 164.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.55 137.64 20.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.297 1.548 . . . . 0.0 110.936 166.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.63 156.08 37.26 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.944 1.354 . . . . 0.0 114.483 -176.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.5 p -141.49 113.72 8.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.119 -1.855 . . . . 0.0 108.47 153.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 53' ' ' TYR . . . -84.59 -26.65 38.08 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.683 -0.636 . . . . 0.0 114.23 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -152.34 128.89 10.72 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.845 2.458 . . . . 0.0 107.133 175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.59 -28.63 0.48 Allowed Glycine 0 CA--C 1.533 1.204 0 C-N-CA 128.753 3.073 . . . . 0.0 116.93 159.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.78 175.18 8.23 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.482 1.113 . . . . 0.0 110.609 168.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -150.83 83.94 1.34 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.498 -0.751 . . . . 0.0 112.797 -170.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.68 148.86 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.232 1.413 . . . . 0.0 112.341 176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.0 m -164.7 140.15 5.64 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.251 1.82 . . . . 0.0 110.217 170.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.2 p -118.1 139.13 51.68 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.627 1.571 . . . . 0.0 112.684 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.78 29.81 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.076 1.351 . . . . 0.0 112.925 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.7 mt -96.36 140.86 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.386 1.475 . . . . 0.0 109.582 167.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.4 m -139.42 -176.71 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.43 1.892 . . . . 0.0 110.978 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -73.55 139.78 45.86 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.73 -1.231 . . . . 0.0 111.861 162.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.79 -171.29 12.71 Favored Glycine 0 N--CA 1.477 1.373 0 C-N-CA 125.9 1.714 . . . . 0.0 113.574 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -79.84 -22.27 43.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.5 p -113.31 93.52 4.44 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.067 1.347 . . . . 0.0 108.942 159.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.35 -100.41 0.22 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.77 0.714 . . . . 0.0 114.156 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -78.7 167.38 21.3 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.942 1.297 . . . . 0.0 111.898 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.61 156.88 26.49 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 127.702 2.572 . . . . 0.0 111.004 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.5 ttp -106.11 104.96 14.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.335 1.054 . . . . 0.0 110.367 -168.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -98.63 138.93 35.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.478 1.035 . . . . 0.0 111.867 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.98 142.32 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.015 0.912 . . . . 0.0 112.138 170.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.2 t -124.61 139.8 53.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.328 1.851 . . . . 0.0 112.181 -167.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 26.4 m-85 -137.15 137.36 39.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.1 m -81.38 126.34 31.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 127.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -114.31 138.71 15.07 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 120.922 1.692 . . . . 0.0 111.372 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -118.16 166.88 12.04 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -154.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.6 p -83.37 -26.69 30.26 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -130.48 28.89 4.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.209 1.004 . . . . 0.0 113.69 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.0 -144.95 4.51 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 121.542 -0.724 . . . . 0.0 113.993 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 24' ' ' GLY . 46.2 p90 -165.83 141.03 4.84 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.81 1.244 . . . . 0.0 110.776 -170.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -141.77 154.52 45.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.427 1.091 . . . . 0.0 112.47 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.49 164.86 35.88 Favored Glycine 0 CA--C 1.528 0.865 0 O-C-N 121.993 -0.442 . . . . 0.0 114.037 -170.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t -160.27 127.6 4.47 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.051 1.34 . . . . 0.0 109.021 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -139.94 131.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.977 -147.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -111.68 127.6 55.82 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.812 0.845 . . . . 0.0 109.721 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.5 t -95.67 133.3 39.9 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.535 0.734 . . . . 0.0 109.469 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -98.59 113.61 64.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.128 1.371 . . . . 0.0 111.151 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -66.23 -29.16 47.24 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.473 2.782 . . . . 0.0 114.506 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -127.35 57.35 1.5 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.201 1.8 . . . . 0.0 110.531 -170.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -73.41 37.03 0.82 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.826 1.679 . . . . 0.0 115.67 -170.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -120.74 105.25 10.57 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.368 1.867 . . . . 0.0 110.68 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -117.57 4.01 12.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.617 1.967 . . . . 0.0 113.858 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.1 p -53.0 -13.79 0.49 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 116.701 2.112 . . . . 0.0 116.701 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -78.44 -19.37 53.32 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.881 1.672 . . . . 0.0 113.838 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -106.17 170.27 8.01 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.945 1.698 . . . . 0.0 113.636 -165.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.8 tp -122.3 -32.03 3.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -164.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -146.55 171.77 14.57 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.023 1.729 . . . . 0.0 111.232 169.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.9 tt -107.32 165.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.457 1.503 . . . . 0.0 110.088 157.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.0 m -145.59 152.0 38.99 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.465 -1.397 . . . . 0.0 110.756 159.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -142.1 163.39 33.01 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.179 0.992 . . . . 0.0 112.358 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -100.73 138.15 38.17 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.871 0.869 . . . . 0.0 110.844 170.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 tt -145.59 153.32 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.811 1.244 . . . . 0.0 112.637 176.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HE2' ' NE1' ' A' ' 113' ' ' TRP . 44.4 pttt -145.25 168.35 20.63 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 149.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.3 t -77.1 130.68 37.69 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.749 1.62 . . . . 0.0 107.867 156.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . 0.292 12.0 p -123.57 0.53 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.451 1.101 . . . . 0.0 112.201 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -169.36 132.01 1.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.674 2.39 . . . . 0.0 108.803 146.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.91 107.93 0.84 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.377 0.99 . . . . 0.0 112.125 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -51.98 139.25 23.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.492 1.117 . . . . 0.0 112.728 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.4 80.35 1.51 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.624 1.57 . . . . 0.0 110.841 -167.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -55.1 148.11 14.67 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.293 1.037 . . . . 0.0 112.788 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -29.55 115.0 0.1 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.473 2.309 . . . . 0.0 115.078 -161.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.2 pt -103.16 163.32 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.842 1.657 . . . . 0.0 111.178 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -117.07 145.65 43.61 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.016 0.926 . . . . 0.0 112.261 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -115.82 153.65 31.1 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 127.24 2.216 . . . . 0.0 110.789 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 25.8 ttt -144.03 144.49 31.67 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.915 1.286 . . . . 0.0 111.764 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.9 mt -124.81 138.25 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.57 1.948 . . . . 0.0 108.358 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.3 136.46 47.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.438 1.495 . . . . 0.0 110.842 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -96.31 171.86 8.32 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.934 1.694 . . . . 0.0 110.739 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -81.0 159.2 24.91 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.11 -1.619 . . . . 0.0 112.355 172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 t -107.23 152.49 24.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 112.38 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.7 pt -81.59 -4.24 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.447 -0.783 . . . . 0.0 112.701 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -96.44 -8.76 31.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.429 1.492 . . . . 0.0 112.607 161.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.05 44.4 Favored Glycine 0 CA--C 1.539 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 114.311 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.06 141.57 45.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 127.922 2.489 . . . . 0.0 109.011 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.27 -140.68 15.78 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.437 1.494 . . . . 0.0 113.355 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -131.91 4.26 4.14 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -170.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.99 -77.11 0.23 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.498 1.523 . . . . 0.0 113.737 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -155.57 132.04 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.0 109.473 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -90.64 123.58 34.37 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -129.13 133.67 47.73 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.627 1.571 . . . . 0.0 110.731 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.04 160.06 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.64 1.176 . . . . 0.0 113.527 -163.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -155.85 168.96 25.55 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.434 1.494 . . . . 0.0 112.101 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 m -131.51 135.35 47.0 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.011 1.724 . . . . 0.0 112.363 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.87 162.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.541 1.537 . . . . 0.0 113.629 -176.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 p -114.44 134.4 22.31 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 125.114 1.365 . . . . 0.0 112.88 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -91.42 -162.7 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 125.033 3.822 . . . . 0.0 110.804 164.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -146.16 -179.07 6.48 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.674 1.59 . . . . 0.0 109.716 164.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 p -82.44 -10.7 58.93 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.372 1.869 . . . . 0.0 113.993 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 91.5 p -93.47 147.14 23.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.217 1.007 . . . . 0.0 110.125 157.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.406 ' NE1' ' HE2' ' A' ' 76' ' ' LYS . 64.7 m95 -55.21 128.59 34.64 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.487 -0.758 . . . . 0.0 111.702 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -121.12 125.51 47.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.515 1.526 . . . . 0.0 109.552 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m -83.11 113.36 20.57 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 165.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.3 97.65 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.171 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -77.17 124.76 28.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.652 1.181 . . . . 0.0 109.813 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.2 mt -135.87 133.25 19.79 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 123.706 0.802 . . . . 0.0 111.036 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -87.41 162.02 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.84 2.36 . . . . 0.0 112.015 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -51.97 -29.02 18.81 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.207 -0.933 . . . . 0.0 113.476 164.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.4 m -71.34 -21.37 62.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.271 1.028 . . . . 0.0 113.496 -170.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.3 m -90.58 -10.4 43.53 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 114.16 1.171 . . . . 0.0 114.16 -176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -82.33 140.21 33.68 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.127 -0.983 . . . . 0.0 111.541 171.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.52 162.72 34.67 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -175.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -79.18 129.96 34.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.168 1.387 . . . . 0.0 112.046 -167.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -87.33 91.57 8.77 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.052 0.842 . . . . 0.0 108.947 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 127' ' ' LEU . 1.2 pt? -101.81 1.66 37.41 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 -149.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -104.54 -16.77 14.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.709 1.203 . . . . 0.0 112.312 160.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -113.91 103.52 11.26 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.913 1.233 . . . . 0.0 111.656 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -134.51 162.01 60.26 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 124.457 1.103 . . . . 0.0 111.575 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.61 159.51 19.25 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.564 2.176 . . . . 0.0 112.905 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.91 -21.66 8.07 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.8 3.0 . . . . 0.0 112.995 170.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -101.58 92.4 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.883 1.706 . . . . 0.0 110.266 164.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.81 169.87 11.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -162.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -43.44 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.704 2.802 . . . . 0.0 109.505 157.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 26.6 ptt? 42.37 36.4 0.75 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.789 2.036 . . . . 0.0 115.317 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 87.2 p -72.23 -8.38 54.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.57 -13.75 54.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.863 1.22 . . . . 0.0 113.552 -175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.2 m -136.77 142.01 42.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.985 1.314 . . . . 0.0 111.888 -172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.05 127.73 33.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.734 1.614 . . . . 0.0 111.773 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -111.98 86.31 2.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.183 0.593 . . . . 0.0 111.936 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.13 26.98 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.567 1.547 . . . . 0.0 112.531 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -113.35 -8.52 13.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.454 2.302 . . . . 0.0 111.411 163.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.08 44.82 1.56 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.556 1.942 . . . . 0.0 112.365 -166.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.5 mm -85.51 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.731 -1.23 . . . . 0.0 111.435 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -95.22 -58.43 2.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.176 1.391 . . . . 0.0 112.293 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 66.4 p -161.99 166.85 25.46 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.291 1.036 . . . . 0.0 112.895 -171.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 29.6 pt -127.57 145.52 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.255 1.422 . . . . 0.0 112.182 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -140.47 145.1 36.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.137 1.775 . . . . 0.0 111.147 -163.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -83.36 146.61 28.38 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.93 0.892 . . . . 0.0 111.125 164.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 42.5 mtm -124.57 131.89 53.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.175 0.99 . . . . 0.0 112.659 169.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -72.09 142.73 49.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.624 1.169 . . . . 0.0 111.377 166.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.11 -3.1 1.6 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.987 1.715 . . . . 0.0 113.194 171.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -155.72 149.13 24.84 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.002 1.721 . . . . 0.0 110.1 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -98.02 41.37 1.13 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.68 1.592 . . . . 0.0 112.277 -161.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -82.58 161.55 22.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.755 1.222 . . . . 0.0 112.573 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 56.1 m -121.68 146.17 47.28 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.008 1.723 . . . . 0.0 111.105 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 164.98 -164.96 37.39 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.254 0.93 . . . . 0.0 113.289 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -132.21 141.58 49.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.159 1.783 . . . . 0.0 112.123 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -133.63 161.66 34.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.184 0.994 . . . . 0.0 112.334 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 p -146.49 140.79 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.891 0.876 . . . . 0.0 112.109 -170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 92.1 t -133.53 157.32 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 126.0 1.72 . . . . 0.0 112.252 -172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -161.7 165.53 28.0 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 126.645 1.978 . . . . 0.0 110.474 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.55 ' H ' ' HA ' ' A' ' 12' ' ' ASP . 5.3 t-20 69.57 33.24 3.11 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 122.669 2.486 . . . . 0.0 115.446 141.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.3 mt -75.0 130.35 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.419 1.488 . . . . 0.0 109.278 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.82 145.43 31.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.373 0.988 . . . . 0.0 113.559 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.94 137.34 37.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.656 1.183 . . . . 0.0 109.944 162.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.0 mm -121.28 141.17 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.112 1.765 . . . . 0.0 110.308 -170.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.15 -7.17 0.23 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.903 1.239 . . . . 0.0 115.798 -178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.27 149.45 24.55 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.098 1.449 . . . . 0.0 112.482 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 38.0 tp -103.19 55.21 0.75 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.182 1.793 . . . . 0.0 109.607 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 C--O 1.251 1.137 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -150.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.43 170.04 15.11 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -170.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 m -72.69 164.43 26.52 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.233 1.413 . . . . 0.0 113.047 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.46 -32.43 10.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 113.296 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.4 123.68 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.274 1.03 . . . . 0.0 111.994 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.72 -5.71 61.21 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.736 1.636 . . . . 0.0 116.059 -169.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.88 143.77 46.65 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.661 1.584 . . . . 0.0 111.97 172.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -122.85 141.69 51.59 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.399 1.08 . . . . 0.0 112.501 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.7 mtt -96.11 143.71 27.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.998 0.919 . . . . 0.0 113.228 -164.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.34 -46.99 2.67 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.384 1.874 . . . . 0.0 110.516 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.532 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 8.0 t0 -113.98 134.17 55.01 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.498 162.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.601 ' H ' ' HB3' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -145.38 -24.71 0.48 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.811 2.045 . . . . 0.0 112.036 161.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.601 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -167.79 -13.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 2 C-N-CA 134.155 4.982 . . . . 0.0 113.678 -61.294 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.38 -22.27 61.16 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -148.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 50.66 17.38 2.04 Favored Glycine 0 CA--C 1.545 1.936 0 N-CA-C 115.174 0.83 . . . . 0.0 115.174 -158.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.6 t 50.49 116.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 130.17 3.388 . . . . 0.0 115.302 -166.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.2 tp -151.19 157.42 42.63 Favored 'General case' 0 N--CA 1.479 1.009 1 C-N-CA 134.48 5.112 . . . . 0.0 110.474 -11.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -113.58 -6.46 13.39 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -85.69 137.23 32.97 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.638 1.175 . . . . 0.0 112.633 -170.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 152.13 40.31 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.292 1.425 . . . . 0.0 113.336 173.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -152.02 151.25 30.91 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.799 1.299 . . . . 0.0 111.614 169.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -165.42 154.4 12.1 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -151.52 146.81 26.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.931 1.292 . . . . 0.0 111.765 156.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.48 -4.75 2.14 Favored Glycine 0 N--CA 1.474 1.196 0 N-CA-C 116.934 1.534 . . . . 0.0 116.934 -169.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -151.84 116.53 5.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.337 1.855 . . . . 0.0 108.802 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.66 -4.78 2.75 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 127.133 2.301 . . . . 0.0 117.552 164.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.01 169.5 8.68 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.44 1.496 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -141.52 78.57 1.64 Allowed 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -163.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.79 146.74 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.069 0.948 . . . . 0.0 113.514 175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.8 t -159.46 146.72 16.96 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 128.383 2.673 . . . . 0.0 109.236 168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.5 p -140.66 130.61 24.59 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.934 1.293 . . . . 0.0 113.257 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.93 169.45 21.71 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 171.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 53.6 mt -76.26 150.0 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.579 1.551 . . . . 0.0 112.109 -167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.5 m -137.75 170.01 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 126.206 1.802 . . . . 0.0 110.819 167.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.4 m -85.42 113.2 21.53 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.364 -1.46 . . . . 0.0 110.697 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.75 174.44 44.49 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.604 1.097 . . . . 0.0 114.546 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -62.91 -34.73 78.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.836 0.855 . . . . 0.0 112.719 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -117.47 102.86 9.55 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.199 1.4 . . . . 0.0 107.465 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.35 -112.04 3.35 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.705 1.622 . . . . 0.0 112.942 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -110.67 158.0 19.1 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.882 2.073 . . . . 0.0 110.984 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.48 -178.45 15.44 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 126.353 1.93 . . . . 0.0 110.972 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.8 tpt -130.05 137.95 50.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.682 0.793 . . . . 0.0 110.264 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -87.33 142.46 27.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 109.938 162.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 138.38 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.904 1.282 . . . . 0.0 110.153 162.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -126.98 137.6 53.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.61 1.564 . . . . 0.0 112.148 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 54' ' ' TRP . 28.4 m-85 -139.06 139.12 37.68 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.3 m -84.52 127.12 33.87 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.624 131.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.69 163.56 19.64 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.754 1.168 . . . . 0.0 111.621 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 52' ' ' GLY . 14.1 t -128.66 174.89 9.02 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.707 1.254 . . . . 0.0 114.123 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.9 p -71.31 -40.96 70.49 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.274 1.83 . . . . 0.0 114.966 -175.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -140.82 9.25 2.16 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.07 1.348 . . . . 0.0 113.936 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' H ' HG23 ' A' ' 49' ' ' THR . . . -87.31 -134.64 4.27 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.194 1.378 . . . . 0.0 114.361 -176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -166.53 134.84 2.82 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.362 1.865 . . . . 0.0 111.929 174.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.8 -176.9 48.27 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 116.449 1.34 . . . . 0.0 116.449 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -161.0 147.81 15.1 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.415 1.486 . . . . 0.0 111.215 -171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.7 t -135.41 150.61 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -164.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -143.99 134.09 24.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.047 1.339 . . . . 0.0 111.182 171.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.987 1.315 . . . . 0.0 110.159 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.11 146.74 36.99 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -162.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -60.98 -35.75 86.2 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.756 2.971 . . . . 0.0 114.082 167.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -127.21 133.4 50.26 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.656 1.182 . . . . 0.0 111.481 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.63 0.31 29.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.495 1.521 . . . . 0.0 115.131 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.72 124.01 46.28 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.865 1.266 . . . . 0.0 111.783 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CZ3' HD12 ' A' ' 142' ' ' LEU . 0.1 OUTLIER -137.4 5.03 2.69 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -171.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -65.57 -3.58 4.75 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -167.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -107.66 6.69 28.02 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.426 1.89 . . . . 0.0 114.192 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -107.66 154.88 20.81 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.493 1.517 . . . . 0.0 110.677 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.55 -36.34 18.97 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -156.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -158.35 168.02 28.13 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.477 2.311 . . . . 0.0 109.552 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.0 tt -87.98 158.07 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 121.1 0.476 . . . . 0.0 110.015 156.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.9 p -148.0 146.22 28.83 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 122.982 0.513 . . . . 0.0 111.5 161.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.27 158.14 43.91 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.206 1.003 . . . . 0.0 111.904 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.91 118.33 36.73 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -175.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.78 134.28 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 121.607 -0.683 . . . . 0.0 111.952 -167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 173.0 17.35 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.657 1.183 . . . . 0.0 112.352 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.7 t -78.34 153.07 31.99 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.008 1.723 . . . . 0.0 110.94 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.45 22.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.226 1.81 . . . . 0.0 110.838 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -146.68 -179.36 6.73 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 129.351 3.06 . . . . 0.0 108.179 168.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.92 -4.32 33.7 Favored Glycine 0 CA--C 1.54 1.605 0 O-C-N 120.026 -1.671 . . . . 0.0 115.813 178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 p -56.38 143.28 35.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.519 1.928 . . . . 0.0 114.829 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.68 -7.86 0.12 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.547 2.054 . . . . 0.0 116.547 -167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -75.61 165.35 25.22 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.893 0.877 . . . . 0.0 112.83 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.7 143.93 57.44 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.883 1.273 . . . . 0.0 113.854 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.7 pt -129.13 168.41 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.069 2.148 . . . . 0.0 109.962 172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -113.51 141.25 47.36 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.257 0.623 . . . . 0.0 110.934 168.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -95.22 153.52 17.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 152.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.9 ttm -135.8 146.2 47.3 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.142 0.977 . . . . 0.0 109.264 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.6 mt -116.51 135.26 57.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.725 1.21 . . . . 0.0 108.641 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.74 112.89 26.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.334 1.854 . . . . 0.0 109.291 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.42 170.1 15.8 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.256 1.422 . . . . 0.0 111.157 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -77.15 138.54 39.55 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.871 -1.768 . . . . 0.0 110.457 167.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.8 t -77.85 150.58 34.18 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.196 0.999 . . . . 0.0 110.965 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.0 pt -82.42 -13.6 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.573 -0.705 . . . . 0.0 112.419 173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -97.09 -8.23 30.77 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.822 1.649 . . . . 0.0 112.796 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.3 8.02 81.96 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.407 1.479 . . . . 0.0 115.66 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.2 p -95.97 133.09 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 118.467 1.134 . . . . 0.0 112.499 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.69 7.42 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.228 0.918 . . . . 0.0 115.381 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -125.53 7.73 7.64 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -152.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.75 -85.05 0.2 Allowed Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.366 1.936 . . . . 0.0 115.615 167.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -145.96 125.81 13.53 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.283 1.833 . . . . 0.0 106.885 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -85.39 120.42 26.84 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.972 0.806 . . . . 0.0 113.053 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -120.58 132.38 55.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.121 1.368 . . . . 0.0 111.51 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.76 128.82 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 -156.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -93.41 162.04 14.14 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 129.169 2.987 . . . . 0.0 111.665 173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 66.7 m -140.32 119.56 12.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.354 1.062 . . . . 0.0 110.74 160.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 160.89 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 125.759 1.624 . . . . 0.0 112.306 -165.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.4 p -120.44 147.24 44.86 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 125.145 1.378 . . . . 0.0 113.349 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -88.8 149.99 6.0 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.6 2.867 . . . . 0.0 114.463 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.78 171.89 7.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.897 2.079 . . . . 0.0 111.597 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 62.9 p -79.47 -18.88 51.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.6 p -141.25 157.62 44.99 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -163.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -51.09 128.96 23.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.4 1.48 . . . . 0.0 113.21 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -162.84 114.9 1.56 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.38 2.272 . . . . 0.0 108.629 -165.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -89.21 99.86 12.76 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.092 0.86 . . . . 0.0 109.039 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.6 mm -79.11 97.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 C-N-CA 125.504 1.522 . . . . 0.0 108.568 -171.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -76.07 128.29 34.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.946 0.879 . . . . 0.0 111.287 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -140.0 133.08 15.1 Favored Pre-proline 0 N--CA 1.474 0.772 0 C-N-CA 124.285 1.034 . . . . 0.0 109.803 176.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -75.82 169.44 22.21 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.483 2.122 . . . . 0.0 111.952 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -77.17 8.31 4.13 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.8 p -101.57 -12.03 18.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.701 2.0 . . . . 0.0 113.737 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 m -80.89 10.9 4.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 -170.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -155.03 160.97 41.45 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.838 -1.164 . . . . 0.0 113.98 -168.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 162.89 16.38 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.569 1.548 . . . . 0.0 112.022 -156.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -87.0 140.42 29.58 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.045 1.293 . . . . 0.0 112.134 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -101.95 140.58 36.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 157.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.43 5.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -71.78 -11.12 60.66 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 120.55 -1.344 . . . . 0.0 112.14 164.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.32 136.22 31.32 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.217 3.407 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -155.94 172.31 6.2 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -170.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.81 164.29 16.68 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.999 3.133 . . . . 0.0 112.914 163.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.38 -27.28 16.26 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.255 2.637 . . . . 0.0 113.691 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -134.87 104.26 0.5 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.97 1.748 . . . . 0.0 109.839 172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.404 ' H ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -104.56 162.5 13.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.87 136.17 33.4 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 149.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 27.4 ttt -130.62 56.03 1.79 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 109.013 172.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 64.5 p -84.24 -16.96 41.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.52 -2.22 79.03 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.822 0.725 . . . . 0.0 113.865 -175.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.4 p -133.47 142.27 48.19 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.863 1.665 . . . . 0.0 112.264 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.9 tp -70.86 116.7 11.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.933 1.293 . . . . 0.0 108.213 166.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -103.55 89.33 3.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.38 1.072 . . . . 0.0 111.835 -168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.446 HD12 ' CZ3' ' A' ' 65' ' ' TRP . 0.7 OUTLIER -77.35 26.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.646 1.178 . . . . 0.0 113.786 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -105.39 -2.91 23.26 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.692 0.797 . . . . 0.0 112.819 155.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -149.54 44.11 0.93 Allowed 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -155.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 38.0 mm -98.56 147.53 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 124.858 1.263 . . . . 0.0 112.813 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -105.68 -48.84 3.55 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.399 1.08 . . . . 0.0 113.687 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.6 p -160.44 166.44 29.23 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.48 156.31 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.77 1.628 . . . . 0.0 111.712 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.475 ' CE1' HG13 ' A' ' 57' ' ' VAL . 90.6 m-70 -143.19 150.0 38.77 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.913 1.685 . . . . 0.0 111.081 -165.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -120.79 131.3 54.4 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.353 1.861 . . . . 0.0 109.552 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 69.3 mtp -144.55 161.93 37.85 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -64.97 133.67 52.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.454 2.301 . . . . 0.0 113.846 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.11 8.17 3.73 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.034 1.334 . . . . 0.0 112.595 161.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -148.34 168.18 23.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.338 2.255 . . . . 0.0 109.436 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -117.3 5.07 12.59 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.905 1.282 . . . . 0.0 113.156 -171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -78.62 164.16 24.88 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.751 1.62 . . . . 0.0 111.987 173.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 57.9 m -67.23 173.67 3.72 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.126 1.771 . . . . 0.0 112.833 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 170.54 164.34 26.1 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.815 0.721 . . . . 0.0 113.573 168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -129.07 139.04 52.18 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.324 1.05 . . . . 0.0 110.236 169.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -139.09 153.98 48.1 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.885 0.874 . . . . 0.0 112.624 -165.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -138.84 134.71 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.489 1.516 . . . . 0.0 111.633 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.72 145.24 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.311 1.444 . . . . 0.0 111.68 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -157.38 175.16 14.35 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.34 1.056 . . . . 0.0 108.98 178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t30 67.83 46.99 1.18 Allowed 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 149.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -73.7 115.45 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.786 0.835 . . . . 0.0 109.375 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -133.0 137.33 46.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.496 1.518 . . . . 0.0 112.496 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 83.4 mt -80.44 139.38 36.48 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.01 1.324 . . . . 0.0 110.187 174.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.1 mm -76.91 124.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 123.905 0.882 . . . . 0.0 110.643 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.75 -43.7 14.12 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.432 1.491 . . . . 0.0 113.526 -176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -144.38 146.83 32.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.226 2.21 . . . . 0.0 110.546 172.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.25 68.04 4.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.868 2.067 . . . . 0.0 109.269 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.255 1.366 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -147.19 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 120.621 0.248 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 155.45 18.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.257 1.023 . . . . 0.0 113.742 -167.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.9 m -65.93 124.26 22.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.312 1.045 . . . . 0.0 110.937 171.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.92 135.41 38.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 117.926 0.33 . . . . 0.0 111.331 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.32 169.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.435 1.494 . . . . 0.0 112.072 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.98 75.94 1.07 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.683 0.658 . . . . 0.0 111.968 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.18 155.85 22.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.036 1.335 . . . . 0.0 113.609 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -132.67 144.7 50.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.728 2.011 . . . . 0.0 110.921 168.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 31.6 tpp -84.42 134.28 34.47 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.149 0.58 . . . . 0.0 111.334 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.7 tp -98.43 -57.49 2.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.401 1.481 . . . . 0.0 111.438 -177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -151.22 133.54 15.37 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.717 1.607 . . . . 0.0 109.181 162.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -126.36 14.02 7.69 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 112.339 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 66.66 17.37 10.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.736 2.414 . . . . 0.0 115.56 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -85.76 21.58 1.85 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.126 1.77 . . . . 0.0 114.722 -168.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.92 -153.89 7.55 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.959 1.266 . . . . 0.0 113.128 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.6 t -77.72 130.73 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.404 1.082 . . . . 0.0 110.572 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 155.64 18.61 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -163.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -133.15 19.24 4.06 Favored 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -83.89 151.01 25.34 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.982 -1.074 . . . . 0.0 113.335 -173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.02 149.13 20.62 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 125.637 1.589 . . . . 0.0 112.272 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -146.76 145.4 29.93 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.907 1.283 . . . . 0.0 108.719 165.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -162.21 150.88 15.07 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.726 0.81 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.3 p -164.39 121.19 1.61 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.381 1.072 . . . . 0.0 110.978 167.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.3 -11.94 8.53 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 117.128 1.611 . . . . 0.0 117.128 -161.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -131.03 86.55 2.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.607 1.163 . . . . 0.0 109.342 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.82 -18.1 0.48 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 127.587 2.518 . . . . 0.0 117.385 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.52 159.12 29.55 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.172 1.486 . . . . 0.0 111.308 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -151.7 88.61 1.42 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.725 0.81 . . . . 0.0 112.1 -170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.16 156.92 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 0.0 112.568 172.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.5 m -161.55 134.72 6.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.413 1.885 . . . . 0.0 111.221 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.7 p -114.16 140.41 48.54 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.469 1.907 . . . . 0.0 112.072 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 159.22 42.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.266 1.026 . . . . 0.0 112.543 175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.7 mm -94.49 129.03 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.527 1.131 . . . . 0.0 111.007 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.87 -168.18 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.534 1.534 . . . . 0.0 112.062 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.1 m -75.29 143.56 42.92 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.505 -1.372 . . . . 0.0 112.586 168.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.8 -177.25 14.78 Favored Glycine 0 N--CA 1.476 1.329 0 C-N-CA 124.846 1.213 . . . . 0.0 115.238 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -70.62 -27.31 63.97 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.182 1.393 . . . . 0.0 112.238 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 t -144.04 128.92 18.42 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.034 0.534 . . . . 0.0 109.84 166.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.53 -130.93 51.73 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.809 -0.557 . . . . 0.0 112.381 -166.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -95.42 170.15 9.56 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.056 1.342 . . . . 0.0 110.625 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.01 -175.1 14.14 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.393 2.425 . . . . 0.0 111.843 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.9 ttp -132.54 134.97 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.479 1.111 . . . . 0.0 110.969 168.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -110.67 155.75 21.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.574 1.149 . . . . 0.0 113.287 172.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.65 145.43 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.824 1.65 . . . . 0.0 110.334 170.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.6 t -129.68 144.89 51.49 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.341 1.857 . . . . 0.0 109.048 167.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.508 ' CE2' ' CD1' ' A' ' 54' ' ' TRP . 1.9 p90 -149.47 150.8 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 164.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.2 m -91.41 136.96 32.74 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.474 1.509 . . . . 0.0 107.792 149.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -119.2 -176.5 16.3 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 119.817 1.19 . . . . 0.0 114.828 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.6 p -140.32 160.93 38.89 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 57.2 p -77.01 -32.9 57.47 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -136.94 9.92 3.06 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.026 1.33 . . . . 0.0 112.924 -174.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.82 -141.53 5.4 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.166 0.889 . . . . 0.0 112.783 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -166.73 146.58 5.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.316 1.446 . . . . 0.0 110.176 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.508 ' CD1' ' CE2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -157.12 143.45 18.04 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.885 1.274 . . . . 0.0 109.427 -179.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.5 172.02 40.91 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 -167.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 t -156.0 141.07 17.36 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.409 1.484 . . . . 0.0 111.047 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 149' ' ' HIS . 40.3 t -136.97 153.05 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -160.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -140.65 129.23 22.78 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.373 -0.83 . . . . 0.0 112.217 168.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.8 t -100.21 123.59 44.63 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.782 1.633 . . . . 0.0 109.399 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 mp -86.03 146.21 42.54 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 -160.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -81.92 -11.52 11.21 Favored 'Trans proline' 0 C--N 1.353 0.789 1 C-N-CA 125.326 4.017 . . . . 0.0 113.978 169.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -146.38 130.97 17.81 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.166 1.787 . . . . 0.0 111.344 161.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.6 50.75 0.81 Allowed Glycine 0 N--CA 1.47 0.913 0 C-N-CA 126.052 1.787 . . . . 0.0 111.159 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -146.29 48.98 1.19 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.996 1.719 . . . . 0.0 110.468 -165.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -93.51 1.37 56.79 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 119.345 -2.097 . . . . 0.0 115.026 -149.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -56.35 -19.6 15.32 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 -162.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -94.77 5.74 50.99 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.17 1.388 . . . . 0.0 114.615 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -93.73 -156.48 0.49 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.234 1.414 . . . . 0.0 109.64 163.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -39.21 0.37 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.313 1.415 . . . . 0.0 114.752 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.686 ' HA ' ' H ' ' A' ' 120' ' ' PHE . 77.6 mttt -145.21 174.57 10.97 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.565 1.53 . . . . 0.0 113.868 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.2 tt -107.72 171.63 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.461 1.504 . . . . 0.0 110.037 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.27 161.65 42.15 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.727 -1.233 . . . . 0.0 113.14 152.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.79 158.72 38.6 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.511 1.125 . . . . 0.0 113.811 169.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.28 88.55 6.93 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.048 0.939 . . . . 0.0 111.119 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.0 tt -121.78 134.94 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.326 -1.484 . . . . 0.0 113.455 -164.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.857 ' HE3' ' CE3' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -169.57 169.58 8.65 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.536 1.534 . . . . 0.0 114.089 175.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -64.26 155.1 33.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.1 2.56 . . . . 0.0 111.723 160.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.87 -12.77 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 159.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -112.18 -5.62 14.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.306 1.442 . . . . 0.0 114.056 -162.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.21 34.65 57.85 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.546 1.069 . . . . 0.0 113.72 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -76.83 137.5 39.25 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.444 1.097 . . . . 0.0 113.69 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.57 -7.75 54.17 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.138 1.775 . . . . 0.0 114.342 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -76.64 141.42 41.01 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.144 1.778 . . . . 0.0 113.656 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.89 170.24 15.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.927 1.291 . . . . 0.0 112.841 166.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 pt -143.76 -176.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 126.794 2.038 . . . . 0.0 112.057 -174.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -129.85 142.74 50.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.521 -1.362 . . . . 0.0 110.878 163.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.467 ' H ' ' HB2' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -100.91 162.61 12.78 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 159.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 16.1 ttt -148.79 148.51 30.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.249 0.619 . . . . 0.0 112.545 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mm -127.43 139.83 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 127.873 2.469 . . . . 0.0 108.028 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -117.97 126.23 51.93 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.655 -0.653 . . . . 0.0 111.998 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -76.08 152.82 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.255 1.022 . . . . 0.0 111.829 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.24 146.53 52.25 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 113.788 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -57.43 147.45 26.25 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.198 1.799 . . . . 0.0 113.242 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.15 -4.19 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.432 0.693 . . . . 0.0 112.83 165.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -125.66 0.77 7.5 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.22 2.208 . . . . 0.0 113.082 -164.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.34 87.97 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 125.369 1.462 . . . . 0.0 113.893 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.41 139.52 21.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.361 1.465 . . . . 0.0 110.418 -172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.14 -148.58 46.18 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 122.878 0.275 . . . . 0.0 112.58 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -117.55 171.82 7.75 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.206 1.402 . . . . 0.0 112.213 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.16 -38.01 1.43 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.309 1.433 . . . . 0.0 114.507 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -157.65 135.25 10.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.406 1.603 . . . . 0.0 111.962 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -98.36 121.9 40.86 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.146 0.978 . . . . 0.0 112.097 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.82 139.75 51.86 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.026 2.13 . . . . 0.0 111.38 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.66 153.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -167.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.802 ' CD2' HD12 ' A' ' 107' ' ' ILE . 1.8 m-30 -89.88 174.75 7.52 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.419 1.888 . . . . 0.0 110.175 163.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.8 m -151.59 98.19 2.47 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 119.682 -1.886 . . . . 0.0 109.056 155.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.802 HD12 ' CD2' ' A' ' 105' ' ' TYR . 42.6 mt -143.36 162.35 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.244 1.817 . . . . 0.0 111.07 -154.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.2 p -127.8 142.76 45.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 127.095 2.158 . . . . 0.0 112.286 -168.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -91.77 165.97 3.3 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.859 3.039 . . . . 0.0 113.722 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -96.66 -164.59 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.106 1.362 . . . . 0.0 110.618 161.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.4 t -125.49 1.01 7.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.29 2.636 . . . . 0.0 113.171 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.8 p -146.44 128.76 15.82 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.194 2.598 . . . . 0.0 108.241 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.857 ' CE3' ' HE3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -66.58 138.3 57.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -160.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -117.74 151.42 37.32 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 127.504 2.322 . . . . 0.0 107.737 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -89.89 76.0 7.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.855 0.836 . . . . 0.0 108.751 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 mt -72.47 107.35 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.386 1.474 . . . . 0.0 110.567 -163.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.38 112.31 3.97 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.337 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.602 HG22 ' HD2' ' A' ' 119' ' ' PRO . 2.0 mm -88.64 146.54 37.46 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.16 -0.962 . . . . 0.0 109.478 155.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 118' ' ' ILE . 66.1 Cg_endo -71.06 80.09 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.4 2.733 . . . . 0.0 114.299 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.686 ' H ' ' HA ' ' A' ' 70' ' ' LYS . 94.7 m-85 51.93 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 115.799 -2.048 . . . . 0.0 112.823 -135.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.481 ' HA ' ' CG2' ' A' ' 118' ' ' ILE . 1.4 m 169.71 31.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 122.55 2.432 . . . . 0.0 117.452 -154.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.428 ' HB2' ' CG2' ' A' ' 118' ' ' ILE . 2.4 t 66.32 39.08 4.2 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 152.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.27 116.04 7.6 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 118.349 2.722 . . . . 0.0 118.349 -154.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -132.67 157.08 45.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.444 1.098 . . . . 0.0 111.206 155.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -115.88 146.66 41.84 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.689 1.131 . . . . 0.0 113.936 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.2 165.23 3.59 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.644 1.578 . . . . 0.0 110.083 158.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.96 0.64 0.74 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -125.66 -15.35 6.05 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.018 1.327 . . . . 0.0 112.104 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -97.34 85.31 3.63 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.807 -1.183 . . . . 0.0 109.773 161.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -146.12 159.78 44.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.873 0.869 . . . . 0.0 111.013 178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -84.87 172.33 8.89 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.835 3.023 . . . . 0.0 114.829 -169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -80.48 -24.61 5.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.745 2.963 . . . . 0.0 113.66 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.28 42.87 2.82 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.209 1.385 . . . . 0.0 112.867 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 144.38 37.0 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 -161.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.43 123.79 28.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.259 1.824 . . . . 0.0 108.864 157.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.7 tpt -108.48 16.58 22.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.152 0.981 . . . . 0.0 113.482 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 96.0 p -70.95 -18.97 62.61 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -171.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.28 6.4 47.22 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.186 0.898 . . . . 0.0 115.155 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -141.49 157.48 45.09 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.145 1.473 . . . . 0.0 112.32 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.7 OUTLIER -71.63 141.09 49.96 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.424 1.489 . . . . 0.0 111.676 -179.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -124.13 87.3 2.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.101 1.36 . . . . 0.0 109.803 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.7 -13.83 62.63 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 120.695 -1.253 . . . . 0.0 112.639 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.93 -10.51 13.82 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.924 1.69 . . . . 0.0 112.989 168.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -145.92 44.87 1.27 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.076 1.35 . . . . 0.0 114.136 -154.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 36.1 mm -100.7 135.1 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 120.141 -1.6 . . . . 0.0 113.424 -175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -96.78 -52.15 4.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.43 1.892 . . . . 0.0 113.304 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 97.2 p -155.44 162.94 40.65 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.9 pt -117.88 155.33 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.413 1.485 . . . . 0.0 111.605 169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 57' ' ' VAL . 75.5 m-70 -146.71 152.81 39.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.942 1.697 . . . . 0.0 111.85 -165.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -111.73 144.96 40.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 110.375 159.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 44.4 mtt -144.34 156.94 44.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 122.727 1.251 . . . . 0.0 113.933 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -80.53 144.92 32.1 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.889 1.676 . . . . 0.0 115.098 -167.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.02 21.81 3.03 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.223 1.409 . . . . 0.0 111.405 154.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -165.57 143.4 5.87 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.731 2.012 . . . . 0.0 110.049 -160.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER -148.4 7.31 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -175.261 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -52.76 141.15 21.98 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.466 0.575 . . . . 0.0 110.313 146.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.7 m -57.5 132.8 54.24 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.323 1.049 . . . . 0.0 110.713 175.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -147.39 155.08 26.34 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -143.44 126.86 16.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.521 1.529 . . . . 0.0 111.584 -167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -149.43 160.33 43.54 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -169.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.51 ' CG2' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -122.14 153.71 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 126.949 2.1 . . . . 0.0 112.956 174.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.24 146.3 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.462 1.105 . . . . 0.0 111.957 151.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -127.61 -179.29 4.85 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 148.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.12 40.58 1.19 Allowed 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 150.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 24.2 mt -78.14 118.91 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 121.385 -0.822 . . . . 0.0 110.183 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -141.57 155.14 45.78 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.831 1.652 . . . . 0.0 113.062 -170.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 60.0 mt -108.03 144.16 35.74 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.2 1.4 . . . . 0.0 110.108 169.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.7 mm -126.01 136.41 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 109.922 -170.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.22 -174.77 37.55 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.095 1.331 . . . . 0.0 113.228 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -134.0 160.34 38.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.152 0.981 . . . . 0.0 112.035 174.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -142.06 83.15 1.83 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 125.984 1.713 . . . . 0.0 114.013 -172.219 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_